Volume 18, issue 2 by Canadian Medical Association
Western University
Scholarship@Western
Canadian Journal of Surgery
3-1-1975
Volume 18, issue 2
Canadian Medical Association
Follow this and additional works at: https://ir.lib.uwo.ca/cjs
Part of the Surgery Commons
This Book is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Canadian Journal of Surgery by an
authorized administrator of Scholarship@Western. For more information, please contact tadam@uwo.ca, wlswadmin@uwo.ca.
Recommended Citation
Canadian Medical Association, "Volume 18, issue 2" (1975). Canadian Journal of Surgery. 95.
https://ir.lib.uwo.ca/cjs/95
The Canadian Journal of Surgery 
Le journal canadien de chirurgie
V O L U M E  1 8  M A R C H  1 9 7 5  N O.  2
ISSN 0008-428X
LIST OF CONTENTS
APPRECIATION
Frederick Gordon Kergin, 1907-1974.
F. G. Pearson ................................................................. 109
QUILL ON SCALPEL
The International System of Measurement (SI) and Medicine. 
D. A. E. Shephard ..................................................................... 114
REVIEW ARTICLE
Some Aspects of Wound Healing Research: A Review. 
C. Heughen and T. K. Hunt ........................................ 118
Interpreting the Rate of Survival in Carcinoma.
C. Smith ............................................................  129
Fractures of the Medial Humeral Epicondyle in Children.
W. B. Bede, A. R. Lefebvre and M. A. Rosman .....................................  137
Effects and Prevention of Frostbite in Wound Healing.
A. R. C. Butson .......................................................................................................  145
Osteoid Osteoma and Osteoblastoma: Reclassification of 43 Cases Using
Schajowicz’s Classification.
K. S. Morton, P. S. Vassar and W. J. Knickerbocker 148
Vascular Compartment Syndromes.
P. J. Fowler and R. B. Willis....................................................................................... 157
Esophageal Reconstruction: An Experimental Approach to the Control of 
Reflux After Esophageal Resection.
R. D. Henderson, K. Fung, P. Dube and G. Marryatt 165
' Like a Tiffany diamond, in what is often a 
« costume jewellery world, Davis and Geek
Atraumatic Needles are still the synthesis 
* i of quality, sharpness and strength.
•, The range of Davis and Geek needles is
diversified and complete — in size, shape 
and style. What all this means is that 
Davis and Geek Atraumatic® Needles 
are, quite simply, the best needles you
C a n  U Se. ©Registered Trademark.
DAVIS+GECK where progress is born
Cyanamid of Canada Limited, Montreal
March 1975 THE CANADIAN JOURNAL OF SURGERY 103
A
A
P *
V
A
A
► >
A
>-
A
1- * 
> '
A
•<
"I' T
r?
Methylmethacrylate Cement: Its Curing Temperature and Effect on Articular 
Cartilage.
J. Schatzker, ]. G. Horne, G. Sumner-Smith, R. Sanderson and J. P. Murnaghan 172
Pacemaker Infections: A 12-Year Review.
G. G. Lemire, J. E. Morin and A. R. C. Dobell .......................................................  181
Gastrocolic Fistula Complicating Benign Gastric Ulcer: Case Report and 
Review of the Literature.
K. Taguchi and J. G. Beaudoin ...............................................................................  186
La Cholecystite Emphysemateuse: Presentation de Deux Cas Cliniques.
E. Samson, A. Kibrite et P. J. Roy ...........................................................................  192
Glimpses of Surgical History: B for Blood Transfusion.
D. A. E. Shephard ...................................................................................................  164
Book Reviews ........................................................................................................................... 197
Books Received .....................................................................................................................  200
Published every 2 months by The Canadian Medical Association, P.O. Box 8650, Ottawa, 
Ont. K1G 0G8. Printed by Harpell’s Press Co-operative, Gardenvale, Que. HOA 1B0. Postage 
paid in cash at third class mailing rate. Permit No. C2. Return postage guaranteed. All re­
production rights reserved. Subscription rate $15.00 per year ($7.50 per year for trainees 
in surgery).
BLOOD
FLOW
f o r  c lin ic a l 
a p p lic a t io n s  I
• Designed for clinical O.R. 
or cath lab use
• Easily applied handle- 
type probe
• Patient safety assured 
through isolation circuitry
• Simple to operate - 
minimum controls - direct 
meter readout in milliliters 
per minute
Biotronex Laboratory has eliminated 
the guesswork in evaluating the effective­
ness o f an aorto coronary vein bypass.
The B L-603 Clinical Blood Flowmeter 
provides a simple, yet effective method 
of determining graft patency prior to 
surgical closure.
The BL-603 is not a new instrument; 
it is simply an extension of a device 
which has been thoroughly proven in 
hundreds of research applications 
throughout the world. It is depend­
able; designed to highest safety 
standards; simple in operation; precise 
in measurement - a complement to 
modern day cardio-vascular surgery.
Biotronex Laboratory, Inc.
9153 Brookvilie Road Silver Spring, Maryland 20910 Phone: 301/588-6400
* For prophylactic 
security during 
indwelling _ 
catheterization...
Neosporin
Irrigating
Solution
(Sterile)
neomycin sulphate 
polymyxin B sulphate
helps prevent bacteriuria and Gram-negative 
rod bacteremia associated with indwelling 
catheters
wide antibacterial activity against susceptible 
Gram-negative and Gram-positive organisms 
including most strains of Proteus and 
Pseudomonas
low index of allergenicity —  low incidence of 
irritation —  low absorption from mucosa 
recommended in diluted solution for 
continuous bladder irrigation in short-term 
therapy (up to 10 days). NOT FOR INJECTION.
March 1975 THE CANADIAN JOURNAL OF SURGERY 105
The Canadian Journal of Surgery 
Le journal canadien de chirurgie
Co-editors
L. D. M acL ean , Montreal, Que. /  C. B. M ueller, Hamilton, Ont.
Associate Editor 
D. A. E. Shephard
Assistant Editor
G . Pancirov
C .M .A . Publications
C. K. G o o d m an , Business Manager 
N. H utton , Sales Manager R. M. Sin n ott , Production Manager
Editorial Board
R. J. Baird, Toronto, Ont.
J. G. Couture, Quebec, Que.
J. E. Devitt, Ottawa, Ont.
R. C. Harrison, Vancouver, BC 
J.-M. Lessard, Quebec, Que.
J. R. Anderson
R. A. Macbeth, Edmonton, Alta. 
B. M. Mount, Montreal, Que.
H. O. L. Murray, Kamloops, BC 
B. J. Perey, Sherbrooke, Que.
D. R. Wilson, Toronto, Ont. 
(C.M.A. Representative)
Instructions to Contributors
All initial communications should be addressed to the Co-editors, P.O. Box 8650, 
Ottawa, Ont. K1G 0G8 and marked “The Canadian Journal of Surgery”. 
Manuscripts of original articles and other contributions, including a limited number 
of case reports, should be submitted in duplicate with a covering letter requesting 
consideration for publication. Type on one side of plain paper, double spaced with 
wide margins.
Illustrations (e.g. photographs of clinical material, radiographs, photomicrographs, 
graphs and diagrams) must be in the form of glossy, unmounted and untrimmed 
prints, not larger than 5" x 1". A legend must be supplied for each; the legend(s) 
should be typed on a page separate from the text of the article. For a radiograph, 
submit the print rather than the original radiograph; for a photomicrograph, include 
details of the stain and magnification in the legend. Lettering identifying parts 
of the illustration should be large enough to remain visible when the illustration is 
reduced in size for publication. A patient must not be recognizable unless the 
patient’s written consent has been obtained; facial features may require blocking. 
Colour work can be published only at the author’s expense. If an illustration is 
taken from a source other than the author’s, letters of permission from the publisher 
and author for reproduction of the illustration must be obtained.
Tables, the design of which is best considered in regard to the rectangular format 
of the Journal, should be submitted separate from the text, one to a page. 
References should be cited by number in the text, in occurrence, and listed at the 
end of the article according to the style used in this issue of the Journal. In 
general, references to journals should follow the style used in Index Medicus.
An abstract, not exceeding 125 words in length, should accompany each article, on a 
separate page.
Galley proofs will be sent to authors before publication. Minimal alterations only 
in the contents are permitted. Reprints must be ordered when galley proofs are 
returned to the Journal; if ordered later, an extra charge for additional type-setting 
will be made.
Gelfoam
used by a generation of physicians 
in hepatic surgery, hemorrhoidectomy, 
cholecystectomy and decubitus ulcer
still the only absorbable hemostat 
that meets all these criteria:
u absorbed completely in four to six weeks
■ safe as a permanent packing in any tissue; won’t interfere with 
bone regeneration, cause cyst formation or excessive scar tissue
■ effective dry or moistened with thrombin solution, isotonic 
sodium chloride or antibiotic
■ non-irritating, naturally-occurring, neutral pH; may be cut, 
molded, or sutured in place when necessary
■ stimulates natural clotting and healing of disrupted tissue
Upjohn
749 REGISTERED TRADEMARK: GELFOAM, GELFILM CE 7734.1
THE UPJOHN COMPANY OF CANADA 
DON MILLS, ONTARIO
M E M B E R
^ P M A C
1
4
*
I
4
Y
* *
v
4
4
* \  
4
•a
a
N*
r
r
> r
m
 
W
 
* 
£
-4
-
M arch 1975 THE CANADIAN JOURNAL OF SURGERY 109
4
FREDERICK GORDON KERGIN 
1907-1974
i .  Dr. Frederick Gordon Kergin died in Toronto on Dec. 20, 1974, at the age of 67.
The son of Dr. W. T. Kergin, he was born at Port Simpson in British Columbia in January 
> 1907 and enjoyed an active and highly successful career, becoming one of Canada’s most
respected and distinguished doctors. During his life he contributed significantly to med­
ical education, the encouragement of surgical research, and the progress of clinical surgery 
k  * in Canada. All those who knew Dr. Kergin will remember him as an exceedingly bright 
L and perceptive man, a man of unswerving inte grity, who had an exceptional devotion to the 
pursuit of honesty and truth. These qualities were complemented by an intense vitality 
-5 and a sincere enthusiasm for life, both outside and within the bounds of his chosen 
profession of medicine.
Dr. Kergin was an outstanding student and achieved many academic honours 
V  -r throughout his life. After elementary schooling in British Columbia, he attended the Uni- 
versity of Toronto and graduated with high honours from biology and medical sciences in 
1927, and from medicine in 1930. In 1931 he was awarded a Rhodes scholarship and
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spent the next 2 years at Oxford University, obtaining a master’s degree in physiology and 
anatomy, again with first class honours. In 1933 he began a 4-year period of postgradu­
ate training in clinical surgery at the University of Toronto (Gallie course) and in Lon­
don, England. He became a fellow of the Royal College of Surgeons of England in 
1935, and of the Royal College of Physicians and Surgeons of Canada in 1939. He was 
appointed to the surgical staff of the Toronto General Hospital and the teaching staff of 
the University of Toronto in 1937.
His academic career in surgery was interrupted by World War II, during which 
he served with distinction in the Royal Canadian Army Medical Corps. He was one of 
the medical officers who arrived in England in advance of the first Canadian troops in 
1941, and he rose to the rank of lieutenant colonel. After the war he resumed his teach­
ing appointment in the department of surgery at Toronto. He became head of the ward 
“B” service at Toronto General Hospital, and senior surgical consultant at the Toronto 
Hospital for Tuberculosis. This was during the era when the surgical treatment of pul­
monary tuberculosis was at its peak.
In 1957, he was appointed professor and head of the university department of 
surgery at the University of Toronto, and surgeon-in-chief at the Toronto General Hos­
pital. During his next 9 years of leadership as chairman of the department, research ac­
tivity was strongly supported and considerably expanded. Dr. Kergin devoted much atten­
tion to the further development of postgraduate surgical training at the University and 
was responsible for introducing the concept of interhospital coordinating committees in 
the various surgical specialties.
In 1966, Dr. Kergin was appointed associate dean in the faculty of medicine at the 
University of Toronto. In this capacity, he was actively involved in planning changes 
in the medical undergraduate curriculum, and he played a major role in the development 
and conversion of Sunnybrook Hospital to a full-time teaching institution. Beginning in 
1971, Dr. Kergin served as a member of the board of trustees at Sunnybrook Medical 
Centre.
Throughout his career, Dr. Kergin’s great vitality and capacity for work involved him 
with many activities and in many organizations. Thoracic surgery was a special interest 
from the earliest days, and he achieved distinction as one of the pioneers in this 
field in Canada, the United States and Great Britain. Amongst the honours accorded Dr. 
Kergin as a thoracic surgeon were the presidency of the American Association for Tho­
racic Surgery in 1966, and a Hunterian professorship in the Royal College of Surgeons 
of England. In postgraduate education he was active in the affairs of the Canadian 
Royal College and Canadian Medical Association; he was chairman of the editorial 
board of the Canadian Journal of Surgery for many years and a trustee of the R. S. Mc­
Laughlin Foundation.
Dr. Kergin was held in the highest regard by his colleagues and students, to whom 
his personal interest and assistance were a constant stimulus. He is particularly and 
fondly remembered by his many residents, who will continue to meet annually as members 
of the Kergin Surgical Society. I was fortunate to be one such resident, and, like many 
others, will remember Dr. Kergin as a man of outstanding ability and as a friend whose 
efforts profoundly affected our careers in surgery. With his wife, Suzanne, and their son, 
Michael, his many colleagues share both sorrow at his death and pride at a life of 
great accomplishment.
F. G. Pearson 
Toronto General Hospital,
Toronto, Ont.
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Spray before incision. Subsequently, spray as 
each tissue layer is exposed, e g., at the levels 
of the fascia and the  peritoneum. Spray  when 
exposing the hepatic pedicle p rio r to  inc is ion . 
Spray as the gallbladder is ra ised to 
expose the cystic duct and artery  and spray 
each layer as closing.
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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
THE INTERNATIONAL SYSTEM OF MEASUREMENT (SI) AND MEDICINE
By 1980 Canadians will be accustomed 
to thinking in terms of measurement units 
such as kilograms, centimetres and litres 
rather than the customary pounds, inches 
and gallons. Physicians are to some extent 
familiar with the metric system because 
drugs have long been measured in metric 
units and the results of biomedical research 
are usually expressed in the same manner. 
But fewer physicians and even fewer Cana­
dians in general are conversant with the 
essence of the current basis of the metric 
system: Le Systeme International d’Unites, 
or the International System (SI) of Units.
SI is a comprehensive specification for 
units of measurement that is rational and 
coherent, universal in application and in­
terpretation, and applicable to all scientific 
disciplines, including medicine. It is the out­
come of scientists’ efforts to improve the 
metric system, which, over the years, has 
left room for error and misunderstanding 
because of differences in usage in different 
countries and different disciplines. Many 
countries now favour SI as a system of 
measurement; and, in medicine, the logic 
of SI has convinced physicians in Australia 
and Great Britain, for example, to change 
over to SI. But physicians in Canada and 
the United States have not yet seriously con­
sidered SI, even though it offers many ad­
vantages for medicine— and even though 
the introduction of SI into North America 
seems inevitable. What are SI units and 
what are their advantages?
SI units are of two kinds, “base units” 
and “derived units”, which are related in a 
logical mathematic manner. Base units are 
reference units for specific quantities. There 
are seven base units: the metre is the base 
unit for length; the kilogram the base unit 
for mass; the second, for time; the mole, 
for amount of substance; the kelvin, for
thermodynamic temperature; the ampere, 
for electric current; and the candela, for 
luminous intensity. Each unit has a specific 
definition; for example, the mole is the 
amount of substance of a system that con­
tains as many elementary entities as there 
are atoms in 0.0072 kg of carbon-12. 
Derived units are formed by combining base 
units according to algebraic relations linking 
the corresponding quantities. Thus the ex­
pression for the newton (the force that gives 
to a mass of 1 kg an acceleration of 1 m /s *s, 
better written as 1 m*kg-s'2) links the base 
units for mass, length and time. Some de­
rived units are related to other derived units; 
for example, the pascal (or newton per square 
metre) is derived from the newton. But the 
pascal is itself derived from three base units 
so that, complex as these interrelationships 
may seem, they are always rational and co­
herent.
Coherence is a definite advantage of SI 
because, in the derivation of units from 
others (essentially from base units) through 
multiplication and division, unity is the 
fundamental numerical factor. Calculation is 
simplified. Calculations are made either in 
terms of unity or of the power of 10 so 
that the numerals themselves do not change; 
only the magnitude of the power of 10 
changes. And the decimal basis of the sys­
tem permits one to limit the range of 
numerical values in statements to that be­
tween 0.1 and 1000. This process is facili­
tated by the use of specific multiples and 
prefixes. The length of 0.006 52 m is better 
written 6.52 mm; and a platelet count of 
425 000/mm :i is just as readily written 
425 x 10:Vmm:!. (In fact, because the litre 
is the preferred unit for volume, the latter 
expression should be translated into the ex­
pression 425 x 109/1.)
The logic of SI and the facility with which
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SI can be used and interpreted in all scien­
tific disciplines in all countries are important 
advantages of this new system. Scientifically, 
these two advantages, which stem from co­
herence and rationality that characterize SI, 
are attractive but, even so, the objection may 
be raised that this has little to do with bed­
side medicine. And besides, opponents ask, 
have we not been asked to master enough 
systems of measurement in medicine? Is 
not our business bedside care?
To answer these criticisms one should 
consider the advantage of using a unit such 
as the mole. Its use permits one to determine, 
and compare, the concentrations of a variety 
of biochemical substances because a uniform 
unit system can be applied to measurement 
of these substances. Preferably, millimoles 
per litre should be used for most substances. 
It is thereby possible to consider the biologic 
relationships of substances as different as 
glucose, urea, bilirubin, bicarbonate and 
potassium— and such relationships are less 
readily appreciated when concentration is 
based on mass rather than amount of sub­
stance. The mole makes biochemical deter­
minations easy to understand in terms of 
body concentration because the mole is a 
logical unit for consideration of the con­
centration of substances in body fluids. Thus 
the concentration of hydrogen ion is more 
meaningful in terms of nanomoles per litre 
than in the dimensionless terms of pH; and 
the concentration of a polyvalent ion such as 
phosphate, for which the degree of dissocia­
tion and therefore the effective equivalent 
weight is dependent on pH, is better ex­
pressed in molar terms than in terms of 
equivalents or millequivalents, which make 
for ambiguities. Osmolal significance of 
plasma components, too, is better understood 
in molar terms; one can determine the osmo­
lal significance of these components as well 
as the osmolality of a fluid of known com­
position when direct measurement of os­
molality is not feasible.
In brief, SI appears to be appropriate for 
the majority of measurements that physicians 
deal with. Measurement of some substances, 
however, still has not been finalized. As one 
example, hemoglobin cannot yet be con­
sidered in molar terms because there is no 
agreement on the reference species for hemo­
globin, and therefore its molecular weight;
as another example, it is unlikely that en­
zyme activity will be considered in molar 
terms until there is agreement as to method 
on a molecular basis. But for the commonly 
determined substances —  blood glucose, 
blood urea nitrogen, serum electrolytes, 
serum creatinine—interpretation in terms 
of millimoles per litre is likely to be fa­
voured.
How far one should go is a matter for 
debate. It appears that the Australians have 
adopted SI lock, stock and barrel; that is, 
every measurement is now being reported in 
SI units whether the measurement is, for 
example, that of a relatively straightforward 
analysis such as blood glucose (mmol/1) or 
even hydrogen ion (nmol/1) or analyses re­
ported in less familiar terms such as acid 
phosphatase (/zmol/min *1), oxygen tension 
(kilopascals) and vitamin B12 (pmol/1). 
Whether Canadian physicians should ac­
cept SI en bloc is uncertain but it is im­
portant that the matter be debated.
Change for change’s sake is unacceptable 
but SI is a logical system of measurement 
and merits discussion. And there are ob­
jections to SI. One is related to unfamiliar­
ity. Behind unfamiliarity lurks the spectre 
of danger to patient care; some physicians 
believe that any new system will introduce 
dangers through errors in interpretation. An­
other objection is the view that SI is one 
more system of measurement being thrust on 
physicians by nonmedical scientists; first it 
was milligrams per cent, then milliequival- 
ents per litre, and now it is to be millimoles 
per litre. And the notations required by SI 
are different from those that are familiar to 
physicians.
Another objection is the lack of suitabil­
ity of some units for medical purposes. For 
example, the pascal is to be the unit for 
pressure; but for blood pressure is not even 
the kilopascal too large (1 kPa =  7.5006 
mm Hg)?
A more serious objection, perhaps, con­
cerns logistics. Apparatus will have to be 
recalibrated, new report forms will have to 
be designed, and all health professionals will 
require re-education. Cost is considered a 
major factor, and also human change. 
Change in a human system is always a ma­
jor undertaking, especially when benefits are 
difficult to see or are likely to become
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evident only after many years. With SI, 
education of an entire generation may be 
necessary before benefits become appar­
ent—and there is no doubt that education 
is the single most important factor determin­
ing success of any transition to SI. As yet 
few medical students are taught SI units 
but the place of teaching of SI units in 
medical curricula is a matter of major im­
portance.
Whether the objections to SI are entirely 
valid for Canadian physicians can be de­
cided only after much debate. It is important 
that all groups within the Canadian medical 
profession consider both the objections to 
and the advantages of SI. It is important be­
cause Canadians cannot afford to ignore a 
system of measurement that many physicians 
in other countries have wished to incor­
porate into medical practice. The experience 
of these other countries and a growing 
volume of literature is now available for 
Canadian physicians to study, and it seems 
appropriate at a time when Canada is in­
troducing the metric system in all spheres 
that Canadian physicians should examine a 
specialized aspect of the metric system that 
is singularly applicable to medicine.
D. A. E. Sh e p h a r d , MB, FRCP[C]
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REVIEW ARTICLE
SOME ASPECTS OF WOUND HEALING RESEARCH:
A REVIEW
C. HEUGHAN, MB, BChir, FRCS(Eng), FRCS[C]* and THOMAS K. HUNT, MDt
Summary: Mammalian response to injury essen­
tially is that of tissue repair and re-epithelializ- 
ation. The most important component of repair 
tissue is collagen, and after injury collagen 
turnover is greatly increased. Collagen biosyn­
thesis is initiated by nuclear D N A  of fibroblasts; 
the steps in biosynthesis are complex but 
studies of collagen biosynthesis may eventually 
have clinical potential. Normally, wound healing 
lasts for up to 2 years but nutritional and meta­
bolic factors, such as malnutrition, delay heal­
ing; hyperalimentation would likely be beneficial 
under these conditions. Other factors that influ­
ence wound healing are the oxygen tension in 
tissues, the hemodynamic status, and the ef­
fects of substances such as cortisone, vitamins 
A  and C, and zinc.
Resume: Les mammiferes combattent essen- 
tiellement les lesions par une reparation des 
tissus et par une nouvelle epithelisation. Le 
composant le plus important de la reparation 
tissulaire est le collagene dont I'activite est 
considerablement augmentee apres une lesion. 
La biosynthese du collagene est declenchee par 
le D N A  nucleaire des fibroblastes. Les etapes 
de cette biosynthese sont complexes, mais leur 
etude peut, en fin de compte, se reveler bene- 
fique sur le plan clinique. La cicatrisation nor- 
male de plaies peut prendre jusqu'a 2 ans, mais 
certains facteurs, tant nutritifs que metaboliques 
(la denutrition notamment), retardent la gue- 
rison. II est probable qu'une suralimentation 
puisse, dans ces conditions, avoir un role 
favorable. Parmi les autres facteurs qui influen- 
cent la guerison des plaies, figurent la tension 
d'oxygene tissulaire, I'etat de I'hemodynamique 
et les effets de certaines substances, comme 
la cortisone, les vitamines A  et C et le zinc.
With increasing specialization among ani­
mal species, the capacity to respond to 
physical injury by regeneration of tissue that 
has been destroyed has been progressively 
lost. Mammals are able to regenerate only 
epithelium, liver and bone. Consequently, 
mammalian response to injury essentially
♦Department of surgery, Memorial University of 
Newfoundland, St. John’s, Nfld. 
tDepartment of surgery, University of California, 
San Francisco, Calif.
consists of connective tissue repair and 
re-epithelialization.
The most important structural compo­
nent of repair tissue is the fibrous protein, 
collagen, which, in conjunction with muco­
polysaccharides, fills the gap left by injury. 
Besides acting as a filling material, the 
collagenous matrix joins the original tissue 
edges together with a network of interlacing 
fibres (Fig. 1), and the collagen-mucopoly­
saccharide matrix forms a bed over which 
regenerating and migrating epithelium 
grows, and through which new vasculature 
penetrates.
This network of collagen is responsible 
for the mechanical strength of healing 
wounds, and there is a close correlation be­
tween collagen content and tensile strength 
during the first 2 to 3 weeks of healing.1' 2
Recent studies of wound healing have 
been dominated by analysis of the biosyn­
thesis and chemistry of collagen. This re-
Fig. 1.—Scanning electron microscopic view of 
wound collagen. Note fine fibres and lack of 
orientation (x 10 000).
March 1975 THE CANADIAN JOURNAL OF SURGERY 119
view seeks to correlate recent advances in 
basic science with findings in the experi­
mental surgical laboratory, and to assess 
the clinical implications of some recent ad­
vances in knowledge of the chemical and 
nutritional determinants of connective tis­
sue turnover.
Some Aspects of Collagen
Biochemistry
Collagen, the chemistry and biology of 
which have been well reviewed by Grant 
and Prockop,3 is a structural protein that 
is widely distributed throughout the body. 
It is the major component of tendons and 
ligaments, it provides a framework on which 
cells of the parenchymatous organs are 
mounted, it is responsible for many of the 
mechanical properties of skin and it pro­
vides a pressure casing for the muscular 
arteries. The basement membrane of cells 
consists of a unique form of collagen dif­
fering chemically from that in other loca­
tions in that it contains cysteine.
Physically, collagen is characterized by 
great tensile strength and lack of elasticity 
at the molecular level. In the body, how­
ever, where it forms a lattice whose inter­
stices are filled with extracellular fluid, 
collagenous tissue is viscoelastic. Collagen 
turnover, although normally slow, is greatly 
increased following injury.
The chief steps of collagen biosynthesis 
are enumerated as follows:
1. Fibroblast proliferation.
2. Amino acid chain assembly.
3. Hydroxylation.
4. Glycosylation.
5. Extrusion of collagen from fibroblast.
6. Removal of telopeptides.
7. Cross-linking of aldehyde groups.
8. Orientation along lines of stress.
9. Binding to glycosaminoglycans.
During the first 5 days after injury the
fibroblast population of the wound in­
creases. Collagen biosynthesis is initiated by 
the nuclear DNA of the fibroblast, in which 
each amino acid in the protein is represented 
by three purine or pyrimidine bases. When 
collagen production is “switched on”, an 
appropriate chain of base triplets is trans­
ferred, in an inverted form, to newly syn­
thesized messenger RNA that travels in the 
cytoplasm to the ribosome where it dictates
the assembly of a chain of amino acids, each 
link of which corresponds to a particular set 
of three purine or pyrimidine bases. During 
this process, some of the proline and lysine 
residues are chemically modified by the 
addition of a hydroxyl group, and some of 
these derivatives are further modified by the 
addition of a carbohydrate complex to form 
a glycosylated amino acid.
The hydroxylation of proline is of parti­
cular interest. Hydroxyproline is found al­
most exclusively in collagen; furthermore, 
it is readily identified by a relatively simple 
colour reaction, which serves as a method 
of identification and quantitation of collagen. 
The conversion of labelled proline to label­
led hydroxyproline provides a measure of 
the rate of collagen synthesis, and the speci­
fic activity of the label in hydroxyproline 
may be used to follow the breakdown of 
collagen. Proline hydroxylation is effected 
by prolyl hydroxylase, which requires fer­
rous iron, vitamin C, molecular oxygen and 
alpha-ketoglutarate as cofactors. Lack of 
any of these substances impairs hydroxyla­
tion and probably prevents the egress of col­
lagen from the fibroblast. Collagen can only 
be synthesized from proline and not from 
available hydroxyproline.
Newly formed collagen leaves the fibro­
blast and is rendered insoluble by the re­
moval of small segments from the end of the 
molecule. A deficiency of the enzyme that 
effects the removal of these fragments has 
been described in dermatosparaxis, a dis­
ease of cattle.4- 5 The animals have weak 
skin that fails to heal after injury. In addi­
tion, joint and bone deformities often de­
velop. Microscopically, the skin collagen 
bundles are disorganized. There is no report 
of a comparable disease affecting humans.
Recently extruded collagen is soluble in 
cold, neutral salt solutions. With time this 
property is lost but the polymer remains 
soluble in cold, dilute acids. Mature col­
lagen is insoluble in both salt and acid 
solutions. The proportions of salt-soluble, 
acid-soluble and insoluble collagen may 
therefore be used as a guide to the rate of collagen turnover.
The changes in the solubility of collagen 
are due to chemical polymerization, a pro­
cess that requires the oxidative deamination 
of some lysine and hydroxylysine residues
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to form aldehyde radicals. The aldehyde 
groups from adjacent molecules then con­
dense to form stable, intermolecular, chem­
ical cross-links. This process occurs at cer­
tain specific sites on the molecule; thus, 
mature collagen has a recognizable crystal­
line structure.
Cross-linking can be prevented either by 
blocking the enzyme systems responsible 
for oxidative deamination with beta-amino- 
proprionitrile or by blocking the resulting 
aldehyde radicals with D-penicillamine so 
that condensation cannot take place. Both 
experimental and clinical trials of these com­
pounds have been conducted in attempts to 
limit the undesirable adhesions that may 
form, for example, after surgery on tendons 
or in joints affected by rheumatoid arthritis. 
Although promising, the use of cross-linking 
inhibitors is not yet sufficiently safe and re­
liable to justify clinical application. 6 7
It appears that some human disorders in­
cluding acromegaly, myositis ossificans, 
some cases of osteogenesis imperfecta and 
possibly Ehlers-Danlos and Marfans syn­
dromes are associated with inherited defects 
of collagen cross-linking. 8
The final stages of healing are character­
ized by orientation of collagen molecules in 
the direction of lines of stress and the forma­
tion of a stable, compound structure of col­
lagen and mucopolysaccharides. Electron 
microscopic studies have shown that collagen 
is bound to a proteoglycan matrix;9 other 
studies have shown that this is probably 
achieved by ionic bonding. The nature of 
the interaction between collagen and the 
mucopolysaccharide matrix is still unclear. 
The mucopolysaccharide matrix may de­
termine the aggregation or the orientation of 
collagen fibres; alternatively, its role may 
be mechanical. 10  14
The structural characteristics of collagen 
are determined by the physical attributes of 
the interlocking chain of amino acids con­
stituting the molecule. In vitro, if there is 
any major change in this chain—for exam­
ple, by substituting a proline analogue for 
proline— the resulting protein is released 
into the extracellular space at a decreased 
rate; in vivo, a major change leads to dimin­
ished wound strength. This finding provides 
another possible method whereby undesir­
able scar formation may be limited. 15 ' 18
Since the physical characteristics of col­
lagen are largely dictated by its molecular 
structure, it is hardly surprising that collagen 
shows little species variation. Therefore, ob­
servations on laboratory animals can be ex­
trapolated to man.
Despite its great mechanical strength, col­
lagen may be broken down rapidly. The 
degradation of collagen is known, under 
some conditions, to be more rapid than its 
synthesis, and this is true of wounds of al­
most any age. The mechanisms of this rapid 
breakdown are incompletely understood, al­
though there are certain pointers. Skin and 
colonic mucosa taken by biopsy are both 
capable of breaking down native soluble 
collagen that has been converted into a gel 
by warming to body temperature, and some 
bacteria also show collagenolytic activity. 
By contrast, serum from some patients con­
tains a factor capable of inhibiting colla- 
genase. 19
Another possible mechanism for collagen 
breakdown is by lysosomal enzymes. These 
include not only collagenase but also en­
zymes capable of degrading the mucopoly­
saccharide matrix in which the collagen fi­
brils are embedded. It seems possible that 
under conditions of rapid collagen turnover 
there is a delicate balance between collagen 
synthesis on the one hand and the net effect 
of collagen lysis and anticollagenase on the 
other. 19  Thus, although the rate of collagen 
turnover is normally slow, in wound tissue 
it is rapid, and interference with production 
in the face of an unchanged breakdown may 
result in disruption of old wounds. The best 
known example of this phenomenon is 
scurvy.
Sutures are required to hold before any 
new collagen is formed. Therefore, until new 
collagen has been formed, the integrity of 
the wound depends on pre-existing collagen 
between each suture and the wound edge. 
Collagen lysis may be observed in the creep­
ing of retention sutures towards the centre 
of the wound.
Collagen lysis seems to be to some extent 
a systemic phenomenon that is induced by 
trauma. A striking example of this process 
is the propensity of abdominal aortic aneur­
ysms to rupture after diagnostic laparotomy, 
even though the aneurysm itself has not 
been manipulated. The walls of human
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aortic aneurysms have no demonstrable col- 
lagenolytic activity (Stoney R, Hunt TK, 
unpublished data).
More precise information on the balance 
between collagen synthesis and collagen lysis 
will probably elucidate the mechanisms not 
only of normal healing but also of the over­
abundant production of connecdve tissue 
that produces, for example, keloid scars, and 
the defective connective tissue production 
that is exemplified in patients receiving glu­
cocorticoids. Similarly, the etiopathogenesis 
of diseases characterized by destruction of 
normal collagen or destruction, or overpro­
duction, of basement-membrane collagen, 
may eventually be understood, so that their 
control may be given a rational basis.
Some of the amino acids resulting from 
the biodegradation of collagen are used in 
subsequent biosynthesis.20- 21
The Sequence of Normal Healing 
The tensile strength of incised wounds 
builds up similarly in all species. Although 
the general pattern is the same, the time 
scale varies. Fig. 2 shows the pattern of this 
build-up, which can be conveniently divided 
into three overlapping stages.
During stage 1, the wound edges are on­
ly tacked together with fibrin. The classic 
changes of acute inflammation are taking 
place together with debridement, by macro­
phages, of dead tissue, foreign particles and 
bacteria. Fibroblasts are proliferating.
During stage 2, which lasts from about 
the 5 th to the 15th day, rapid collagen syn­
thesis is reflected by a rapid rate of gain in 
tensile strength.
Fig. 2.—Tensile strength-time curve for incised 
wounds.
Stage 3, which lasts between 6 months 
and 2 years, is characterized by a slow in­
crease in tensile strength that is attributable 
to orientation of the collagen fibres in the 
direction of strain, to cross-linking and to 
the formation of a stable collagen-mucopo­
lysaccharide matrix.
N utritional and M etabolic Factors
in R epair
The assembly of the amino acid chains 
during the primary stage of collagen biosyn­
thesis is normally a rapid process. It is 
theoretically possible that starvation and 
protein deficiency may interfere with the 
formation of collagen; however, newly syn­
thesized wound collagen is derived partly 
from the amino acids that appear through 
local collagen breakdown.20 Thus, severe 
and prolonged negative protein balance is 
likely to impede repair, and, under such 
conditions, hyperalimentation would likely 
be beneficial. Although mild hypoproteine- 
mia should not delay healing, the resulting 
edema does inhibit collagen synthesis.
Under normal circumstances, proline hy- 
droxylation is the rate-limiting step of wound 
collagen synthesis. Experimentally, healing 
may be delayed by a lack of any of the 
cofactors for prolyl hydroxylase. Thus, both 
hypoxia and scurvy cause defective collagen 
synthesis.
Under conditions of adequate nutrition, 
which normally exist in western countries, 
the rate-limiting factor in collagen biosyn­
thesis is the rate of delivery of oxygen to the 
repair cells. The observation by Cousteau 
and his team of divers that their wounds 
healed more rapidly when they had been 
breathing an oxygen-rich atmosphere (Po2, 
about 300 mm Hg) has stimulated experi­
mental and clinical work on the effects of 
breathing oxygen on wound healing.22' 25
During active collagen synthesis, the 
oxygen tension (Po2) in the wound space 
of experimental wounds is only 10 mm Hg. 
An increase in the oxygen concentration of 
the inspired air, although promptly increas­
ing the Pao 2 7 leads to a delayed and com­
paratively small response in the extracellu­
lar oxygen tension in the wound, and faster 
collagen synthesis. It has been postulated 
that the low extracellular Po2 in wound tis­
sue is attributable to both limitation of the 
diffusion of oxygen from the capillary to the
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fibroblast and to a high demand for oxygen 
by the repair cells. This view was corro­
borated by the observation that wounds in 
experimental animals heal more rapidly in 
terms of collagen synthesis, gain in tensile 
strength and increase in DNA content when 
the animal breathes oxygen at concentra­
tions up to 70% . Above this concentration, 
healing is impaired because of the separate 
problem of pulmonary oxygen toxicity. 
Breathing a mixture containing only 12% 
oxygen leads to a gain in both tensile 
strength and collagen accumulation, per unit 
time, that is slower than normal.
Administration of 40% oxygen should 
accelerate the rate of healing of primary 
human wounds by about 15%, and in ex­
tensive wounds with dead space this increase 
may approach 50%. It appears that, at 
least in theory, administration of an oxygen- 
rich gas mixture should be useful, both 
clinically and economically, in treating ex­
tensive wounds.
The delay in healing rate that occurs as 
the result of a diminution in oxygen avail­
ability is of practical importance. In hypo­
volemia there is a decrease in wound Po2, 
and restoration of the circulating volume 
with blood or with dextran leads to restora­
tion of the normal Po2 and collagen syn­
thesis rate.26
Wound Po2 is also decreased in hyper­
volemia induced by an intravenous injection 
of normal saline (dose, 2.5 to 10 ml/kg).27 
It seems likely that the decrease in Po2 re­
sults from local edema increasing the inter­
capillary distance. A corollary of this ob­
servation is that any other cause of edema, 
such as hypoproteinemia, is also likely to 
delay healing resulting from an increase in 
the distance across which oxygen must dif­
fuse from capillary to collagen-forming cell. 
It seems possible that tissues other than 
granulation tissue—for example, brain and 
kidney— may be similarly affected by gen­
eralized edema.
Anemia has been incriminated as a cause 
of defective healing, despite the fact that 
the normal physiologic mechanisms are able 
to counteract its effects to some extent.28’31 
Several groups of workers have been un­
able to demonstrate any impairment of 
wound Po2 or a collagen synthesis due to 
mild, uncomplicated, normovolemic ane­
mia.32- 38 Clearly, gross anemia will affect 
oxygen delivery; it seems likely that the 
effect is only significant when the hema­
tocrit is 20% or less.
Major, remote trauma has several hemo­
dynamic effects.34 These include hemodilu- 
tion, anemia and hyperviscosity due to an 
abnormally high concentration of circulat­
ing macromolecules, particularly fibrinogen. 
Experimentally, the intravenous injection of 
high-molecular-weight dextran, which mim­
ics the circulatory disturbances that normal­
ly follow major trauma, decreases both 
wound tissue Po2 and collagen synthesis 
per unit time; “clinical” dextran produces 
a similar but smaller effect.35
Gas tensions at various points in the ad­
vancing granulation tissue may be measured 
directly by use of a microelectrode intro­
duced into the wound tissue; in rabbits this 
fills a plastic chamber implanted into the 
ears. The result of such recordings is shown 
diagrammatically in Fig. 3.25, 36, 37 The 
Po2 close to a wound capillary is between 
60 and 80 mm Hg. Near the advancing edge 
of granulation tissue, approximately 100 /urn 
away, the Po2 approaches zero. In this zone 
of very low oxygen tension, the main cells 
are macrophages, which are capable of en­
gulfing bacteria (even in such a hypoxic en­
vironment) but not of killing them.38 A 
major component of intracellular killing of 
bacteria is oxygen-dependent.39
Nearer to the capillary there is a zone 
where the oxygen tension gradient is ex-
£ 80 / \ \
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Fig. 3.—Oxygen tensions in rabbit ear-chamber 
granuloma. Left side represents oldest part of 
wound containing mature collagen; right side is 
advancing edge of healing tissue adjacent to cen­
tral space. (Reproduced by permission from 
Silver IA: Local and systemic factors which affect 
proliferation of fibroblasts, in Biology of Fibro­
blast. Proceedings o f Sigrid Juselius Symposium, 
Turku, Finland, August 1972, edited by Kulonen 
E, Pikkai.ainen J, New York, Academic Press, 
1973.)
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tremely steep and it is in this region that 
actively proliferating fibroblasts, together 
with a few fibres of recently formed collagen, 
may be found. Behind the capillary, the 
fibroblast population is more sparse and 
fibres of presumably cross-linked collagen 
are more abundant.
Oxygen tension in the centre of an ex­
perimental granuloma may be measured by 
means of other techniques. Fluid may be 
sampled from the central dead space filling 
an implanted stainless-steel, wire-mesh cyl­
inder and then injected into a standard gas 
analysis apparatus.28 This method may be 
modified by filling the cylinder with Teflon 
tubing perfused with anoxic saline. Since 
Teflon is permeable to oxygen, the Po2 of 
the central dead space equilibrates with that 
of the saline perfusing the tube, which can 
then be measured continuously with a stand­
ard Clark type of electrode (Fig. 4).40
A further refinement consists of burying 
a Silastic tube (length, 10 cm) in a sub­
cutaneous tunnel. The tube is perfused with 
anoxic saline whose oxygen tension equili­
brates with that in the surrounding wounded 
tissue.41 The Po2 of the saline is then meas­
ured with standard apparatus. Because the 
tissue reaction around an implanted tube is 
minimal, the gas tension measured is a clos­
er approximation to “normal” tissue than in 
other techniques. This method has been 
tried in man,42 and may be of value in 
monitoring Po2 in patients who have either 
respiratory or circulatory disturbances likely 
to impair tissue oxygenation. It can also be 
used to measure Pco2 (Fig. 4).
These methods measure the Po2 in the 
centre of the wound, the net result of supply 
from the capillaries and demand by the 
healing tissue. A decrease in Po2 implies a 
decrease in delivery of oxygen which may
Fig. 4.—Indirect methods of measuring Po2 at 
centre of wound.
be due to increased viscosity, to plasma 
changes or to changes in Pao2. Experiment­
ally, it is possible to confirm that oxygen 
delivery has been impaired by weighing the 
collagen that has accumulated in an experi­
mental wound over a given period.
Cortisone and  H ealing
One action of glucocorticoids, in common 
with other anti-inflammatory drugs, is 
stabilization of the lysosomal membrane. 
This decreases the activity of lysosomal en­
zymes released into the wound during the 
first stage of healing and thus diminishes the 
local amino acid pool available for subse­
quent repair. Experimentally, glucocorticoids 
only impair healing if given in suppressive 
doses during the first 5 days after wounding.
The effect of cortisone on the lysosomal 
membrane is directly antagonized by vitamin 
A, which is a lysosomal labilizer. Experi­
mentally, cortisone-retarded healing can be 
restored towards normal by the local or 
systemic administration of vitamin A .20' 21 
There are now some 50 clinical cases in 
which healing of wounds of patients who 
were being treated with glucocorticoids was 
induced with either topical or systemic 
vitamin A (Hunt TK, unpublished data). 
Vitamin A appears to restore fibroplasia and 
epithelialization, but not wound contraction, 
towards normal.
Z inc and  H ealing
In a number of clinical reports it has 
been suggested that healing is impaired by 
zinc deficiency, and in others attempts have 
been made to show that heavy losses of zinc 
from burn surfaces may lead rapidly to 
deficiency in a previously normal patient. 
However, we believe that the case for rou­
tine supplemental zinc is as yet not proved.
Experimental work shows that zinc has 
a fundamental role in protein synthesis in 
unicellular organisms as well as in amino 
acid utilization in the rat liver; the zinc- 
deficient rat also is less able to incorporate 
labelled glycine and proline into collagen. 
In addition, zinc deficiency may impair 
cross-linking.48-50
In fectio n  and  H ealing
Comparatively little is known about the 
effect of infection on healing.
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The majority of pathogenic bacteria con­
sume oxygen so that the Po2 of infected 
wounds is normally low or zero.51 A de­
creased amount of collagen in experimental 
granulomas infected with Proteus sp., has 
been reported. The reason for this is not 
clear. It may be either the “steal” by bac­
teria of all the available oxygen or a high 
rate of collagen breakdown possibly due to 
the presence of bacterial or granulocyte 
collagenase. The effect of infection on cross- 
linking is unknown.52
In animals rendered completely devoid 
of circulating granulocytes by the admin­
istration of antileukocyte serum, healing 
can occur normally.53
Although macrophages are able to engulf 
bacteria in an environment with a Po2 of 
only approximately 1 mm Hg, intracellular 
killing is poor. During the intracellular kill­
ing of bacteria and fungi, the rate of oxygen 
consumption by phagocytes increases. This 
increased oxygen demand reflects a change 
to aerobic metabolism of glucose by the 
hexose monophosphate shunt, and is not 
shown by the leukocytes of some patients 
with deficient phagocytic microbicidal func­
tion and an accompanying susceptibility to 
infection. Energy for phagocytosis can be 
derived from the anaerobic glycolytic path­
way.38
There is a correlation between the severity 
of infection in experimental granulomas of 
rabbits and the concentration of environ­
mental oxygen. The bacterial count in wound 
fluid is lowest in animals breathing 40% 
oxygen and highest in those breathing 12% 
oxygen.54
After extensive burns, there is a derange­
ment of serum immunoglobulin patterns re­
sulting in a decreased efficiency of the de­
fence mechanisms against infections.55' 56 
It seems possible that stimulation of the 
phagocytes, possibly with oxygen, may be a 
valuable adjunct in the prevention of sepsis 
after thermal injury.
Clinically, hyperbaric oxygen therapy in 
osteomyelitis is reportedly of value.57
Healing in Some Special Sites
Colon
The mechanical strength of normal colon 
is provided almost entirely by the submu­
cosal collagen.
The colonic epithelium has a high col­
lagenase activity, which increases proximo- 
distally. Hence, colonic anastomoses in rab­
bits have virtually no bursting strength for 
the first 3 to 5 days. Furthermore, because 
of collagen lysis, the bowel may rupture 
anywhere within 2 cm on either side of an 
anastomosis. This finding suggests one rea­
son why low anterior resections have such a 
high rate of leakage.
Inoculation of the peritoneal cavity with 
pathogenic bacteria has no effect on the 
build-up of bursting strength, but the addi­
tion of foreign materials (e.g. sterilized 
feces) to the region around the contamin­
ated anastomosis caused a prolonged delay 
in the restoration of normal bursting 
strength.58
It appears therefore that, although bac­
terial contamination itself has little effect 
on colonic healing, the additional presence 
of feces or other foreign material, including 
blood or plasma, is likely to delay healing; 
as a result, the anastomosis may require 
protection with a proximal colostomy or 
cecostomy.
Arterial Intima
Injury to the intima of an experimental 
animal in the presence of a high concentra­
tion of serum lipids produces a fatty lesion, 
analogous to human atherosclerosis.
In these lesions, which are avascular, the 
Po2 may decrease to between 5 to 12 mm 
Hg. This may partly explain the inability of 
the arterial wall to remove unwanted fats.59 
There is little evidence of new collagen 
formation in these early fatty lesions. The 
chemical profile of the fat in the arterial 
wall shows changes that may reflect the 
changing Po2 profile.
Other Sites
Despite the increase in knowledge of 
healing and its allied science of collagen 
chemistry, little is known of the mechanisms 
and kinetics of collagen turnover in scar 
tissue. Some methods of increasing healing 
rate have been described and some of the 
effects of therapy have been discussed.
The converse problems of excessive scar 
formation (e.g. keloid) and of undesirable 
scarring (e.g. after operations on tendons 
and after burns) are less amenable to mani­
pulation. The use of cross-linking inhibitors
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or of proline analogues is a promising pos­
sibility.
Abnormalities of collagen metabolism oc­
cur in a wide variety of diseases. Apart from 
the abnormalities in atherosclerosis, the ab­
normality in peptic ulceration may be re­
garded as a defect in healing and that in 
hepatic cirrhosis as an example of repair 
occurring in an organ that normally heals by 
regeneration.
A greater understanding of the mechan­
isms of collagen breakdown and of the im­
munology of collagen can hardly fail to add 
perspective to the study of such diseases as 
rheumatoid arthritis and diseases involving 
the destruction of basement membranes. 
Some transplantation antigens may be asso­
ciated with the collagen molecule.
These possible lines of research poten­
tially are of clinical usefulness from the 
delineation of the antigenically active sites 
on the human collagen molecule.60 This 
raises the theoretical possibility of inhibit­
ing collagen-anticollagen reactions by the 
use of synthetic blocking antibodies.
C onclusions
In this review only a few aspects of a vast 
subject have been discussed. Such vital and 
rapidly advancing subjects as wound con­
traction, and the migration and regeneration 
of damaged epithelium have not been con­
sidered.
Establishment of a relationship between 
clinical practice and research is a highly 
desirable end product of basic surgical re­
search and a justification of the expenditure 
of public money. A 15% increase in the 
rate of healing gained by breathing 40% 
oxygen at atmospheric pressure, the pos­
sibility of restoring cortisone retarded heal­
ing towards normal with vitamin A and the 
demonstration that transfusion of patients 
with mild postoperative anemia in order to 
assure normal healing is unnecessary, facili­
tate such a relationship. The discovery of 
other factors influencing wound healing is 
both likely and imminent.
Every period of major progress in surgery 
has been achieved by a productive union 
with one of the basic sciences. Future ad­
vances may originate in a fruitful (if poly­
gamous) union with biochemistry and im­
munology.
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INTERPRETING THE RATE OF SURVIVAL IN CARCINOMA*
CHANDLER SMITH, MDt
Summary: Carcinomas originate in one organ, 
spread away from that site, cannot be accu­
rately staged, and require total ablation for 
cure. Cure is achieved when all of the tumour 
is located within the tissue ablated by the 
method used. The rate of survival indicates the 
proportion of patients with such localized dis­
ease. A comparison of survival rates is not a 
comparison of therapeutic accomplishments; it 
is a comparison of the cumulative localization 
of the tumours in different series. The superior 
method is that which ablates the primary tu­
mour and the largest amount of surrounding 
expendable tissue at the earliest time. Select­
ing the method according to this principle rather 
than by a comparison of survival rates provides 
the highest prospect for cure. That is the pur­
pose of treatment.
Resume: Les cancers prennent naissance dans 
un organe, se propagent ailleurs a partir de 
cet organe. Leurs etapes successives ne peu- 
vent etre determinees avec precision. Pour gue- 
rir, ces tumeurs doivent etre excisees comple- 
tement. La guerison n'est obtenue qu'a la 
condition que la totalite de la tumeur soit loca- 
lisee dans I'organe excise par I'acte chirurgical 
pratique a ce moment. Le taux de survie indi- 
que la proportion de malades souffrant de cette 
tumeur localisee. Une comparaison des taux de 
survie, comme telle, ne reflete pas les resultats 
therapeutiques et ne permet pas de comparer 
ces derniers. Ce n'est que la comparaison de 
la localisation cumulative des tumeurs dans 
des series differentes. La methode par excel­
lence est celle qui consiste le plus tot possible 
a exciser, et la tumeur primaire, et la quantite 
maximum des tissus avoisinants susceptibles 
d'etre le siege de metastases. Seule une me­
thode conforme a ce principe et non pas celle 
qui consiste a comparer des taux de survie, 
permet de formuler le meilleur pronostic de 
guerison. C'est le but meme du traitement.
*From the department of pathology, George 
Washington University Medical Center, Washing­
ton, DC.
tProfessor and chairman, department of pathol­
ogy, Kansas City General Hospital and Medical 
Center, 24th and Cherry Sts., Kansas City, 
Missouri 64108.
In evaluating cancer therapy, it is custom­
ary to equate the rate of survival with the 
quality of the method so that a comparison 
of survival rates will reveal the superior 
method of treatment. The premise of this 
practice is that random classification by 
clinical staging will establish parity of tu­
mour spread in the groups of patients to 
be compared. This method of analysis is 
presently used in studies of carcinoma of 
the breast, colon, endometrium, uterine 
cervix, and other organs.
Staging, T um our Spread  a nd  Survival
That clinical staging establishes parity of 
tumour spread is in doubt. Haagensen and 
Stout,1 for example, reported that among 
253 patients with carcinoma of the breast 
in whom the axillas were clinically normal, 
49% were subsequently found to have 
metastatic tumour in their axillary lymph 
nodes. Shah, Rosen and Robbins2 reported 
a similar experience. Others have observed 
that different examiners assign different 
stages of the disease to the same patient, 
and “positive axillas” were detected in one- 
third of patients who did not have breast 
cancer.3 In view of this, comments on the 
“fallacy” of the practice of clinical staging4 
are not surprising. The same point could 
be made about staging of carcinomas of 
organs other than the breast; the clinical 
estimate of metastatic disease in the mesen­
teric lymph nodes for cancer of the colon, 
or in the pelvic lymph nodes for carcinoma 
of the endometrium or uterine cervix, is 
scarcely more accurate.3' 9
Although clinical staging may be grossly 
inaccurate, it is nevertheless true that spread 
of the tumour dominates the rate of sur­
vival. Consider a carcinoma in a single 
patient. If the tumour is localized within 
the tissue ablated by the method, cure is 
assured; if the tumour is spread beyond the 
tissue ablated by the method, failure is cer­
tain. The spread of the tumour, therefore, 
determines whether the patient will survive 
or succumb. If the spread of the tumour 
determines the survival of the individual, 
it also determines the survival of the group.
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Thus, the rate of survival is dominated by 
the cumulative spread of the tumours at 
the time treatment is applied. In an actual 
sense this conception is also borne out; 
metastatic disease in regional lymph nodes 
regularly portends an unfavourable result 
for cancers of the breast, colon, uterus, and 
other organs.
If tumour spread cannot be accurately 
assessed before treatment, and if tumour 
spread dominates the rate of survival, it is 
apparent that the rata of survival cannot 
be a reliable index of the quality of the 
method. One may therefore ask, “What does 
the rate of survival express?” It is obvious, 
on the one hand, that without treatment 
there will be no rate of survival, and, on 
the other, that the result of treatment will 
be affected by the unpredictable spread of 
the tumours. The interpretation of survival 
rates should therefore be expanded to ac­
commodate both factors. Accordingly, the 
rate of survival indicates the proportion of 
patients in which the tumour was localized 
within the tissue ablated by the method of 
treatment— or, more simply, the proportion 
of patients with localized disease. The rate 
of survival is never an absolute figure, but 
its reliability increases with the passage of 
time.
This interpretation widens the meaning 
of the rate of survival so that it accom­
modates both the amount of tumour tissue 
ablated, which is the contribution of the 
method, and the extent of the tumour 
spread, which is unpredictable before treat­
ment is given. The latter prevents one from 
equating the rate of survival with the qual­
ity of the method alone. Thus, the pro­
nounced effect of tumour spread on the 
result of treatment cannot be denied, yet 
the incorporation of this effect into the 
meaning of the rate of survival precludes 
its traditional use as an index of therapeutic 
achievement.
The proper interpretation of survival rates 
may be illustrated in two examples. A high 
survival rate does not indicate a superior 
method so much as the localization of the 
tumours within the tissue ablated by that 
method in many of those patients. Con­
versely, a low survival rate does not fault 
the method so much as indicate a deep 
spread of the tumours beyond the tissue
ablated by that method in many of those 
patients. Thus, a comparison of survival 
rates is not a comparison of the quality of 
the two methods of treatment; it is a com­
parison of the cumulative data concerning 
localization of the tumours in two series 
of patients.
Identification of the Superior
Method of Treatment
If the rate of survival does not express 
the quality of the method, how is the supe­
rior method to be identified? It is to be 
identified from considering the biologic 
features of the tumour. It is evident that 
the tumour arises in one organ, and that 
later it may spread from that site; the ex­
tent of spread is not accurately discernible 
from clinical examination of the patient, 
and cure requires the ablation of all of the 
implanted tumour. These features forecast 
the principle of treatment: the ablation of 
the primary tumour and the largest amount 
of contiguous expendable tissue at the earli­
est possible time. What is “expendable” 
depends on the site of the tumour and the 
condition of the patient, so an arbitrary 
judgment about expendability is unavoid­
able. Nevertheless, the boundaries of that 
judgment can be foreseen; that is, the meth­
od cannot be so radical as to jeopardize 
the patient’s recovery, and it cannot be so 
conservative as to allow recurrence from 
residual tumour left in expendable tissue. 
Between these limits, which must be judged 
individually for each patient, lies the high­
est prospect for cure.
The method that complies with this prin­
ciple of treatment is radical therapy. The 
superiority of the radical method, however, 
is reflected only in the occasional patient 
in whom the tumour has spread to the re­
gional lymph nodes but not beyond. Other­
wise, in cases of carcinoma of the breast, 
for example, the radical and conservative 
methods succeed equally because the tu­
mour is localized to the site of origin, or 
fail equally because the tumour has spread 
beyond the regional nodes. In these in­
stances both methods achieve the same re­
sult. Nevertheless, the patient who can be 
cured only by the radical method cannot 
be identified before treatment is given, 
therefore, the highest prospect of cure for
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all patients is ensured only when the meth­
od is selected according to principle of 
treatment rather than by a comparison of 
survival rates.
For cancers of the breast and uterus, the 
principle of treatment favours the radical 
method because the axilla in the former 
instance and the adnexas in the latter are 
expendable tissues that may be sacrificed 
without an increase of mortality over con­
servative methods. Radical treatment for 
carcinoma of the colon, however, may not 
be superior because the mortality of ab­
dominoperineal resection is likely to be a 
more critical factor than the gain derived 
from the extra tissue ablated by that meth­
od, as Crile and Turnbull have pointed 
out.10 In this instance, the radical method 
may violate the principle of treatment by 
excessively jeopardizing the recovery of the 
patient. The implacable question the sur­
geon cannot avoid is whether the higher 
prospect for cure by the radical method 
justifies the increased mortality of that pro­
cedure. Only the surgeon, who is aware of 
his own skill, the condition of his own pa­
tient and the relative risk of the conserva­
tive and radical methods, may answer this 
question.
Realistic Interpretation of
Survival Rates
As long as the tumour spreads only away 
from the site of origin, and cure requires 
the ablation of all of the tumour, the result 
of treatment cannot be improved by reduc­
ing the amount of tissue ablated by the 
method or by delaying the application of it. 
This claim is not invalidated by poor sur­
vival rates after radical treatment or good 
results after conservative therapy. For ex­
ample, good survival after conservative 
treatment allows the possibility that a rad­
ical method used in its place might have 
achieved an even better rate of survival. 
On the other hand, a poor result after rad­
ical treatment disallows the possibility that 
conservative therapy applied to those same 
patients could have improved that result. 
Regardless of the rate of survival, there­
fore, compliance of the method with the 
principle of treatment provides a result that 
cannot be improved by any method that 
does less. Accordingly, the superior method
is not that which occasionally achieves a 
high rate of survival; it is that which con­
sistently complies with the principle of 
treatment.
The comparison of survival rates is also 
affected by a realistic interpretation of them. 
Because the rate of survival expresses the 
proportion of patients with localized can­
cer, it is evident that the result after con­
servative therapy might be improved by a 
method that does more, but the result after 
radical treatment cannot be improved by a 
method that does less. A comparison of 
survival rates provides no way to conclude 
that the conservative method is superior or 
that the radical method is inferior, and 
massive undertakings for this purpose have 
no way of succeeding.
The proper interpretation of the rate of 
survival also allows expression of the biol­
ogic nature of the tumours. Highly aggres­
sive tumours tend to be deeply spread and 
associated with poor results, whereas in­
dolent tumours tend to be sharply localized 
and associated with good results. The pro­
posed interpretation thus accommodates the 
“biologic predeterminism” of MacDonald.11
The recommended interpretation, does 
not include a consideration of vascular, 
hormonal, or other factors that determine 
the extent of the tumour spread. Nor should 
it. Although, these factors may be impor­
tant in determining the particular extent of 
the tumour at the time of treatment, it is 
only the fact of that spread that determines 
whether the individual, or the series of in­
dividuals, will survive. Such considerations 
are therefore neither unimportant nor ger­
mane to the interaction between tumour 
distribution and tissue ablation.
A method of treatment is said to 
“achieve” a certain rate of survival. This 
implies that the method is the sole cause 
of the result. The suggested interpretation 
of survival rates, however, disputes this be­
cause it incorporates the biologic nature of 
the tumours. In order to emphasize this 
biologic effect, and to dampen the impli­
cation that the method is the sole cause of 
the result, it would perhaps be useful to 
relabel the rate of survival as the “tumour 
localization index” or some similar term. 
This would emphasize the observation that 
the biologic nature of the cancers vis-a-vis
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the method, rather than the method alone, 
determines the result of treatment. More­
over, it is closer to the truth than a term 
that calls no attention to this biologic effect. 
A more realistic term would also encourage 
consideration of the tumour-host relation­
ship. This is altogether appropriate as im­
mune factors come to have an increasingly 
prominent role in oncology.
Finally, there is no statistical way of ve­
rifying the proposed interpretation of sur­
vival rates. Just as it is an intellectual 
exercise to presume that the rate of survival 
is determined by a single factor—the meth­
od of treatment— so is it an intellectual 
exercise to realize that the results of treat­
ment are determined by two independent 
factors—the extent of the tumour spread 
and the tissue ablated by the method. What 
stands to the credit of the dual factors is 
the registered inaccuracy of clinical staging 
and the established observation that metas­
tatic disease at the time of treatment de­
cidedly affects the rate of survival. Those 
who contend that the rate of survival ex­
presses the quality of the method alone must 
either proclaim the precision of the clinical 
staging or deny that tumour spread domi­
nates the result of treatment.
One concludes that the rate of survival 
is determined by two factors, each inde­
pendent of the other, that the rate of sur­
vival unreliably expresses the quality of 
treatment, and that a comparison of 
survival rates cannot be expected to iden­
tify the superior therapy for several com­
mon primary cancers. The principle of 
treatment is sound, and compliance with 
this principle rather than making a com­
parison of survival rates is the surest guide 
to the best therapy. This combination of 
a realistic interpretation of survival rates
and a sound principle of tumour therapy 
defeats the old, enduring difficulties; that 
is, it allows the superior method to be 
identified, it guarantees the highest prospect 
of cure for all patients and it permits sur­
vival rates to be understood usefully in 
terms of the tumour-host relationship rather 
than erroneously in terms of the quality of 
the method of treatment. These are the 
benefits of a realistic interpretation of sur­
vival rates.
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FRACTURES OF THE MEDIAL HUMERAL EPICONDYLE IN CHILDREN*
W. B. BEDE, MD, A. R. LEFEBVRE, MD and M. A. ROSMAN, MD, FRCS[C]
Summary: A  review of 50 children with frac­
tures of the medial humeral epicondyle facili­
tated a simple classification of this injury and 
its management. The “ apparent isolated" frac­
ture of the medial humeral epicondyle is un­
common; it is more frequently associated with 
elbow dislocation, with or without spontaneous 
reduction, at the time of injury. Analysis of the 
results of treatment of medial humeral epicon- 
dylar fractures in this group of children showed 
that, in the case of those with an "apparent 
isolated" injury, treatment with a sling only 
gave good results in 90c7r whereas poorer results 
followed open treatment or fractures associated 
with dislocation. Closed treatment is therefore 
recommended. Open reduction is indicated only 
with (a ) ulnar neuritis at the time of injury or 
(b ) intra-articular fragment.
Resume: Une revue de 50 cas de fractures de 
I'epicondyle humeral interne chez I'enfant a fa- 
cilite une classification simple de cette lesion 
et de son traitement. La fracture "apparemment 
isolee" de I'epicondyle humeral interne est une 
rarete Clinique. Elle est plus souvent accompa- 
gnee de luxation du coude, avec ou sans reduc­
tion spontanee, au moment de la lesion. L'ana- 
lyse de nos resultats therapeutiques dans ce 
groupe d'enfants a revele que, dans le cas de 
lesion "apparemment isolee", le traitement con- 
sistant dans le port d'une simple echarpe a don- 
ne de bons resultats dans 90% des cas. tandis 
que nous n'avions que des resultats mediocres 
apres reduction ouverte ou dans les cas de 
fractures accompagnees de luxation. Nous con- 
seillons done le traitement ferme. La reduction 
ouverte n'est indiquee que si Ton note (a ) une 
revrite cubitale au moment de la blessure ou 
(b ) la presence d'un fragment intra-articulaire.
F r a ctu r e  of the medial humeral epicon­
dyle and its association with total disloca­
tion of the elbow was first described in 
1851 by Cooper. A classification of this 
injury was proposed by Watson-Jones,1 
who noted an incidence of 25% of asso­
ciated elbow dislocations. Since then, Smith" 
has accumulated the largest published series
*From the department of surgery, Montreal Chil­dren’s Hospital, Montreal, Que.
Reprint requests to: Dr. M. A. Rosman, division of orthopedic surgery, department of surgery. Montreal Children’s Hospital, 2300 Tupper St., Montreal, Que. H3H 1P3.
of medial epicondylar fractures; he has con­
cluded that conservative treatment gives the 
best results, even with gross displacements, 
except when the fragment is intra-articular 
or there is ulnar neuritis.
In this paper we review the results of 
treatment of 50  cases of fractures of the 
medial humeral epicondyle in childhood. 
This total comprises 22 “apparent isolated” 
fractures of the medial epicondyle (Fig. 1) 
and 28 epicondylar fractures associated with 
known dislocation of the elbow (Fig. 2). 
These fractures were seen at the Montreal 
Children’s Hospital from Jan. 1, 1960 to 
May 1, 1974. We present evidence to sup­
port the idea that this apparent isolated in­
jury is often associated with a dislocation of 
the elbow that reduces spontaneously, and 
that, if not seen on the original radiographs 
of the injury, is evident at follow-up clinical 
and radiologic examination. We propose a 
classification of this injury that will help 
physicians in its management.
Fig. 1.—Isolated fracture of medial humeral epicondyle.
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F indings of Study
Details of Patients
During the period 1960 to 1974, 50 pa­
tients were seen with fractures of the medial 
humeral epicondyle. The mean age at injury 
was 12.5 years (range, 6.0 to 17.9 years), 
closely paralleling the appearance and fus­
ion of the apophysis of the medial epicon­
dyle. The mean follow-up period was 3.7 
years.
C lin ic a l
l im ite d  m otio n  
t e n d e rn e s s  
o v e r g ro w th  
c u b itu s  v a lg u s  
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se p tic  a rth ritis
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Fig. 3.—Summary of total complications for 
all patients (both fracture groups considered 
together).
TABLE I.—M ean D isplacement of Apparent Isolated F ractures and F ractures Associated with
D islocation
Nos. of patients and displacement (mm)
Total no.
Fracture group 1-3 4-6 7-10 11-15 Intra-articular of patients
Apparent isolated.......................... 7 2 13 0 0 22
Associated with dislocation......... 3 0 7 1 17 28
Fig. 2.—Fracture of medial humeral epicondyle 
with known dislocation of elbow.
TABLE II.—Results of Treatment of 50 P atients with Apparent Isolated Fractures and
Fractures Associated with D islocation
Result* (%)
Fracture group Treatment Good Poor
Apparent isolated fractures (n = 22) Immobilization only (n =  13) 90 10
Open reduction (n =  9) 75 25
Associated with dislocation (n = 28) Closed reduction only (n =  21) 72 28
Closed followed by open reduction (n = 7) 50 50
*For criteria see text.
TABLE III.—Classification of Injury (Related to Stress F orce)
Type of injury Displacement
I Simple fracture 0 - 4  mm
II Fracture-dislocation with spontaneous reduction 5 mm and over
III F racture-dislocation At level of joint or intra-articular
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Classification of Fractures
There were two groups of fractures: (1) 
22 apparent isolated fractures and (2) 28 
fractures and associated elbow dislocation. 
The mean displacement of the fracture in 
the two groups is shown in Table I. Dis­
placement was 10 mm or less in patients 
with isolated fractures, whereas in the ma­
jority of patients with associated dislocation 
the displacement was intra-articular.
Methods of Treatment
Of the isolated fractures, 13 were treated 
by immobilization and 9 by open reduction 
(Table II). The mean displacement in the 
former was 4 mm and in the latter 9 mm. 
Treatment of fracture with dislocation was 
by closed reduction of the dislocation (21 
cases), or by closed reduction of the dis­
location followed by open reduction of the 
fracture (7 cases). The mean displacement 
in the first group was 4 mm and in the 
second group, 8.5 mm.
Immobilization time was about equal
Fig. 4a
whether the fracture occurred in isolation 
or was associated with dislocation; the aver­
age was 34.7 days and 32.1 days respec­
tively.
Results of Treatment
The overall results were assessed by clin­
ical and radiologic examination at follow-up. 
The result was judged to be good when, 
subjectively, the elbow was functional, pain­
less and stable and was not grossly deformed 
and, objectively, range of motion was less 
than or equal to 15% of normal, cubitus 
valgus was less than 10°, there was no ten­
derness, and no clinical ulnar neuritis. Re­
sults that did not meet these criteria were 
considered poor, or unacceptable. Table II 
summarizes the findings at follow-up. With 
apparent isolated injury, immobilization 
alone gave good results in 90% of cases, 
whereas open reduction gave good results in 
only 75% , taking into consideration all de­
grees of displacement. With fractures asso­
ciated with dislocation of the elbow, closed 
reduction alone gave good results in 72%
Fig. 4b
Fig. 4.—Nonunion complicating apparent isolated fracture, (a) Fracture with 5-mm displace­
ment in 9-year-old girl treated in plaster splint only, (b) Asymptomatic nonunion 2 years later with 
good result.
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Fig. 5a Fig. 5b
Fig. 5.—Nonunion and clinical valgus deformity and valgus instability complicating apparent 
isolated fracture, (a) Fracture with 10-mm displacement in 10-year-old boy treated by open reduc­
tion. (b) Nonunion with deformity and instability 1 year later with poor result.
1973
non-umo
Fig. 6a Fig. 6b
Fig. 6.—Nonunion complicating fracture associated with dislocation that was not intra-articular. 
(a) Fracture with 4-mm displacement after closed reduction of dislocation and application of plaster 
splint only, (b) Asymptomatic nonunion 4 years later, good result.
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of cases and closed reduction followed by 
open reduction gave good results in only 
50%.
Complications
Complications were divided into clinical 
and radiologic for both groups together 
(Fig. 3). Nonunion with associated com­
plications is illustrated in Figs. 4 to 7.
D iscussion
In fractures of the medial humeral epi- 
condyle with associated dislocation of the 
elbow, the periosteum is separated from the 
humeral metaphysis at the time of disloca­
tion. Calcification may occur in this area 
during the healing period leaving long- 
lasting radiologic evidence of the disloca­
tion (Fig. 8). Lateral periosteal calcification 
was seen in 55% of medial epicondylar 
fractures with associated dislocation and in 
11% of apparent isolated fractures in this 
series. This supports the assumption that a 
proportion of the children presenting with 
apparent isolated fractures actually sus­
tained a dislocation of the elbow with a 
spontaneous reduction at the time of injury.
Results were more unsatisfactory and 
complications were more frequent in pa­
tients who presented with associated dis­
location than in children with isolated frac­
tures and also in those treated by open 
rather than closed reduction of the fracture. 
Closed reduction is therefore advocated for 
all patients, except those presenting with 
either signs and symptoms of ulnar neuritis 
or in an intra-articular medial epicondylar 
fragment. Mobilization of the elbow is 
recommended as soon as the acute symp­
toms of the injury resolve.
Table III provides a simple classification 
for this injury: (1) simple fracture, without 
dislocation; (2) fracture associated with a 
dislocation, with spontaneous reduction; (3) 
fracture and dislocation without spontan­
eous reduction. Correlation of this classifi­
cation to management only occurs with 
type 3 injury with an intra-articular frag­
ment, which requires open reduction.
Co nc lu sio n s
A review of 50 cases of medial humeral 
epicondylar fracture, with or without asso­
ciated dislocation of the elbow, allows us
Fig- 7a Fig. 7b
Fig. 7.—Nonunion, valgus deformity and stiffness of elbow complicating fracture-dislocation of 
elbow with intra-articular medial epicondylar fragment in 13-year-old girl, (a) Treatment by closed 
reduction of dislocation produced extra-articular medial epicondyle, displaced 4 mm; this was splinted 
only, (b) Tender nonunion with deformity and stiffness of elbow 4 years later with poor result; 
note lateral calcification.
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Fig. 8.—Long-term follow-up radiograph of 
fracture associated with dislocation of elbow 
showing lateral periosteal calcification.
to conclude that there are only two indica­
tions for open reduction with medial epi- 
condylar humeral fracture of the elbow:
1. signs and symptoms of ulnar neuritis, 
and
2. the presence of an intra-articular frag­
ment that remains intra-articular after closed 
reduction of the elbow dislocation.
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EFFECTS AND PREVENTION OF FROSTBITE IN WOUND HEALING
A. R. C. BUTSON, MD, FRCS(Eng), FRCS[C], FACS*
Summary: Observations on wounds sustained 
at subfreezing temperatures in husky dogs and 
in man suggested that exposed wet tissues 
readily become frozen. Frostbite of wounds 
caused tissue necrosis, wound sepsis and 
delayed healing, but immediate wound suture 
protected against this sequence. To explore 
the effect of wound closure on healing of frost­
bitten tissue, healing of paired dorsal wounds 
was studied in 20 rats. In each animal one 
wound was sutured and the other was left 
open. In 10 animals both wounds were frozen 
with Dry Ice. All sutured wounds healed pri­
marily. Most of the control open wounds had 
healed at 15 days, but in the frozen wounds 
healing was delayed and infection ensued.
It is suggested that at temperatures much 
below freezing the immediate treatment of a 
wound should include prevention of frostbite 
by wound closure.
Resume: L'observation de plaies subies a des 
temperatures inferieures au point de congelation 
par des chiens esquimaux et par I'homme, per- 
met de croire que des tissus organiques mouil- 
les et exposes au froid gelent rapidement. La 
gelure de plaies entraine la necrose tissulaire, 
I'infection des plaies et retarde la cicatrisation, 
mais la suture immediate de ces plaies protege 
le sujet contre cette sequence pathologique. 
Pour explorer I'effet de la suture des plaies 
sur la cicatrisation des plaies gelees, nous avons 
etudie la cicatrisation de plaies dorsales syme- 
triques chez 20 rats. Chez chaque animal, nous 
avons suture une plaie et I'autre est demeuree 
ouverte. Chez 10 de ces animaux, les deux 
plaies ont ete gelees avec de la neige carbo- 
nique. Toutes les plaies suturees ont gueri par 
premiere intention. La majority des plaies ou- 
vertes des "t6moins" ont gu6ri en 15 jours, 
mais concernant les plaies gelees la cicatrisa­
tion a et6 retardee et elles se sont infectees.
Nous croyons done qu'aux temueratures bien 
au-dessous du point de congelation, le traite- 
ment des plaies doit comporter la prevention 
des gelures par une suture immediate.
As a medical officer on an Antarctic exped­
ition some years ago, I noticed that lacera­
tions sustained by husky dogs in fights 
healed poorly. The wounds became necrotic
* Department of surgery, St. Joseph’s Hospital, 
Hamilton, Ont.
Reprint requests to: Dr. A. R. C. Butson, 25 
Charlton Ave. E., Hamilton, Ont. L8N 1Y2.
and infected, with regional lymphadenitis 
and abscess formation. These dogs were 
kept out of doors all year and the tempe­
rature, which averaged — 15 °C, at times 
reached — 3<5°C. I also noted that if the 
lacerations were sutured immediately, wound 
infections did not develop. Details of heal­
ing of 19 wounds were recorded. The 
wounds of four dogs were not sutured; all 
became infected, healing was delayed and 
antimicrobials were required to effect heal­
ing. The 13 wounds treated by primary 
suture, however, all healed rapidly without 
infection. The other two wounds were sut­
ured after 3 and 7 days and both healed 
satisfactorily with slight delay. A further 
observation was that infections developing 
in the open wounds were consistently more 
severe than infections of similar unsutured 
lacerations sustained in a temperate envi­
ronment. Open lacerations in husky dogs 
froze solid at these temperatures, and it 
appeared that the wet blood and tissue 
fluids accelerated the freezing process.
A concomitant observation concerned 
frostbite in a man who sustained a seem­
ingly trivial laceration of a great toe from 
an unpared adjacent toenail. The blood 
from the great toe laceration froze, frostbite 
of the great toe ensued and ultimately the 
distal part of the great toe was lost.
It seems that the presence of wet blood 
and tissues is of paramount importance in 
the development of frostbite in wounds; if 
this wetness could be prevented then frost­
bite would be unlikely. It is well known 
that tissue necrosis, usually accompanied by 
wound infection and delayed healing, deve­
lops once deep frostbite has occurred,1-4 
but there appears to be no information 
about the influence of wet blood and tissues 
as factors in the development of frostbite 
in wounds. This paper reports the results 
of experiments made to investigate this.
M ethod
After anesthesia had been induced in 20, 
white, albino, Wistar rats (weight range, 
200 to 630 g) with pentobarbital (2 mg/ 
100 g), the hair over the dorsal region was 
clipped short with electric clippers. Two
146 THE CANADIAN JOURNAL OF SURGERY Vol. 18
incisions (length, 2 cm) were then made 
on either side of the dorsal spine, each 
wound being extended through the latis- 
simus dorsi, trapezius and erector spinae 
muscles. The wound on the left side was 
sutured with three or four interrupted silk 
sutures; the wound on the right side was 
left open (Fig. 1). In 10 of the rats both 
dorsal wounds were then frozen solid by 
direct .application of solid carbon dioxide 
(Dry Ice) for 4 to 10 minutes (the smaller 
animals would not tolerate more than 6 
minutes of local freezing), and in the other 
10 (controls) the wounds were not frozen. 
The skin and underlying tissue became 
frozen to a depth of about 0.3 cm. The 
wounds were then allowed to thaw and the 
animals to recover from the anesthetic in 
their cages at a room temperature of 22 °C. 
The unhealed area of each wound was 
measured twice weekly. Wound swabs were 
taken for culture from all discharging
Fig. 1.—Sutured and open wounds. Note frost­
bite of open wound.
wounds at intervals from the 6th to 19th 
day. The animals were killed on either the 
15th or 19th day. The wounds were then 
biopsied.
R esults
Skin closure was found to protect against 
deep frostbite injury. There was primary 
healing of all 10 control, sutured wounds 
and of 8 wounds that were sutured and 
then frozen (Fig. 2). Two sutured and then 
frozen wounds partly broke down on the 
surface and discharged pus, apparently due 
to superficial frostbite injury.
In the open wounds, healing was delayed. 
The area of open wound that was unhealed 
at 15 days for both frozen and control 
wounds can be determined by reference to 
Figs. 3 and 4. With one exception the un­
sutured wounds in the control rats were 
almost healed at 15 days. In contrast, the 
frozen, unsutured wounds were largely un­
healed at 15 days and showed the typical 
microscopic appearance of frostbite with 
coagulative necrosis and necrotizing myo­
sitis (Fig. 5). These results were highly 
significant when Student’s t test was ap­
plied (P <  0.001).
The duration of freezing also influenced 
healing. The unsutured wounds that were 
frozen for 8 to 10 minutes had healed less 
than those frozen for 4 to 6 minutes (Fig. 6).
Most of the wounds were dry and scabbed 
and unsuitable for culture. Of the discharg­
ing wounds all cultures grew Staphylococcus 
aureus, two grew Streptococcus jecalis, one 
grew Pseudomonas pyocyaneus, one grew
Fig. 2a Fig. 2b
Fig. 2.—Healing of sutured wounds, (a) Unfrozen wound (control) (hematoxylin and eosin, 
x 128). (b) Frozen wound (hematoxylin and eosin, x 128).
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Proteus mirabilis and one grew Enterobac- 
ter. In contrast, only one of the unfrozen 
control wounds grew a pathogenic organism 
—alpha hemolytic streptococcus.
D iscussion
The histologic changes seen in these ex­
perimental frostbite injuries are similar to 
those demonstrated by Lewis1 and are sim­
ilar to those developing after a thermal burn. 
The progression of change in deep frostbite 
of an open deep wound to tissue necrosis 
and frequent severe wound infection, and 
the protection from this sequence of events 
afforded by simple wound closure have been 
demonstrated by the present experiments.
The effect of a low environmental tem­
perature on the rate of wound healing has 
been investigated in rabbits by Filston and 
Vennes,5 who showed that an environ­
mental temperature of -7°C slowed the 
healing rate of wounds in rabbits’ ears. In 
this study a low environmental temperature
during wound healing was not considered 
pertinent.
During World War II the number of Ger­
man and Russian military and civilian cas­
ualties in eastern Europe was estimated at 
20 million.0 Of these, 3 million must have 
been sustained at temperatures substantially 
below freezing, and many of these wounds 
must have become frozen. Physicians who 
served on eastern European front noticed 
freezing of gunshot wounds, especially where 
the skin wound was extensive. In civilian 
practice in Canada it is likely that every 
year a number of accidental wounds occur 
at freezing temperatures. The application 
of the results of this study suggest that at 
temperatures much below zero a wound 
should be prevented from becoming frozen 
by immediate first-aid wound closure by 
taping, clipping or suturing, or by the use 
of a hot pack applied to the wound. This 
does not mean that the general principles 
of surgical management of a contaminated
Fig. 3.—Healing of open wounds at 15 days. 
Note frequency of different areas of unhealed 
tissue for unfrozen and frozen wounds. Differ­
ence between unfrozen and frozen wounds is 
significant (P <  0.001). Fig. 5.—Unhealed centre of frozen open wound. Photomicrograph after 15 days; note necrotizing 
myositis (hematoxylin and eosin, x 320).
Fig. 4. — Appearance of five typical control 
animals and five typical wound-frozen animals 
at 15 days.
Fig. 6.—Effect on open wound healing of in 
creased exposure to freezing. Each column repre 
sents one open wound in one rat.
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wound should be neglected. As soon as the 
casualty has been evacuated to a surgical 
facility, the wound may still have to be 
cleansed, debrided and then sutured or 
packed open, as circumstances dictate.
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OSTEOID OSTEOMA AND OSTEOBLASTOMA: RECLASSIFICATION 
OF 43 CASES USING SCHAJOWICZ’S CLASSIFICATION*
K. S. MORTON, MD, CM, FRCS[C], P. S. VASSAR, MB, BS, FCAP and 
W. J. KNICKERBOCKER, MD
Summary: Forty-three cases of benign osteo­
blastic tumour of bone from the University of 
British Columbia bone tumour registry have 
been reviewed and reclassified according to 
the classification of Schajowicz and Lemos. 
Their classification has the advantage that the 
relationship of the two lesions is recognized 
and overlap, both radiologically and micro­
scopically, is allowed for. The terminology used 
in the new classification, however, is cumber­
some and confusing and appears to be of no 
great advantage. W e therefore recommend in­
stead the terminology modified from that of
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Dias and Frost, which incorporates the obser­
vations put forth by Schajowicz and Lemos: 
(a ) cortical osteoblastoma, (b ) medullary 
osteoblastoma, (c )  periosteal osteoblastoma 
and (d ) multifocal osteoblastoma.
Resume: Nous avons passe en revue 43 cas 
de tumeur osseuse osteoblastique benigne 
enregistres dans les archives des tumeurs os- 
seuses de Colombie-Britannique et les avons 
reclassifies d'apres la classification de Schajo­
wicz et Lemos. Cette derniere presente I'avan- 
tage d'identifier la relation existant entre les 
deux lesions et tient compte du chevauche- 
ment, tant au point de vue radiologique que 
sur le plan microscopique. Malheureusement, 
la terminologie utilisee dans la nouvelle clas­
sification est incommode, prete a confusion et, 
en definitive, ne presente pas de grands avan- 
tages. Nous conseillons done de la remplacer 
par la terminologie modifiee d'apres celle de 
Dias et Frost qui incorpore les observations 
mises au point par Schajowicz et Lemos: (a) 
osteoblastome cortical, (b ) osteoblastome me- 
dullaire, (c )  osteoblastome periostique et (d ) 
osteoblastome multifocal.
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The entity known as osteoid osteoma was 
so named by Jaffe1 in 1935, on the basis 
of five cases. Some concern persisted about 
the distinction of osteoid osteoma from 
Brodie’s abscess and from Garre’s scleros­
ing osteomyelitis, but by 1940 Jaffe and 
Lichtenstein2 had reported 35 cases, and 
the concept of this entity was generally 
accepted. By 1945 Jaffe3 had collected re­
ports of 62 cases and had described the 
appearance of osteoid osteoma in both cor­
tical and cancellous bone. These reports, 
and that of Sherman,4 clearly delineated 
the entity with a distinctive clinical presen­
tation, radiologic appearance and pathologic 
characteristics.
Background
Osteoid osteoma, which generally occurs 
under the age of 20 years, is more common 
in males and can involve any bone, though 
tibia and femur are the most common 
sites.5 It is considered to be a benign neo­
plastic disease of bone2 with a fairly well- 
established natural history.6' 8 Certain hab­
itually discussed clinical features—night pain 
and aspirin relief—remain a mystery but it 
has been shown to be hypervascular9 and 
to contain nerve fibres.10 Radiologically, 
it appears characteristically as a central 
radiolucency with surrounding sclerosis, de­
pending on its origin in cancellous or cor­
tical bone. Grossly, the appearance of a 
central nidus is characteristically noted as 
a dark-red spherical or oval focus of can­
cellous-like bone, surrounded by ivory-like 
sclerosis. Microscopically, the nidus consists 
of osteoid trabeculae in a vascular connec­
tive-tissue stroma. In adjacent bone, perio­
steal reaction has been reported,11' 12 as 
have changes in adjacent joints.12’ 13 In 
addition, severe growth disturbance has been 
reported in association with osteoid osteoma 
in two cases,14 and recurrence has been 
recognized as distinctly possible.15
In 1932 Jaffe and Mayer16 described a 
tumour of a metacarpal bone containing 
osteoblastic osteoid tissue and noted certain 
similarities of this tumour to osteoid osteo­
ma. The lesion seems to have been the same 
condition described in 1954 as giant osteoid 
osteoma by Dahlin and Johnson17 and as 
osteogenic fibroma of bone by Golding and
Sissons.18 These lesions became accepted 
as benign osteoblastoma as a result of re­
ports by Jaffe19 and by Lichtenstein20 in 
1956. The distinction of this condition from 
osteoid osteoma was based mainly on its 
larger size and lack of reactive sclerosis. 
By 1964 Lichtenstein and Sawyer21 were 
able to add 20 more cases to their original 
11 and to describe it as a benign osteoid­
forming and bone-forming tumour occurring 
particularly in the limb bones, the vertebral 
column, and the calvarium most often in 
children or teenagers. Lichtenstein and 
Sawyer emphasized that the radiographic 
features are not distinctive, but generally 
a benign osteoblastoma is lucent and well 
circumscribed. Sometimes it may appear 
mottled. If, however, there is much sur­
rounding sclerosis, Lichtenstein and Sawyer 
prefer to call it osteoid osteoma, even if the 
lesion is larger than usual.
Microscopically, benign osteoblastoma 
can be distinguished from osteogenic sar­
coma by its lack of nuclear atypism and 
mitoses; from giant cell tumour by the pre­
sence of much more bone and osteoid; and 
from osteoid osteoma largely on the basis 
of size and lack of surrounding sclerosis,21 
but also by its more cellular appearance 
with abundant osteoblasts.19
Paralleling the occurrence of the peri­
osteal osteoid osteoma and anticipating 
Schajowicz’s classification,22 Lichtenstein 
and Sawyer21 reported two cases of osteo­
blastoma of periosteal origin, later referred 
to also by Goldman.23
The similarity of the two lesions implied 
by the earlier description of Dahlin and 
Johnson17 of giant osteoid osteoma is there­
fore apparent, but most authorities still in­
sist on regarding them as separate entities 
based primarily on their clinical and radio- 
logic differences. However, we have found 
that clinically, radiologically and patholog­
ically the increasing number of borderline 
lesions with features of one or the other 
entity make dogmatic designation difficult. 
Accordingly, the attempt by Schajowicz and 
Lemos22 in 1970 to place these two lesions, 
osteoid osteoma and benign osteoblastoma, 
in proper perspective and to account for 
some of these borderline lesions appealed 
to us. These authors proposed a classifica­
tion incorporating all the observed features
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of both conditions, based on 142 cases of 
“osteoid osteoma” and 42 of “benign osteo­
blastoma”. Their classification, in slightly 
reworded form, is reproduced in Table I. 
In essence they prefer the term osteoblas­
toma as representing the neoplastic nature 
of the lesions and their cell of origin. They 
avoid the qualification “benign” as being 
both redundant and possibly misleading, on 
the basis of some rather aggressive recur­
rences and the occasional arguable report 
of malignant change.24 Both the circum­
scribed and genuine osteoblastomas have 
cortical medullary and periosteal forms and 
the distinction between circumscribed and 
genuine is based largely on size. Schajowicz 
and Lemos22 also introduced a third cate­
gory, that of multifocal osteoblastoma, to 
account for occasional reports of somewhat 
bizarre cases.15
Diagnostic Criteria and Illustrative
Cases
The University of British Columbia bone 
tumour registry has listed 32 conventional 
osteoid osteomas and 11 osteoblastomas. 
Cortical and medullary (cancellous) forms 
of osteoid osteoma were included but peri­
osteal forms were not. Nor did we acknowl­
edge the one multifocal lesion previously 
reported as recurring osteoid osteoma by 
Dunlop, Morton and Elliott.15
Using the classification suggested by 
Schajowicz and Lemos,22 these 43 cases 
are grouped as shown in Table II. Four 
osteoid osteomas were accordingly clas­
sified as circumscribed osteoblastomas of 
periosteal origin and one was classified as 
sclerosing multifocal osteoblastoma. The re-
TABLE I.—Classification of Schajowicz and 
Lemos (Modified)
Circumscribed osteoblastoma (formerly osteoid 
osteoma; nidus less than 2 cm)
Cortical, sclerosing 
Medullary, cancellous 
Periosteal
Genuine osteoblastoma (formerly benign osteo­
blastoma; nidus larger than 2 cm)
Medullary, cancellous 
Periosteal 
Cortical, sclerosing 
Multifocal osteoblastoma 
Medullary 
Peripheral
maining 38 cases were retained in the cate­
gories of circumscribed osteoblastomas (27 
cases) and genuine osteoblastomas (medul­
lary or cancellous) (11 cases).
It is thus clear that, in most instances, 
the benign bone-forming lesions are in­
cluded in the classical categories of osteoid 
osteoma or osteoblastoma. But the proof of 
the value of the new classification is estab­
lished only by satisfaction of two criteria: 
first, whether this classification serves the 
purpose it was designed for and, second, 
whether that purpose is of practical value. 
The first of these criteria (whether the clas­
sification serves the purpose) is best eval­
uated by consideration of some of our 
borderline cases in more detail.
Case Reports
Case 1.—A 29-year-old woman complained 
of an ache with localized tenderness over a 
mass that was fixed to the mid-portion of the 
right fibula. Radiographs showed a sclerotic 
and lytic eccentric expansion of the fibular 
shaft. Histologic examination of the excised 
specimen was typical of osteoid osteoma.
c o m m en t .-—Histologically, this lesion ap­
peared to be a benign osteoblastic tumour 
but, radiologically, we found it difficult in 
1955 to call it osteoid osteoma. A diagnosis 
of benign osteoblastoma was considered at the 
time of Jaffe’s19 and Lichtenstein’s20 descrip­
tions in 1956, but it did not seem to fit their 
criteria on the basis of size. Classification of 
this lesion becomes possible by Schajowicz 
and Lemos’22 concept of circumscribed osteo­
blastoma or osteoid osteoma of periosteal 
origin.
Case 2.—An 18-year-old girl had had a 
painful, stiff and swollen, tender ankle for 3
TABLE II.—R eclassification of 43 Benign 
Osteoblastic T umours (University of British 
Columbia Bone Tumour Registry)
Circumscribed osteoblastoma 
Cortical (n = 14) 
Medullary (n = 13) 
Periosteal (n = 4)
Genuine osteoblastoma 
Medullary (n = 11) 
Periosteal 
Cortical
Multifocal osteoblastoma 
Medullary 
Peripheral (n = 1)
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years, which had been treated as tuberculous 
arthritis. Radiographs showed an area of radio- 
lucence in the body of the talus with a faint 
sclerotic periphery but no central calcification. 
Histologic examination of the excised, soft, 
dark nidus showed florid osteoblastic activity 
with bone production and multinucleated giant 
cells. The original diagnosis was benign osteo­
blastoma.
c o m m en t .— This case was previously re­
ported as a benign osteoblastic lesion resemb­
ling osteoid osteoma.12 We now believe this 
lesion is an osteoid osteoma (circumscribed 
osteoblastoma of cancellous origin, Schajo- 
wicz) with unusual features of hypertrophic 
synovitis13 and distant hyperostosis.11 Al­
though the classification of Schajowicz and 
Lemos22 is not essential for the categorization 
of this lesion, we believe that their broader 
concept of benign osteoblastic lesions permits 
an easier acceptance of this somewhat bizarre 
picture.
Case 3 .—A 45-year-old man had noted pain 
and swelling in the right hand for 18 months; 
the treatment was excision of a ganglion. Six 
years later pain persisted and radiographs and 
histologic examination led to a diagnosis of 
osteoid osteoma of the base of the second 
metacarpal. The lesion recurred and, 18 
months later, was excised a second time;
Fig. la
however, it recurred with multiple foci of 
osteoid tissue in the same region after ano­
ther 18 months. This third excision was fol­
lowed 1 year later still by excision of a small 
soft-tissue nodule of osteoid tissue.
c o m m en t .— This case was reported previ­
ously as a recurring osteoid osteoma.1 r> It now 
seems clear, based on the description of 
Schajowicz and Lemos,22 that this tumour 
represents a multifocal sclerosing osteoblas­
toma (multifocal osteoid osteoma); these auth­
ors described both medullary and juxtacortical 
(peripheral) forms.
Case 4.—A 15-year-old boy complained of 
pain in the left hip for several months, relieved 
in part by aspirin. Radiographs showed a 1.5- 
cm lytic lesion in the femoral neck; the lesion 
was excised. The microscopic pattern was typ­
ical of osteoid osteoma in some areas (Fig. la) 
with osteoid trabeculae and sparse stroma, but 
in others (Fig. lb) the pattern was much more 
cellular and exuberant with frequent giant 
cells, more suggestive of osteoblastoma.
c o m m en t .— The clinical history and radio- 
graphic appearance are clearly consistent with 
a diagnosis of osteoid osteoma, although the 
size of the lesion (1.5 cm) is in the range 
characteristic of giant osteoid osteoma (osteo­
blastoma) as originally described by Dahlin 
and Johnson.17 We were intrigued by the
Fig. lb
Fig. 1.—Case 4. (a) Dense irregular osteoid trabeculae suggest diagnosis of osteoid osteoma in 
this microscopic field, (b) In same section as in (a) microscopic appearance is clearly more cel­
lular and vascular with multinucleated giant cells and osteoid trabeculae. Features of this area alone 
could be interpreted as those of osteoblastoma (hematoxylin and eosin, x 254).
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variable histologic pattern of the lesion and 
we concluded tha t it illustrates criteria for 
each or both diagnoses. A ccording to  the ter­
minology of Schajowicz and Lem os,22 it would 
be referred to  as a circumscribed osteoblas­
tom a of m edullary (cancellous) origin.
The second criterion (whether the new 
classification is of practical use) may best 
be considered by questioning the value of 
classifications in general. Their greatest 
value is probably as a teaching technique. 
Once the concept that they represent is 
properly understood and once one has 
knowledge of a description, the need for 
classification as such diminishes. Naming 
the lesion continues to be important for 
communication and for its implied treat­
ment and prognosis, but constantly relating 
it to the total classification is probably un­
necessary and can be awkward.
Initially we had registered in the bone 
tumour registry 32 osteoid osteomas and 
11 osteoblastomas. Use of the new termi­
nology, however, permitted us to classify the 
turnovers as 31 circumscribed osteoblas­
tomas, 11 genuine osteoblastomas, and 1 
sclerosing, peripheral, multifocal osteoblas­
toma. By applying and making use of the 
basic concept of the classification of Scha­
jowicz and Lemos, we believe we have 
come to a greater understanding of benign 
osteoblastic tumours of bone— particularly 
their radiographic and microscopic appear­
ances— but we find the new terminology at 
best awkward and at worst confusing.
Recently Dias and Frost25 reached the 
same conclusion. In their view osteoid 
osteoma and osteoblastoma are variants of 
the same process, the nature of the reaction 
being determined by its location in bone. 
Accordingly they have proposed the terms 
cortical osteoblastoma (for osteoid osteoma) 
and spongious osteoblastoma (for benign 
osteoblastoma) recognizing also the useful­
ness of Schajowicz’s categories periosteal 
osteoblastoma and multifocal osteoblastoma. 
Our only criticism of this approach is in 
the use of the awkward description spon­
gious, for which we would substitute medul­
lary.
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VASCULAR COMPARTMENT SYNDROMES*
P. J. FOWLER, MD, FRCS[C] and R. B. WILLIS, MD
'•immary: In a 5-year period (1968 to 1973) 33 
jses of vascular compartment syndrome were 
sen. Seven case reports illustrate various 
tiopathogenetic factors in the development of 
scular compartment syndrome. A  review of 
tne 33 cases has permitted discussion of the 
pathophysiology and clinical features of these 
syndromes, together with introduction of a 
clinical classification on which treatment is 
based. Mild cases may be treated by application 
jf ice, elevation, and observation; for severe 
:ases fasciotomy is the treatment of choice. 
Two techniques of fasciotomy are available: 
multiple skin incisions with fasciotomy between 
the incisions for single-compartment syndromes 
and extensive skin incisions over the length of 
the fasciotomy for multicompartment syndromes 
or severe single-compartment syndromes.
Resume: Au cours d'une period© de 5 annees 
,1968 a 1973), nous avons vu 33 cas de syn- 
"rome du compartiment vasculaire. Sept cas 
nt permis d'illustrer divers facteurs etiopatho- 
sques du developpement de ce syndrome. 
? revue globale des 33 cas a permis de dis- 
:er la physiopathologie et les caracteristiques 
ces syndromes et, en outre, d'aboutir a une 
■sification clinique sur laquelle repose le 
ament. Les cas benins peuvent etre traites 
('application de glace, I'elevation et I'observa- 
°ar contre, pour les cas severes on choisit 
otomie. On dispose de deux techniques 
.sciotomie: des incisions cutanees multiples 
c fasciotomie entre les incisions dans le cas 
syndromes 5 compartiment unique, et les in- 
isions cutanees multiples sur toute la longueur 
de la fasciotomie dans les syndromes a compar- 
timents multiples ou les cas severes de syn­
dromes a compartiment unique.
r  O ne of the most important yet neglected 
' areas in the management of trauma is 
the recognition and prompt treatment of 
I vascular compartment syndromes. The
f
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classic description of such a syndrome is 
that of Volkmann,1 who noted ischemic 
contracture in the lower leg after the ap­
plication of constricting bandages. Common­
ly, Volkmann’s ischemic contracture is as­
sociated with supracondylar fractures of 
the humerus and resultant ischemia to the 
flexor compartment of the forearm, but this 
entity is only one of several vascular com­
partment syndromes. Others are the isolated 
anterior, the isolated posterior and the multi­
compartment syndromes in the lower ex­
tremity.2'8
In this paper we provide representative 
case reports of examples of these syndromes 
and discuss the pathophysiology, clinical 
features, classification and treatment of 
vascular compartment syndromes. A retro­
spective study of vascular compartment syn­
dromes in 33 cases seen during the 5-year 
period from 1968 to 1973 was the basis of 
this review.
Case R eports
Case 1 .—A 26-year-old man was admitted 
to hospital in Moose Factory, Ont. after being 
rescued from James Bay during a storm. His 
legs had been immersed in the water for 16 
to 20 hours. On admission, both legs were cold 
and swollen. Shock was treated by administra­
tion of intravenous fluids. He was then trans­
ferred to the Victoria Hospital, London, Ont. 
in renal failure. Approximately 36 hours after 
rescue his legs were grossly swollen, pulseless 
and anesthetic. There was no pain on passive 
toe movement. He was still toxic 36 hours 
later despite renal dialysis. Fibulectomy and 
fasciotomy were performed. All four lower 
extremity compartments were decompressed 
through the bed of the excised fibula. His con­
dition deteriorated and, 8 days after admission, 
left below-knee amputation was performed. 
The entire right anterior compartment grad­
ually sloughed but this leg was saved.
At the time of discharge there was no active 
dorsiflexion of his toes, only slight plantar 
flexion, and decreased sensation on the dorso­
lateral aspect of his right foot. At present he 
has a right foot-drop brace and a left below- 
knee prosthesis.
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c o m m en t .—This is an example of multi­
compartment vascular syndrome due to im­
mersion limb cold injury.
Case 2 .—A 19-year-old man was seen in 
the emergency department IV2 days after 
“jumping over a high fence”. The right leg 
was swollen and tender over the entire anterior 
compartment. There was pain on passive plan­
tar flexion of the toes, and muscle testing re­
vealed zero power in the extensor hallucis 
longus and tibialis anterior muscles.
The anterior compartment was decom­
pressed through multiple skin incisions, the 
fascia being incised throughout its length. De­
layed primary closure of the skin incisions oc­
curred on day 5, and this was followed by an­
terior compartment functional recovery.
c o m m en t .-—This example of isolated an­
terior compartment syndrome was due to in­
direct soft-tissue injury.
Case 3 .—A 23-year-old man sustained a 
fracture of the left radius and ulna in a traffic 
accident. He was referred to the Victoria Hos­
pital, London, Ont. 15 days after the accident. 
His arm was in a circular plaster cast; contrac­
ture of the wrist and fingers was noted. Fasci- 
otomy was not performed because of the 15- 
day interval between fracture and diagnosis. 
After 4 months he still had a persistent flexion 
contracture of his wrist and fingers. Because 
of this, radical excision of both superficialis 
and profundus muscles and neurolysis of me­
dian and ulnar nerves were performed. Re­
constructive surgery on the hand was per­
formed subsequently.
c o m m en t .—In this case Volkmann’s is­
chemic contracture of the forearm followed 
- fracture of both bones of the forearm—pos­
sibly a more common cause than supracondylar 
fracture of the humerus.
Case 4 .—A 20-year-old man sustained closed 
fractures of his left tibia and fibula during a 
baseball game. These were treated with open 
reduction and Lottes’ nail fixation. Four hours 
later he complained of pain, numbness and 
loss of active toe motion. An anterior com­
partment fasciotomy alone was performed.
Two months later he was seen because of a 
fixed equinovarus foot with claw toes. He re­
quired reconstructive surgery and treatment of 
trophic ulceration because of failure of recog­
nition of a posterior compartment syndrome.
c o m m en t .—This is an example of an un­
recognized posterior compartment syndrome I 
resulting in reconstructive surgery and treat-1 
ment of trophic ulceration.
Case 5 .—A 19-year-old man, who was in 
volved in a motor vehicle accident, sustaine< 
an open fracture of his right femur, an opei 
fracture of his right tibia and fibula, and dis 
ruption of the femoral artery at the fracture 
site in the femur. Primary repair of the femora 
artery by end-to-end anastomosis was carried 
out, followed by debridement of the areas a 
both fracture sites and extensive fasciotomy o 
the anterior, lateral and both posterior com­
partments. The degree of herniation of muscle 
through the fascia was impressive.
Six days later delayed primary closure of 
the wounds was performed, but bulging 
through the anterior fasciotomy incision was 
even more obvious and the incision could not 
be closed. It required split-thickness grafts 5 
days later. Despite these measures, foot-drop 
was noted temporarily after grafting, but there 
was no evidence of posterior or lateral com­
partment problems.
c o m m en t .—This case demonstrates the need 
for fasciotomy in fractures associated with ar­
terial injury.
Case 6.—A 17 year-old boy suffered fron 
recurrent patellar subluxation requiring 
Hauser stabilization procedure. On the 3rd da'] 
after operation his foot was blue and he haq 
a mild foot-drop. The cast was removed and 
the leg elevated. The peroneal nerve, explored 
on the 4th postoperative day, appeared to bd 
normal.
Five months after surgery, strength in the1 
extensor hallucis longus, peronei and tibialis 
anterior muscles was greatly diminished. The 
Muscle biopsy revealed ischemia, and electro­
myographic studies and nerve conduction con­
firmed this. The patient has been able to walk 
without a foot-drop brace.
c o m m en t .—This is a well-recognized com­
plication following reconstructive knee sur­
gery. Five cases of the identical presentation 
following the Hauser procedure were dis­
cussed at the American Academy of Ortho­
paedics meeting in 1973.9
Case 7.—A 17-year-old girl took an over­
dose of propoxyphene hydrochloride (Darvon) 
and, while being treated in the emergency 
department, suffered severe grand mal seizures
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with violent tonic muscle contractions. Ortho­
pedic consultation was requested 24 hours later 
because of swelling of the anterior compart­
ment of both legs. Treatment by application 
of ice and elevation for 1 hour was not suc­
cessful and, 30 hours after admission, fascio- 
tomy was carried out through multiple skin 
incisions.
The patient now has a power of 4 in all 
muscle groups of the anterior compartment 
except the extensor hallucis longus, which has 
a power of 2.
c o m m en t .— This is an example of an un­
usual presentation of isolated anterior com­
partment syndrome following grand mal seiz­
ure with violent tonic muscle contraction.
P a th o ph y sio lo g y
Several theories have been postulated for 
the cause of the resultant contractures. In 
1881, Volkmann1 described arterial occlu­
sion and its sequelae as the cause. Brooks10 
in 1922 described venous obstruction, and 
Jepson2 in 1926 implicated external com­
pression as the major factor responsible for 
the syndrome. Others have implicated ar­
terial spasm,11 capillary paralysis1- and 
peripheral nerve injuries.1:1
The single factor common to these syn­
dromes is interruption of the arterial sup­
ply.2- 4- 14-18 The initial injury causes an 
arterial lesion or hemorrhage in strictly con­
fining osseofacial compartments. This re­
sults in edema, swelling and significant in­
creases in tension within these confined 
compartments. If the degree of trauma is 
slight, the process will often resolve, but if 
it is severe the increase in tension impairs
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Fig. 1. —Factors in pathophysiology of vascular 
compartment syndromes (modified from McQuil­
lan WM, Nolan B: Ischemia complicating in­
jury. J Bone Joint Sttrg [Br] 50: 482, 1968).
venous return, produces more swelling 
and edema and reduces arterial flow. All of 
these factors lead to ischemia. The patho­
physiologic factors of importance in vascu­
lar compartment syndromes are depicted 
diagrammatically in Fig. I .3
Rorabcck and Macnab10 investigated the 
isolated anterior compartment syndrome 
and gave arteriolar occlusion as the cause 
for the ischemia. Their experimental evi­
dence showed that a pressure of only 30 to 
50 mm Hg was necessary to cause occlusion 
of nutrient arterioles to muscle.
Persistent, severe, or complete ischemia 
is the result of interruption of the arterial or 
arteriolar supply and eventually leads to 
myonecrosis, fibrosis and the resultant con­
tracture. Occlusion of vessels in the peri­
neurium of the peripheral nerves results in 
the same fibrotic mechanism.20
C l in ic a l  F eatu res
The classic clinical warnings of ischemia 
are pain, pallor, absence of pulses, puffiness, 
paresthesia and paralysis. The most reliable 
sign is painful limitation of movement of 
either fingers or toes.5- 8- 18 The pain is ag­
gravated by passive movements that stretch 
the affected muscles. Examples of such 
movement are extension of the fingers caus­
ing pain in the flexor compartment of the 
forearm with classic Volkmann’s iscnemia 
and flexion of the toes with isolated anterior 
compartment syndrome of the lower ex­
tremity.
Evaluation of the peripheral circulatory 
status is not useful in monitoring these syn­
dromes because the pulses are often present 
and the skin is kept warm by an adequate 
collateral circulation.5- 7- 8- 18
C l a s s ific a t io n
To facilitate selection of the method of 
treatment we have subdivided the vascular 
compartment syndromes into three classes 
(I [mild], II [moderate] and III [severe]) 
with respect to pain on passive movement, 
swelling, weakness and sensation. Table I 
summarizes the distribution of vascular com­
partment syndromes according to anatomical 
localization and their severity among the 
33 patients.
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TABLE I.— D istribution and Severity of Vascular Compartment Syndromes
Anatomic basis of syndrome
/
{mild)
Class
I I
{moderate)
I I I
(severe)
Total no. of 
patients
Upper extremity:
Volkmann’s ischemia of forearm................. 0 3 4 b
Lower extremity:
Anterior compartment................................... 3 4 u V
Posterior compartment.................................. 3 6 0 9
Multicompartment......................................... 0 6 5 11
Total............................................................................ 6 18 9 33
T r e a t m e n t
The treatment is relatively simple once 
the diagnosis has been made. In class I the 
physician can temporize with the application 
of ice, elevation of the limb and close ob­
servation of the patient. Close observation 
is essential because the condition can de­
teriorate rapidly.
If the condition does not resolve or if it 
worsens, fasciotomy is the treatment of 
choice. Certainly, if the process is not re­
solving, conservative management, epidural 
anesthesia and sympathectomy are to be 
condemned, whatever the class.6’ 717
There are two chief techniques of fascio­
tomy (Fig. 2):
1. Multiple skin incisions and extensive 
fasciotomy between the incisions is most 
often selected in cases of single-compart­
ment syndromes.
2. An extensive skin incision over the en­
tire length of the fasciotomy is recommended 
in the management of multiple-compartment 
syndromes or severe single-compartment 
syndromes. The skin incisions are left open,
Fig. 2.—Methods of fasciotomy. (a) Multiple 
skin incisions and fasciotomy between incisions, 
(b) Extensive skin incision and fasciotomy.
and are closed on a delayed, primary basis 
or are skin grafted (Fig. 3).
Once the impressive herniation and bulg­
ing of the muscle mass from its compart­
ment after fasciotomy have been seen, the 
need for the procedure is readily apparent. 
The technique of fibulectomy and fascio­
tomy as recommended by Ernst and
Fig. 3.—Method of delayed primary skin clo­
sure. (a) Suture alone, (b) Suture and split-thick­
ness skin graft.
Fig. 4.—Access to all four lower extremity 
compartments after fibulectomy (modified from 
Ernst CB, Kaufer H: Fibulectomy-fasciotomy: 
important adjunct in management of lower ex­
tremity arterial trauma. J Trauma 11: 365, 1971).
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Kaufer2 is ideal for class III multicompart­
ment lesions because it provides access to 
all four lower extremity compartments 
through the bed of the excised fibula (Fig. 4).
Ischemic compartment syndromes in the 
upper limbs are largely confined to children, 
and those in the leg are more common in 
adults.4
The incidence of posterior compartment 
syndrome following tibial fractures ap­
proaches 10% in some series.21 Because 
severe deformity and disability may develop 
in patients who receive no specific treatment, 
the following recommendations concerning 
indications for fasciotomy merit emphasis.
Indications for Fasciotomy
1. Fracture associated with arterial in­
jury: The high incidence of vascular com­
partment syndrome following fracture with 
arterial injury makes fasciotomy an abso­
lute necessity.4- 6- 10- 17
2. Arterial injury alone: If the patient has 
an isolated arterial injury and the interval 
between injury and operation is 4 to 6 hours, 
fasciotomy is indicated.14- 15
3. Extremity fractures with extensive 
soft-tissue injury: Extensive soft-tissue in­
jury associated with both closed and open 
upper and lower extremity fractures war­
rants fasciotomy because this procedure is 
simple and safe."’- 8 18
4. Diagnosis of class II or III vascular 
compartment syndromes.
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an emerging problem.
“Bacteroides species are often over- “Our experience with this series of seriously 
looked as a cause of serious infec- ill patients provides clinical confirmation to - *  
tion both by clinicians and micro- complement recent in vitro evidence that, 4 
biologists. They are most commonly clindamycin is the antibiotic of choice for 
associated with intra-abdominal use in bacteroides infections. Not only was 1 
and pelvic sepsis following gastro- the response in 17 of the 18 patients favour- vj 
intestinal surgery.” able, but in several it was dramatic.” r
T ra cy ,0 .,e t al.(29 Jan .’72). Haldane, E .V . and van Rooyen,C.E.( 1972). \
Brit, med. J.,p . 280. C.M .A.J.,p. 1177.
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.bacteroides infection
[
•  I.M. injection or I.V. infusion 
‘ achieves prompt and high peak 
. serum levels of active clindamycin
•  well tolerated locally and sys- 
L, temically following I.M. injection 
I or I.V. infusionr
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*Depending on the severity of the infection.
**Dalacin C Phosphate Sterile Solution should not be 
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fusion. See product monograph supplied with each pack­
age for complete dosage information and infusion rates.
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bophlebitis, erythema, swelling and pain at the infusion site 
have been observed following intravenous infusion. 
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the drug. This diarrhoea has been occasionally associated 
with blood and mucus in the stools and has at times resulted 
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Abnormalities in liver function tests have been reported 
occasionally. Usual antibiotic side effects -  rash, urticaria, 
pruritus, fever, leukocytosis, nausea, diarrhoea, changes 
in blood pressure, shortness of breath and bad or bitter 
taste in mouth have been reported.
Not indicated in patients who have demonstrated sensi­
tivity to clindamycin or lincomycin. Safety in infants be­low 30 days of age or in pregnant women not established. 
Use with caution in patients with a history of asthma and other allergies. As with other antibiotics, periodic liver 
function tests and blood counts should be performed dur­ing prolonged therapy.
Detailed information available upon request.
Availability:
Dalacin C Phosphate Sterile Solution -  Each ml contains 
clindamycin-2-phosphate equivalent to clindamycin base 150 mg in 1 ml and 2 ml ampoules.
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GLIMPSES OF SURGICAL HISTORY: 
B FOR BLOOD TRANSFUSION
D. A. E. SHEPHARD
Blood, with its rich symbolism, has long seemed 
magical but the history of BLOOD TRANSFU­
SION is relatively recent. Man first had to con­
ceive the idea of injecting substances into the body 
and to formulate the concept of the circulation. 
The 17th century was crucial. Libavius (1615) was 
one of several to suggest blood transfusion but 
the seminal event was the discovery of the cir­
culation by Harvey (1616). An astronomer-archi­
tect, Wren, injected drugs— and blood— into ani­
mals in 1656; a physician-anatomist, Lower, trans­
fused blood from one animal to another in 1665; 
and a philosopher-mathematician-physician, Denys, 
transfused blood into a human being in 1667. 
Denys’ patient received about 270 ml of lamb’s 
blood; but another of his patients died after a 
transfusion. Transfusion lost favour, perhaps 
fortunately because the technique way not under­
stood and was certainly misused: it was used for 
conditions as varied as lung disease, bowel dis­orders, senility and insanity.
Its reinstatement was the work of the English 
obstetrician, Blundell. Puerperal hemorrhage dis­
mayed him. His experiments demonstrated two 
points: death from hemorrhage could be prevented 
by tranfusion of blood from animals of the same 
species, and successful transfusion required spe­
cies-compatible blood. Blundell way the first to 
transfuse human blood into humans (1818). He 
also showed that passage through instruments 
did not damage blood and that air bubbles need not be harmful.
Coagulation, phlebitis and reactions remained 
problematical. Coagulation was overcome to some 
extent with Aveling’s rubber bulb to expedite 
blood flow (it could also be carried in the pocket 
from patient to patient). Defibrinated blood (even 
when a wire egg beater and a hair sieve were 
used) also helped. Another idea way the use of 
sodium phosphate as an anticoagulant (but Brax- 
ton-Hicks found that it was toxic).
Once again the technique declined. By 1873 
obstetricians regarded transfusion as a desperate 
measure. Again it way being misused: all sorts 
of patients, including “the burnt, the uremic, the 
syphilitic and the mad" received blood —  even animals’ blood.
The final victory came with the 20th century. 
Landsteiner and also Shattock detected agglutinins 
and isoagglutinins; Landsteiner, and others, also 
identified the major blood groups; Kimpton and 
Brown paraffined containers; Lewisohn and others 
preserved blood with sodium citrate; and Fantus 
made blood banking possible. These techniques, 
as well as the use of heparin, finally made com­
plex operations possible and saved a myriad lives.
Upjohn THE U P JO H N  C O M P A N Y  OF CA NA DA
865 YO RK MIL LS  R O A D / D O N  MILLS, ON TARIO
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ESOPHAGEAL RECONSTRUCTION: AN EXPERIMENTAL APPROACH 
TO THE CONTROL OF REFLUX AFTER ESOPHAGEAL RESECTION*
R. D HENDERSON, MB, FRCS[C], K. FUN G , MD, P. DUBE, FRCS(Eng) and 
G. MARRYATT, RNA
Summary: A study of the properties of replace­
ment gastric tubes and colonic segments, and 
their use in the prevention of reflux after eso­
phageal resection indicates that, in order to 
prevent reflux, these tubes must be maintained 
in a subdiaphragmatic position. Gastric tubes 
have a higher intrinsic pressure barrier than 
colonic tubes— a 2.5- to 6-cm segment pre­
vents reflux and the tube maintains a pressure 
barrier 10 cm H ,,0  higher than stomach pres­
sure, whereas colonic segments require 12 cm 
of subdiaphragmatic length to control reflux and 
maintain a pressure barrier only 2 cm H ,,0  
above gastric pressure. Removal of the intrinsic 
pressure barrier by myotomy allows free reflux 
in tubes that previously had prevented reflux.
Resume: Apres avoir etudie les proprietes des 
tubes de remplacement de I'estomac et du 
colon et leur utilisation pour prevenir le reflux 
apres resection de I'oesophage, nous avons 
constate que, pour remplir leur but, ces tubes 
doivent etre maintenus en position sous le 
diaphragme. Les tubes gastriques ont une bar- 
riere de pression intrinseque plus elevee que 
les tubes du colon: un segment de 2.5 a 6 cm 
empeche le reflux et le tube maintient une bar­
riers de pression de 10 cm H o0  plus forte 
que la pression gastrique, tandis que, pour 
enrayer le reflux, les segments du colon doi­
vent avoir une longueur sous-diaphragmatique 
de 12 cm et ne maintiennent une barriere de 
pression, par rapport a la pression gastrique, 
que de 2 cm H20 . La suppression de la bar­
riere de pression intrinseque par myotomie per- 
met le reflux libre dans les tubes qui, aupa- 
ravant, empechaient le reflux.
A f t e r  esophageal resection, some form of 
replacement surgery is necessary. Various 
approaches have been tried and at present 
replacement by stomach1'6 and by colon7'9 
are the most popular methods. Of the well- 
recognized problems in replacement surgery, 
the long-term effect of gastric reflux upon 
the replacement organ is particularly im­
portant.
* Supported by the Ontario Cancer Treatment and 
Research Foundation, grant no. 235.
Reprint requests to: Dr. R. D. Henderson, room 
139, university wing, Toronto General Hospital, 
Toronto, Ont. M5G 1L7.
At 6 months after the use of stomach 
as a replacement organ, the incidence of 
peptic stricture has been reported as 27% .10 
Anderson and Randolph11 used a gastric 
tube to replace the esophagus, and reported 
ulceration and perforation in the tube seg­
ment. In colonic replacement of the eso­
phagus, reflux is less often a problem, but 
peptic ulcers of the colon have been re­
ported,12’ 13 and some experimental data 
suggest that the colon mucosa is sensitive 
to gastric juice irritation.
The present study was designed to deter­
mine the pathophysiologic properties of 
gastric tubes and colonic segments, and to 
investigate how these could be used to pre­
vent reflux in experimental esophageal 
reconstruction.
G a st r ic  T u b e  Stu d y
Dogs in this study were prepared by 
excision of the lower 10 cm of esophagus 
and replacement of this segment by a gas­
tric tube of the same circumference as the 
esophagus. The tube was taken from the 
greater curvature of the stomach and con­
structed over a metal cylinder (circumfer­
ence 6.5 cm, equivalent to a no. 50 French 
bougie). The constructed tube was anasto­
mosed to the distal esophageal stump. All 
dogs had a vagotomy and pyloroplasty.
The animals were trained to accept eso­
phageal motility tubes while fully conscious 
and each dog was studied before and after 
surgery. Preoperatively, three manometric 
studies were performed using a three-tube 
system of polyethylene PE 240 tubes bound 
together with side openings 5 cm apart. 
Constant water infusion was maintained by 
a 2202 Harvard pump. Statham P23De 
strain gauges were used as sensing devices 
and a 1508 Honeywell ultraviolet visicorder 
recorded the pressure.
After 2 weeks’ convalescence, each dog 
had three manometric studies. Barium cine­
matographic and combined radiologic, man­
ometric and pH studies were done to relate 
pressure changes in the gastric tube to its 
anatomical position.
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Intra-abdominal V ersus
Intrathoracic Gastric T ubes
After the basic operation, the gastric tube 
was placed in one of three positions as fol­
lows (Fig. 1):
1. In Group I (three dogs), a 6-cm gas­
tric tube was maintained below the dia­
phragm and wrapped two-thirds around by 
gastric fundus (fundal plication).
2. In Group II (four dogs), a 6-cm seg­
ment of gastric tube was placed below the 
diaphragm without gastric fundal plication.
3. In Group III (three dogs), a 6-cm gas­
tric tube was placed entirely within the 
chest with the point of junction between 
the tube and stomach at the diaphragmatic 
level.
All preoperative manometric studies 
showed normal canine esophageal motor 
function.
The results in Group I and II dogs (seven 
dogs) were identical. There was no radiol­
ogic or pH evidence of reflux with an intra- 
abdominal tube segment of 6 cm. Mano- 
metrically, the tube segment had a zone of 
elevated pressure of 16 cm HoO, the mean 
gastric pressure was 6 cm H 20  and the 
mean esophageal pressure was — 2 cm H 20 ; 
a pressure barrier of 10 cm H 20  between 
gastric tube and stomach was maintained 
(Fig. 2, Table I).
Radiologically, Group III dogs (three) 
showed free reflux at all times. During 
combined radiologic and manometric stud­
ies it was possible to produce free reflux 
by abdominal compression, which simulta­
neously raised esophageal pressure and 
produced a fall in esophageal pH. The 
manometric pattern seen in this group of 
dogs was exactly the same as in the pre­
ceding groups except that there was a def­
inite elevation of esophageal pressure from 
— 2 to + 18  cm H20 .
This study showed that a 6-cm segment 
of subdiaphragmatic gastric tube prevented 
reflux. We now believed it necessary to 
examine further the length of gastric tubes 
that would prevent reflux and for this pur­
pose gastric tubes of varying length were 
constructed.
GASTRIC TUBE
T 16
G 6 E -2
T-G - 10
GASTRIC TUBE 
MYOTOMY G 6 T 6
E -1.5
T-G - 0
COLONIC TUBE G 14 C 16
E -6.5
C-G - 2
COLONIC TUBE
MYOTOMY G 8 C 8
Fig. 2.—Average manometric pressures in gas­
tric and colonic tube segments and average gastric 
(G) and esophageal (E) pressures at each stage 
of study. Comparison of tubal pressure (T) minus 
gastric pressure (G) (T -G )  shows that normal 
gastric tube has pressure barrier of 10 cm H20 . 
After myotomy T - G  becomes 0. In colonic 
tubes, tubal pressure (C) minus gastric pressure 
(G) (C-G)  is 2 cm H20  and after myotomy 
C - G becomes 0.
Fig. 1.—Basic operation and placement of gastric tube in Groups I, II and III. In Group I, 
6 cm of tube is maintained below diaphragm and wrapped with stomach. In Group II, 6 cm of tube 
is maintained below diaphragm without gastric wrap. In Group III, gastric tube is entirely intra­
thoracic. Note acute angle in Group I and obtuse angle in Group II.
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SUBDIAPHRAGMATIC GASTRIC TUBE
L engths
In six dogs, gastric tubes of varying 
lengths were constructed. One dog had a 
4-cm tube, two dogs had a 3-cm tube and 
two had a 2.5-cm tube. Study of these dogs 
was carried out as in stage I and showed 
the normal tubal pressure and no evidence 
of radiologic, manometric or pH reflux. 
One dog had construction of a 2-cm tube 
and showed free reflux demonstrated by all 
techniques.
M yotomy— Subdiaphragmatic
G astric T ubes
Having demonstrated that subdiaphrag­
matic tubes prevented reflux and that these 
tubes by themselves had an intrinsic pres­
sure, we believed it was necessary to exam­
ine the properties of the tube by myotomiz- 
ing the gastric tubes. Five of the previously 
studied dogs were selected for myotomy of 
the subdiaphragmatic gastric tube. These 
dogs had tubes 6, 6, 4, and 3 and 2.5 cm 
in length and had been fully studied to 
demonstrate that they did not have reflux. 
A second operation was performed using a 
transabdominal approach, and the intra­
abdominal segment of the tube was myo- 
tomized from the level of the diaphragm 
to its point of junction with the stomach. 
After myotomy of the intra-abdominal tube 
segments, the dogs with one exception freely 
refluxed radiologically, manometrically and 
by pH studies. The one dog (with a 3-cm 
tube) without reflux, at autopsy was shown 
to have an incomplete myotomy.
Manometrically, there was a reduction 
in pressure of the tube segment with total 
elimination of the pressure barrier from the 
gastric tube to stomach (Fig. 2).
Colonic  Segm ent  Study
This same experimental model has been
used to study the properties of colonic seg­
ments used to replace the lower esophagus. 
The dogs were again studied manometric­
ally and found to have normal preoperative 
motor function.
The dogs were prepared preoperatively 
with neomycin. For exposure a short thor­
acoabdominal incision was used. Colonic 
segments were vascularized from the ascend­
ing branch of the left colic artery. The 
distal 10 cm of esophagus was excised, and 
vagotomy and pyloroplasty were performed. 
End-to-end anastomosis and cologastric 
isoperistaltic anastomosis were constructed. 
The colonic segments of varying lengths 
were positioned differently in the various 
dogs: in three, a 6-cm colonic segment was 
placed in a subdiaphragmatic position; in 
three dogs the segment was above the dia­
phragm and in two dogs a 12-cm colonic 
segment was positioned supradiaphragma- 
tically.
Reconstruction by any of these three 
methods produced identical results. All dogs 
had free radiologic and manometric reflux. 
The manometric studies showed an average 
gastric pressure of 14 cm H aO and a low 
basal tone in the colonic segments of 16 
cm HoO. There were superimposed colonic 
segmental contractions of up to 20 cm 
amplitude and of 30 to 60 seconds’ dura­
tion. The pressure barrier from colon to 
stomach averaged 2 cm H aO (Fig. 2).
Despite prolonged continuous manome­
tric studies, there was no evidence of peri­
staltic colonic motor activity.14’ 15 When 
boluses of water and 0.1N HC1 were in­
jected, the colonic segment responded by 
a slow pressure rise followed by a sharp 
nonperistaltic pressure wave, which corre­
sponded to the pressure wave of esophageal 
peristalsis.
Combined fluoroscopic and manometric 
studies showed that the injected bolus, made
TABLE I.—Average and Range of Pressures (cm H20) in Tube Segments and T ubal Barrier to
Reflux*
Stomach Tube T -  G
Average Range Average Range Average Range
Gastric tube 6 2 — 10 16 7.5 — 25 10 7.5 — 20Gastric tube myotomy 6 0 — 12 6 0 — 12 0 1 — 1.3Colonic tube 14 8 — 20 16 10 — 20 2 1 — 3Colonic tube myotomy 8 4 — 10 8 4 — 10 0 1 — 1
*Minimum of three studies per dog.
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radiopaque by addition of barium, was 
forced back into the distal esophagus by 
colonic contraction waves and the bolus 
then triggered esophageal peristalsis, which 
cleared it through the colonic segment and 
into the stomach.
Having found that a 6-cm subdiaphrag- 
matic colonic segment did not control reflux, 
we then constructed a 12-cm subdiaphrag- 
matic colonic segment in three animals. 
They showed no radiologic or manometric 
evidence of reflux. The manometric pres­
sures and motor function in these dogs were 
identical to those seen in the earlier studies.
As a final stage of study, the three dogs 
with 12-cm subdiaphragmatic colonic seg­
ments that had been proved to be compe­
tent were then fully myotomized from the 
level of the diaphragm to the point of junc­
tion with the stomach. All dogs in this 
group showed free radiologic, manometric 
and pH reflux after myotomy. There was 
a complete loss of the pressure barrier from 
colon to stomach. The average colonic and 
gastric pressures in these dogs were 8 cm 
HoO.
D iscussion
We have shown that a gastric tube of 
esophageal diameter maintained a pressure 
barrier of 10 cm H20  above gastric pres­
sure. When this tube is placed above the 
diaphragm, the same pressure barrier exists 
but free reflux occurs. If the tube is main­
tained 2.5 to 6 cm below the diaphragm, 
reflux is prevented. Myotomy of the sub- 
diaphragmatic tube segment abolishes the 
pressure barrier from tube to stomach and 
allows free reflux (Fig. 2).
Using colonic segments to replace the 
lower esophagus we found that a 6-cm 
segment of colon above or below the dia­
phragm did not prevent reflux. The colo- 
gastric pressure barrier was only 2 cm H 20 . 
When the length of colon was increased to 
12 cm the subdiaphragmatic colonic seg­
ment prevented reflux while a supradia­
phragmatic segment still allowed free reflux. 
Myotomy of the subdiaphragmatic colon 
totally abolished its pressure barrier and 
again free reflux occurred.
The gastric tubes and colonic segments 
appear to act as an effective pressure bar­
rier to reflux in that, if sufficient length
of tube is maintained below the diaphragm, 
reflux is prevented. The mechanism of the 
antireflux barrier provided by these tubes 
probably is more complex than simple 
maintenance of a pressure barrier, but the 
pressure barrier is important because free 
reflux recurs after ablation by myotomy. 
We conclude that two of the major factors 
in preventing reflux are the pressure barrier 
and tubal length. In the gastric tube the 
pressure barrier is higher, and reflux can 
be prevented by a 2.5-cm tube. When the 
gastric tubal barrier is ablated by myotomy, 
free reflux occurs, even with a 6-cm tube. 
In the colonic segment the tubal pressure 
is low and a 12-cm segment of colon is 
necessary to prevent reflux. Reflux again 
occurs in the colon when the pressure bar­
rier is ablated by myotomy.
We believe that the antireflux properties 
of the tube depend upon its subdiaphrag­
matic position (Fig. 3). When intraperi- 
toneal pressure is increased, this acts equally 
upon the stomach and the subdiaphragmatic 
tube. Any increase in gastric pressure will 
be counterbalanced by a similar increase 
in tubal pressure. When the tube itself main­
tains a constant tone, then this pressure 
barrier remains intact and acts to prevent 
reflux from stomach to esophagus. When the
I P P  I T T
AAAAAAAAA I
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Fig. 3.—Antireflux mechanism of tubes. Tube 
segment, either gastric or colonic, is interposed 
between body of stomach and esophagus. Tone 
of tube segment, supported by intraperitoneal 
pressure (IPP) counterbalances gastric reflux pres­
sure (R). If tube segment is intrathoracic then 
it loses support of IPP and tone is no longer 
sufficient to prevent reflux. ITT =  intrathoracic 
pressure.
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tube is placed in the chest, there is no coun­
terbalancing pressure on the tubal segment 
so that increased intraperitoneal pressure 
will independently raise gastric pressure. 
When gastric pressure is raised sufficiently, 
it can overcome the antireflux pressure bar­
rier of the constructed tube and reflux will 
then occur. Subdiaphragmatic myotomy of 
the gastric or colonic tubes reduces the tone 
and as a result there is no effective pressure 
barrier from stomach to esophagus. Reflux 
under these circumstances can freely occur 
(Fig. 3).
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For patients with 
problems of digestion 
orabsorption.
A M  meal.
Until now, someone suffering from short gut syndrome 
or inflammatory 'bowel disease also had to suffer something else: malnutrition.
Because there was no such thing as a nutritious 
predigested diet.Now there is: Flexical.
Flexical absorbs like a clear liquid and nourishes like a full meal.
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FlexicaT.
FLEXICAL is a low residue, "elemental 
diet”  based on protein hydrolysate 
powder and provides all major nutrients 
in a readily-absorbable form.
• Carbohydrate consists primarily of 
glucose and sucrose with some 
added tapioca starch.
• Fat consists of medium chain tri­
glycerides (MCT) and soy oil.
• Protein is in a predigested readily 
assimilable form of amino acids 
and low molecular weight peptides.
The product is nutritionally complete 
supplying, liberal amounts of vitamins 
and minerals. When reconstituted with 
water according to directions, FLEXI­
CAL provides 30 kcal. per fluid ounce 
with a caloric distribution of 8.8% from 
protein,24.6% from fat, 5.5% from MCT 
and 61.1% from carbohydrate, 
indications
FLEXICAL may be used for the nutri­
tional management of medical or sur­
gical patients who have a functional 
gastrointestinal tract and who need a 
low residue diet. FLEXICAL may also 
serve as an alternative to clear fluids 
which, although low residue, are fre­
quently not nutritionally complete. 
FLEXICAL is also useful as an adjunct 
to, or as a transitional phase in the 
replacement of parenteral feeding. 
Administration
FLEXICAL may be administered orally, 
by naso-gastric tube or by enterostomy. 
Oral feedings should be served cold 
with ice cubes and should be sipped 
slowly. Tube feedings should be ad­
ministered by slow, continuous drip or 
by a food pump if additional calories 
or nutrients are required. In the acutely 
ill patient, initial feedings should be 
diluted to V2 strength day one, 3A 
strength day two, and full strength day 
three, dependent on the patient’s toler­
ance. Intolerance is characterized by 
diarrhea, gastric dumping,or nausea, 
and may be adjusted by the dilution 
and rate of feeding.
Nutrient Values
Each 454 gm. of powder (1 can) when 
reconstituted with 1656 ml. water (58 
fl. oz.) will supply about 2 litres at i 
kcal./ml. (30 kcal. per fl. oz.)
Precaution
Always supply enough additional water 
to provide adequate urinary output. 
Normal Dilution
454 gm. (1 lb.) of FLEXICAL Powder to 
1656 ml. (58 fl. oz.) of water. This dilu­
tion supplies 2000 ml. and 2000 kcal.
(1 kcal./ml.)
Flavouring
FLEXICAL is available in the following 
flavours:
Orange, Vanilla, Fruit, Banana 
Packaging
FLEXICAL Powder is packed in 1 lb.
(454 grams) cans.
*T.M. Meod Johnson Canada 
Division of Bristol-Myers Canada Limited, 
Toronto, Canada.
Authorized User.
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MEDICAL PERSPECTIVES IN CORONARY ARTERY SURGERY
A feature of the history of coronary artery 
surgery is the persuasion with which propo­
nents and opponents have proffered their view­
points. A balanced view of the medical per­
spectives of coronary artery surgery is that of 
W. B. Dunkman and his colleagues (Ann In­
tern Med 81: 817, 1974). They conclude that 
although a “plausible rationale and dramatic 
symptomatic relief have resulted in widespread 
acceptance of coronary artery surgery...un­
certainties abound...sufficient to warrant care­
ful, critical appraisal and to caution that by­
pass grafting should not be done on all pa­
tients...The thesis is untenable that surgery is 
warranted whenever an anatomic lesion is dis­
covered that is technically amenable to bypass 
with an acceptable mortality.”
Evaluation o f the results of coronary artery 
surgery is complex. The natural history of 
coronary artery disease and the effects of 
medical management on outcome must be con­
sidered. Data must not be interpreted with 
invalid comparisons; for example, application 
of results of treatment o f chronic stable an­
gina (for which surgery offers better long-term 
results than those of nonsurgical treatment) to 
unstable angina (for which predictions are less 
clear), extrapolation of results in large and 
experienced centres to those in smaller and 
less experienced ones, and translation of bene­
ficial symptomatic results into favourable ef­
fect on mortality. The type of coronary artery 
disease must be considered— whether it is 
chronic stable angina, unstable angina, postin­
farction angina, Prinzmetal’s angina, main left 
coronary artery disease, or acute myocardial 
infarction. And etiologic factors such as hyper­
tension, electrocardiographic patterns, con­
gestive heart failure, sex, age, smoking, serum 
cholesterol and physical inactivity must not be 
forgotten.
Surgery may be useful in certain cases of 
chronic stable angina, unstable angina under 
certain circumstances, uncontrolled Prinz­
metal’s angina, main left coronary artery di­
sease, complicated acute myocardial infarction, 
asymptomatic coronary artery disease, and 
valve replacement with coexisting coronary 
artery disease. This presupposes skilful select­
ive coronary angiography and equally skilful 
surgery. A nd today’s results must be inter­
preted in light of the evolutionary stage of sur­
gical treatment of coronary artery disease. 
Revisions of conclusions will be necessary for 
some time to come.
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METHYLMETHACRYLATE CEMENT: ITS CURING TEMPERATURE 
AND EFFECT ON ARTICULAR CARTILAGE
J. SCHATZKER, MD, BSc, FRCSfC], J. G.
BVSc, MSc, FRCVS.t R. SANDERSON, MD,
Summary: The increasing use of methylmetha­
crylate in orthopedic surgery makes it desirable 
to determine whether the curing temperature 
of methylmethacrylate is high enough to cause 
bone necrosis and whether methylmethacrylate 
damages articular cartilage. Studies in dogs 
showed that methylmethacrylate plug tempera­
tures ranged from 95 to 107°C and that tem­
peratures at the cement-bone interface ranged 
from 50 to 95°. Curing temperatures therefore 
are high enough to cause necrosis of bone. 
Other studies revealed no harmful action of 
methylmethacrylate on articular cartilage. Frac­
tures stabilized with methylmethacrylate can 
therefore be expected to heal provided the nor­
mal criteria of fracture management are fulfilled.
Resume: Depuis que le methylm6thacrylate est 
employe de plus en plus en chirurgie ortho- 
pedique, il devient souhaitable d'etablir si la 
temperature de guerison du produit est assez 
elevee pour causer une necrose de I'os et si 
le produit risque de leser le cartilage articu- 
laire. L'etude experimental chez le chien a per- 
mis de montrer que ies temperatures atteintes 
par des chevilles de methylmethacrylate variaient 
de 95 a 107°C et que Ies temperatures au 
niveau de la surface de contact entre le ciment 
et I'os variaient de 50 a 95°. II s'ensuit que 
Ies temperatures de guerison sont assez hautes 
pour provoquer la necrose osseuse. D'autres 
etudes n'ont pas revele d'action nocive du pro­
duit sur le cartilage articulaire. On peut done 
s'attendre a ce que Ies fractures stabilisees 
par le methylmethacrylate guerissent a condi­
tion que soient reunis Ies criteres normaux du 
traitement des fractures.
*Research fellows, orthopaedic department, The 
Wellesley Hospital, Toronto, Ont.
tOntario Veterinary College, University of 
Guelph, Guelph, Ont.
Reprint requests to: Dr. J. Schatzker, division of 
orthopedic surgery, department of surgery, The 
Wellesley Hospital, 160 Wellesley St. E., Toronto, 
Ont. M4Y 1J3.
HORNE, MB, ChB,* G. SUMNER-SMITH,
MSc* and J. P. MURNAGHAN, MD, BSc*
In the last 5 years, the use of methyl­
methacrylate bone cement in orthopedic 
surgery has greatly increased, and its use 
will probably continue to expand. Despite 
its increasing application, the effects of 
methylmethacrylate on bone, cartilage and 
other organ systems are poorly documented. 
Charnley’s monograph,1 however, provides 
substantial information concerning the ef­
fects of methylmethacrylate on bone, and 
there are scattered reports on the effects of 
the free monomer on the cardiovascular sys­
tem-- and on the ultrastructure of metha­
crylate.4 Recently, a number of new uses 
have been found for bone cement—as an 
adjunct in the reconstruction of comminuted 
fractures near joints, as a buttress for plates 
used to fix intertrochanteric fractures, and 
as an aid in the treatment of pathologic 
fractures •"*— and in these circumstances the 
methylmethacrylate comes into fairly close 
apposition with articular cartilage. In com­
minuted intra-articular fractures the cement 
may actually come in contact with the joint 
or lie very close to the articular cartilage. 
Therefore, the following questions arise:
1. What effect has methylmethacrylate 
on articular cartilage?
2. Does damage occur during exothermic 
polymerization?
3. Is nutrition of the cartilage affected?
4. What influence will the rigid metha­
crylate in its subchondral location have on 
the physical properties of articular cartilage?
Mixture of the cement components leads 
to exothermic polymerization, and attempts 
have been made to investigate the heat pro­
duced. Charnley1 reported temperatures of 
90°C in samples the size of golf balls 4 to 8 
minutes after curing, and Homsy6 recorded 
a temperature of 80 to 100°C at the bone 
polymer interface a few minutes after im­
plantation.
We investigated the curing temperature of 
methylmethacrylate, in vitro and in vivo, 
and its effects on articular cartilage.
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 ^ Method
i- Curing Temperature of Methylmetha­
crylate
►  * -
, We first determined the curing tempera-
*-■ ture of methylmethacrylate in vitro. Holes 
(diameter, 11 mm) were drilled through the 
diaphysis of the tibia of adult dogs and ther­
mocouples were inserted (Fig. 1). One elec­
trode was placed in the centre of the dia- 
y physeal hole (1), one at the edge of the
■ hole (3), one 5 mm from the hole (5) and
one some distance away (6). Reference elec- 
c- trades (2 and 4) were placed in iced water. 
The electrodes were connected as follows: 
1 to 2, 3 to 4, 5 to 6. Methylmethacrylate 
was then prepared and placed in the hole. 
The thermocouples were monitored through 
v a Beckman multichannel recorder.
We then repeated the experiment in vivo 
y with the femur of adult dogs, but the hole
h did not penetrate the medial cortex com­
pletely in order to prevent extrusion of ce-
> *- ment subperiosteally opposite the point of
> insertion.
Effect of Methylmethacrylate on Articular 
Cartilage
We next studied the effect of methylme- 
k thacrylate on articular cartilage. The lateral 
femoral condyle of an adult dog was excised 
by means of a sagittal cut through the in- 
1  ^ tercondylar notch lateral to the cruciate
ligament to preserve the stability. The cut
> was extended proximally for 5 cm and then
taken laterally. The lateral collateral liga­
ment was divided and the condyle was ex-
, * - cised. All cancellous bone and as much sub­
chondral bone as possible was removed
i  i 5 - 6  CHANNEL IH
Fig. 1.—Arrangement of thermocouples.
with a dental burr to create a thin shell of 
cartilage in which both patellofemoral and 
femoratibial articulations were represented. 
The shell was filled with methylmethacrylate, 
replaced and fixed to the medial condyle by 
two cancellous screws. The dogs were al­
lowed to bear weight fully postoperatively; 
there were no adverse effects and, at 6 
weeks, all the dogs walked normally and 
experienced no discomfort. The dogs were 
then killed. The affected extremities were 
removed and the specimens were fixed in 
buffered formalin phosphate. The methyl­
methacrylate was dissolved out with the aid 
of a 1:1 mixture of methylmethacrylate 
monomer and 100% ethyl alcohol. The 
specimens were processed and stained with 
hematoxylin and eosin, toluidine blue or 
WHO stain.
R esults
Curing Temperature
Temperatures recorded in vitro from the 
thermocouple located within the cement 
plug (thermocouple 3 to 4) ranged from 95 
to 100°C and those recorded at the cement- 
bone interface (thermocouple 1 to 2) ranged 
from 50 to 70 °C. The in vivo readings with­
in the cement plug were similar to those in 
vitro, 104 to 107°C; at the bone-cement 
interface, temperatures ranged from 75 to 
95 °C. These temperatures are capable of 
causing bone necrosis at both the plug and 
interface.
Effect on Cartilage
Histologic examination showed that the 
layer of subchondral bone had been rendered 
avascular at the time of surgery by removal 
from the dog. The lacunae in the original 
subchondral bone were devoid of osteocytes. 
The interface between the subchondral bone 
and cement was composed of a very vascular 
layer of connective tissue, which was thicker 
than that reported by Charnley1 for a simi­
lar interval (Figs. 2 and 3). No bone trabe­
culae extended to the cement boundary. 
This was the result of the technique used, 
in which the surface of the subchondral bone 
was made smooth with a dental burr and 
the cement placed directly against it instead 
of being packed into a confined space; the
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Fig. 2. —Area of articular cartilage and cement- 
bone junction (hematoxylin and eosin, x 25).
Fig. 4.—Junction of connective tissue and bone 
showing osteoclastic and osteoblastic activity 
(hematoxylin and eosin, x 50).
Fig. 3.—Detail of cement-bone junction from 
same section illustrated in Fig. 2 (hematoxylin 
and eosin, x 50).
Fig. 5.—Osteoblastic and osteoclastic activity in 
subchondral bone, with new bone deposition 
(methylene blue, x 50).
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Fig. 6.—Normal articular cartilage (hematoxy­
lin and eosin, x 50).
Fig. 8.—Normal metachromasia of chondro­
cytes (toluidine blue, x 50).
Fig. 7.—Normal metachromasia of chondro­
cytes (toluidine blue, x 10).
latter occurs during total hip replacement 
and results in cement being pushed between 
bone trabeculae.
At the junction of the connective tissue 
and subchondral bone, there was distinct 
osteoclastic and osteoblastic activity as the 
necrotic bone was resorbed and new bone 
deposited (Fig. 4). Osteoblastic activity 
could be seen throughout the entire thick­
ness of the subchondral bone (Fig. 5).
The articular cartilage was normal (Fig. 
6). There was no evidence of fissure forma­
tion, chondrocyte proliferation or vacuola- 
tion, or any alteration in the zone of cal­
cification. Special stains for metachromasia 
showed the cartilage had normal staining 
characteristics (Figs. 7 and 8).
Conclusion
Temperatures recorded at the centre of 
the methylmethacrylate plug corresponded 
closely to those reported by Charnley and 
others. However, temperatures at the ce­
ment-bone junction, the area of greatest 
biologic significance, were slightly lower 
(Continued on page 178)
when shock 
threatens 
the lung
Abstract v isua liza tion of lung tissue
• preserves 
lysosome and 
cell membranes, 
thereby preventing 
the release of destruc­
tive lysosomal enzymes3
•  preserves platelets 
thereby reducing the risk
of intravascular coagulation1
•  preserves leukocyte in­
tegrity thereby helping to main­
tain the pulmonary architecture1
Solu-Medrol
helps reduce 
pulmonary 
damage 
and increase 
survival rates
The recovery of patients in shock 
is often complicated by a pattern of 
deteriorating pulmonary function. 
This pulmonary insufficiency pro­
gresses despite restoration of haemo­
dynamic balance and apparent stabili­
zation of the acute episode.
Under conditions of prolonged shock, 
lack of oxygen at the cellular level 
causes alterations in the oxygen-carbon 
dioxide exchange mechanism. These 
changes in cell metabolism lead ultimately 
to interstitial oedema and perivascular 
haemorrhage.1 Polymorphonuclear leuko­
cytes aggregate in the pulmonary capillaries 
and obstruct the pulmonary vascular bed. 
As these trapped cells break down, they 
release lysosomes, tiny subcellular par­
ticles containing proteolytic enzymes.1 
These enzymes attack their host cell and 
go on to dapriage or destroy other cells.2 
The resulting tissue damage may not 
readily repair itself even if the shock 
patient survives.
Prescribing information 
on following page
When administered in conjunction 
with standard therapeutic measures,
Solu-Medrol exerts a protective 
effect on the lung and improves 
the patient’s chance 1
~  Gynec. & Obstet., 734:675.
Of survival. *• Janoff.A. (1964). Shock, 0. 93.
3. DeDuve.C. (1964). Injury, 
Inflammation and Immunity, p. 283.
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In the treatment 
of shock and its 
pulmonary 
complications
Solu-Medrol
soon enough, 
often enough, 
in pharmacologic 
doses
Dosage and Administration:
In treating severe shock, there is a tendency 
in current medical practice to use massive 
(pharmacologic) doses of corticosteroids. (The 
anti-inflammatory activity of 1 mg of Solu- 
Medrol is equal to 4 mg or more of hydrocor­
tisone.)
The suggested dosage of Solu-Medrol for se­
vere shock is 30 mg/kg stat and repeated in 
four hours, if necessary.
Therapy is initiated by administering Solu- 
Medrol intravenously over a period of at least 
ten minutes. In general, therapy should be con­
tinued only until the patient’s condition has 
stabilized -  usually not beyond 48 to 72 hours. 
Solu-Medroi may be given by intravenous in­
jection, by intravenous infusion, or by intra­
muscular injection. The preferred method for 
initial emergency use is intravenous injection. 
Cautions: The general precautions and con­
traindications to systemic corticosteroid ther­
apy should apply to the use of Solu-Medrol. 
However, when used for medical emergencies, 
or in shock-like states, the possible lifesaving 
effects must be weighed against the possible 
undesired hormonal effects. In the treatment 
of shock, Solu-Medrol should be adjunctive to 
conventional supportive therapy such as fluid 
replacement, etc. Although adverse effects 
associated with high-dose short-term corti- 
coid therapy are uncommon, peptic ulceration 
may occur.
Supplied: In Mix-O-Vials containing Medrol 
(as methylprednisolone sodium succinate), 40 
mg, 125 mg, 500 mg, and 1 g vials with water 
for injection.
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than those recorded by Homsy. Nevertheless, 
temperatures were still of an order high 
enough to cause bone necrosis.
There was no histologic evidence of any 
damage to articular cartilage caused by the 
close proximity of methylmethacrylate. 
Similar results were seen in all dogs. There 
was no evidence of sepsis in the subchondral 
bone, and no evidence of intra-articular re­
action. There was osteoblastic activity ad­
jacent to the cement, indicating that cells 
with osteogenic potential are not affected by 
the presence of the cement. Therefore, frac­
tures fixed either by cement alone or using 
cement as an adjunct to metallic fixation 
can be expected to unite normally.
We acknowledge that these observations 
have not been substantiated over a long pe­
riod, so we cannot comment on the possible 
long-term sequelae. However, because re­
vascularization of the subchondral bone was 
noted at 6 weeks, the bone must be con­
sidered normal, and damage to the articular 
cartilage later seems unlikely.
We thank Dr. V. L. Fornasier for his expert interpretation of the histology. We also thank Mrs. I. Urquhart and M. Smith for their help in preparing the histologic sections, Miss D. Gedge for her patience in preparing the manuscript, and Miss M. Bliss and her staff for the preparation of the illustrations.
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PACEMAKER INFECTIONS: A 12-YEAR REVIEW*
GUY G. LEMIRE, MD, JEAN E. MORIN, MD and A. R. C. DOBELL, MD
Summary: In a 12-year period, 546 pacemaker- 
related operations were complicated by 23 in­
fections (infection rate, 4 .2% ). Most of these 
infections were treated successfully, but two  
cases of infection were fatal. The most frequent­
ly encountered organism was Staphylococcus 
epidermidis. In 14 cases, infection occurred de­
spite the preoperative administration of cloxacil- 
lin to which the organism was sensitive in 13 
of the cases. The skin flora constitute the most 
likely source of contamination. The ideal treat­
ment consists of removal of all foreign material 
and replacement with a new pacing system by 
an alternative route.
Resume: Durant une periode de 12 annees, 546 
interventions chirurgicales ont ete pratiquees 
pour implanter ou changer les regulateurs du 
rhythme. Vingt-trois interventions ont ete com- 
pliquees d'infection, pour un taux de 4.2% . La 
grande majorite de ces infections ont pu etre 
traitees avec succes mais, dans deux cas, ont 
eu une issue fatale. Le germe pathogene le plus 
souvent rencontre etait Staphylococcus epider­
midis. Dans 14 cas, I'infection est apparue mal- 
gre I'administration pre-operatoire de cloxa- 
ciliine. antibiotique auquel le germe etait sensible 
dans 13 des 14 cas. La flore cutanee represente 
la source la plus probable de contamination. Le 
traitement ideal consiste a enlever tout corps 
etranger et & le remplacer par un nouveau stimu- 
lateur cardiaque introduit par une autre voie.
F oreign materials, such as synthetic grafts, 
heart valves, or pacemakers, that become 
infected present difficult problems. The pur­
pose of this communication is to review our 
experience with infections of pacemakers 
with respect to the clinical features, the 
etiologic factors, the sequelae and our ap­
proach to the treatment of this type of in­
fection.
Patients and  Surgical P rocedures
During the 12-year period from 1961 to 
1972 inclusive at the Royal Victoria Hospi­
tal, Montreal, 328 primary pacemakers
*From the division of cardiovascular and thoracic 
surgery, McGill University, and department of 
surgery, Royal Victoria Hospital, Montreal, Que.
Reprint requests to: Dr. Jean E. Morin, depart­
ment of surgery, Royal Victoria Hospital, 687 
Pine Ave. W., Montreal, Que. H3A 1A1,
were inserted and 218 pulse generators 
were changed— a total of 546 pacemaker 
procedures (Table I). Infection complicated 
23 procedures in 20 patients (infection rate, 
4.2% ); 14 of these procedures were primary 
insertions and 9 were battery replacements.
O rganism s Isolated , Sites of
In f e c t io n , and C linical
M anifesta tio ns
Infection was confirmed by positive cul­
ture in 20 cases. The organisms isolated were 
Staphylococcus epidermidis (14 cases), S. 
aureus (2) and mixed (4). The sites from 
which the positive cultures were obtained 
included the pulse generator pocket (18), the 
electrode (8), the blood stream (3), the peri­
cardium (1) and the pleura (1); in some 
cases, the same organism was cultured from 
more than one site. In the other three cases, 
obviously infected pacemakers failed to 
yield any organism on routine culture. Mani­
festations of infection included inflamma­
tion over the pulse generator pocket, ero­
sion of the pulse generator through the skin, 
a draining sinus leading to the pacemaker 
electrode and bacteremia.
T r e a t m e n t
The antimicrobial regimen at the time 
of the initial operation varied: 3 patients 
received no antimicrobials, 6 were given 
various antimicrobials after operation, and 
14 were treated with cloxacillin in the pre­
operative and postoperative period for up to 
7 days. In the period 1968 to 1972, cloxa­
cillin was administered before and after op­
eration in the majority of the 474 pace- 
maker-related operations; the 14 infections 
that occurred during this period all grew 
S. epidermidis that were sensitive to cloxa­
cillin in every case but 1.
TA B LE  I .— Pacemaker Infections 1961 to 1972 
Inclusive
Pacemaker procedure Cases Infections %
Transvenous insertion 267 10 3.7
Transthoracic insertion 61 4 6.6
Pulse generator change 218 9 4.1
Total 546 23 4.2
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Treatment of the 23 infections also varied 
according to the clinical situation. In gen­
eral, the infected foreign bodies were re­
moved, including the electrodes when pos­
sible. In two cases, closed-circuit irrigation 
of the infected pulse generator was at­
tempted;1 this was successful in one of the 
two cases.
Complications
Although early recognition prevented 
complications in most cases, septicemia oc­
curred in three patients. Two case reports 
illustrate the range of complications that can 
occur.
Case R eports
Case 1.—A 58-year-old woman was ad­
mitted to the emergency room in cardiac stand­
still. A diagnosis of complete heart block was 
made and, after resuscitation, a transvenous 
pacemaker was inserted; no antimicrobials 
were given. She was discharged 5 days later. 
After 2 weeks, swelling around the pulse gen­
erator pocket was noted; 200 ml of serum 
were aspirated but culture failed to yield patho­
genic bacteria. Then, 5 months later, an in­
flammatory reaction developed where the 
transvenous electrode crossed the clavicle. The 
lead and pulse generator were relocated; a 
small amount of serous fluid in the pocket was 
sterile on routine culture.
One year later, a draining sinus at the site 
of the previous inflammation over the clavicle 
was cultured and grew S. epidermidis. The 
sinus was exised and, because it did not appear 
to be in continuity with the electrode, the latter 
was left in place.
The patient was readmitted 7 months later 
because of fever and pain over the clavicle. 
The sinus was still present and S. aureus was 
cultured from the sinus tract and the blood 
stream. The infected pulse generator and trans­
venous electrode were removed, but the latter 
broke on traction, leaving a remnant in the 
right ventricle and atrium. Another permanent 
transvenous pacemaker was inserted during 
the same procedure. Ampicillin was given post- 
operatively until the 2nd postoperative day 
when cloxacillin, to which the bacteria were 
sensitive, was substituted. The patient’s condi­
tion stabilized and improved until a skin reac­
tion to cloxacillin was detected 2 weeks later. 
Cloxacillin was replaced by oxacillin but she 
reacted adversely to this, and acute anuria 
developed. Her condition deteriorated and she 
died 44 days after admission. This time, blood
cultures grew S. mitis despite administration of 
lincomycin.
c o m m e n t .—We recognize that, despite her 
precarious condition, a thoracotomy should 
have been performed soon after the electrode 
had broken, to remove the remnant from her 
heart.
Case 2.—A 60-year-old man was found to 
have bacterial endocarditis secondary to bac­
teremia due to S. epidermidis. During a period 
of 20 months he had undergone several oper­
ative procedures related to electrode dislog- 
ment and infection of a pulse generator. Septic 
aortic valvulitis resulted in aortic insufficiency, 
for which emergency valve replacement was 
necessary. After a difficult postoperative 
course, the patient was sent home. He died 
suddenly 2 months later. An autopsy was not 
performed.
D iscussion
Pacemaker infections, which are charac­
terized by their apparently benign clinical 
course, usually present as a rather indolent, 
painful swelling of the pulse generator 
pocket, a draining sinus, or a skin ulcera­
tion through which the pulse generator may 
migrate. One facet of our study showed the 
predominance of S. epidermidis as the in­
fective agent, which brings into question the 
pathogenicity of this organism. A well- 
known saprophyte of the skin, S. epidermidis 
should surely be considered a pathogen 
when it is found in the blood stream, in 
sinus tracts, or in infected pulse generator 
pockets. In most of our cases more than 
one positive culture was obtained, the clin­
ical picture of infection was present and no 
other organism was cultured.
Certain patients react to the foreign ma­
terial in pacemakers and, as a result, the 
skin becomes tight and thin around the 
pulse generator. This is particularly true in 
older, thin patients in whom the pulse gen­
erator has eroded through the skin. In these 
patients, it is impossible to determine 
whether the contamination with S. epider­
midis occurs at the time of skin breakdown, 
at the initial operation or during the course 
of a transient bacteremia.
In our patients, the infections generally 
did not manifest themselves immediately 
after implantation; rather, they were de­
tected months or years after the pacemaker
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procedure. This would be in keeping with 
the low virulence of S. epidermidis, and it 
may be that the antimicrobial therapy in the 
perioperative period, as well as the patient’s 
own defence mechanism, delayed the ap­
pearance of the florid infection.
The infection rate in this series of patients 
(4.2%) is high for clean surgical cases de­
spite usual aseptic techniques. It is our im­
pression that most wounds became infected 
at the time of operation, and the speed of 
propagation depended on the virulence of 
the organism, the antimicrobial regimen, and 
the host’s defence mechanism.-' 3
In reviewing these cases, we attempted to 
identify factors that could predispose to in­
fection. Procedures done in the operating 
room did not have a lower incidence of in­
fection than those done in the cardiac ca­
theterization laboratory or the x-ray depart­
ment.
The role of antimicrobials certainly has 
not been clearly defined by this study. The 
general prophylactic use of antimicrobials 
remains controversial4- 5 but in cardiac 
surgery numerous studies6' 8 show their value 
and usefulness. The ideal regimen, however, 
is in question. The choice of antimicrobials 
is important, and, in our institution, be­
cause of our bacteriologic data, a synthetic 
penicillin appeared to be the antimicrobial 
of choice. Our rationale for the use of 
cloxacillin was the effectiveness of this drug 
against our hospital’s S. aureus, the organ­
ism that we initially wanted to combat. At 
present we no longer use antimicrobials pro- 
phylactically. We prepare the skin meticu­
lously with green soap and iodine before 
making the incision and then, once the pace­
maker has been inserted and before the 
wound is closed, we irrigate the wound with 
approximately 500 ml of normal saline so­
lution containing bacitracin (50 U/ml) and 
polymyxin B (0.005%).
Serious complications of infection related 
to pacemakers are the direct result of 
bloodstream infection. Both patients who 
died and the patient who survived septice­
mia due to S. epidermidis were paced trans- 
venously. This necessitates removal of all 
foreign material from the blood stream but 
it is not always easy. Intravascular pacemaker 
lead electrodes are covered by a tight sleeve 
of fibrous tissue that hugs the lead and its
flanged tip, which is embedded in the right 
ventricle. Under the appropriate antimi­
crobial coverage, the foreign material must 
be extracted if the infection is to be cured. 
Unchecked bacteremia may result in meta­
static spread of the infection, as in Case 2 
in which bacterial endocarditis led to mas­
sive aortic insufficiency. Presented with the 
problem of removing an infected pacemaker, 
the physician should determine whether a 
pacemaker is still absolutely necessary. Ex­
traction of the infected pacemaker and 
drainage would thus be the simplest form of 
treatment.
Must each infected pacemaker be removed 
entirely, not withstanding the extent of the 
infection or the route by which the pace­
maker was inserted? Furman and associates1 
and others9’ 10 report the successful use of 
closed-circuit irrigation with the appropri­
ate antimicrobial solution in the treatment 
of infection of the sternum. We attempted 
this twice. Although this represents a lim­
ited experience, the failure in one case, and 
a limited success in the other, were enough 
to discourage us from using this technique. 
The prolonged hospitalization, the limita­
tion of the patients’ activity especially the 
older patients, and the probable ineffective­
ness in reaching the infected lead, all were 
factors that made the technique unattractive 
to us.
Our preferred technique in the case of an 
infected pulse generator when continued 
pacing is required is to divide the electrode 
some distance from the pulse generator and 
connect the cardiac end of the divided lead 
to an external pulse generator. The infected 
pacemaker can be removed and the pocket 
drained. Appropriate antimicrobials and 
local treatment of the infection are continued 
for several days. An entirely new pacemak­
er system is then inserted through an unin­
fected route, and the residual electrode is 
removed. Occasionally we have exposed 
epicardial electrodes where they entered 
the chest and, after applying moderate trac­
tion, have divided them leaving a short 
length of electrode attached to the heart’s 
surface. Infected transvenous electrodes 
should be removed in their entirety. In one 
of our patients a thoracotomy was necessary 
for removal of an electrode from the right 
atrium.
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Two deaths related directly to pacemaker 
infections underscore both the potential dan­
ger of all such infections, especially when 
the transvenous route is used, and the need 
for a definite plan in their treatment.
Conclusions and R ecommendations
Infection of a pacemaker is potentially 
dangerous, especially in the case of pace­
makers that have been inserted by the trans­
venous route. A definite plan for the treat­
ment of pacemaker infections is necessary. 
We propose the following method of treat­
ment:
(a) in bloodstream infections the pace­
maker should be removed entirely 
and a new one inserted by another 
route;
(b) in localized infections, there is an 
option: (1) replace the entire pace­
maker as in bloodstream infection; 
and (2) replace the pulse generator 
and splice to a “clean” lead rem­
nant in a counterincision.
The transthoracic approach is now preferred 
to the transvenous route for most cases.
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POSTOPERATIVE INFECTIONS
Recent understanding of anaerobic infections, 
new laboratory aids to diagnosis of bacterial 
infection, and antibiotic sensitivity tests are 
topics considered by 7. P. Burke (Abdominal 
Surgery 16: 288, 1974). Anaerobic infections 
have probably been overlooked or misdiag­
nosed in the past but there is no evidence that 
their frequency in increasing— though there is 
a possibility that the use of kanamycin and 
gentamicin has favoured the overgrowth of 
resistant strains of Bacteroides sp. and other 
anaerobes. But the major factors in diagnosing 
anaerobic infections are physician awareness 
and collection of appropriate specimens. Use­
ful pointers are infection site (e.g. oropharyn­
geal area, gastrointestinal tract and female re­
productive tract); thrombophlebitis; brain ab­
scesses; a foul or putrid odour; absence of 
growth on routine culture or report of sterile 
pus from obviously infected material; and a 
culture report of a single organism from pus 
with various gram-positive and gram-negative 
bacterial forms. Effective treatment includes 
penicillin G (except for B. fragilis) or, for 
penetrating abdominal injuries, clindamycin in 
conjunction with kanamycin or gentamicin.
Good surgical drainage is essential, along with 
application of hydrogen peroxide. And for the 
myonecrosis caused by Clostridium sp., hyper­
baric oxygen.
New laboratory aids include the nitroblue 
tetrazolium (NBT) and limulus tests and the 
gallium scan. The NBT test is useful in dif­
ferentiating bacterial infection from nonbac- 
terial disease with leukocytosis and fever but 
its early promise may not have been fulfilled. 
The limulus test is a sensitive assay for bac­
terial endotoxin and it may aid in the diagnosis 
of gram-negative bacteremia. But neither test 
may be as promising as *>'Ga-citrate scanning, 
which permits visualization of abscesses (tu­
mours also, so these must be excluded).
Antibiotic sensitivity tests are now standard­
ized. A uniform suspension of microorganism 
for the inoculum and measurement of diameters 
of zones of inhibition surrounding the anti­
biotic-containing discs are the main features of 
standardization. The potency of the discs and 
the zone diameter required to indicate suscept­
ibility are unique for each antibiotic; there is 
correlation with serum antibiotic values. De­
spite this standardization, disc sensitivity is 
sometimes misleading even when performed in 
first class laboratories.
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GASTROCOLIC FISTULA COMPLICATING BENIGN GASTRIC ULCER: 
CASE REPORT AND REVIEW OF LITERATURE*
K. TAGUCHI, MD and J. G. BEAUDOIN, MD
Summary: A review of the literature and report 
of a case of benign gastrocolic fistula indicate 
that epigastric pain is the most frequent early 
symptom. Later, the predominant symptoms are 
diarrhea, weight loss and feculent vomiting. Pa­
tients suffering from rheumatoid arthritis and 
taking steroids appear to be particularly at risk 
of developing a gastrocolic fistula. Barium 
enema is the most reliable method of demon­
strating the fistula. Preferred management is a 
one-stage gastrocolic resection and primary 
anastomosis.
Resume: Apres avoir passe en revue la littera- 
ture pertinente et etudie le rapport d'un cas de 
fistule gastrocolique, nous en sommes venus a 
la conclusion que le symptome precoce le plus 
frequent est une douleur epigastrique. Plus tard, 
la diarrhee, la perte de poids et des vomisse- 
ments fecaloides deviennent les symptomes pre­
dominants. Le risque d'apparition d'une fistule 
gastrocolique est particulierement eleve chez 
les malades souffrant de polyarthrite rhumatoide 
qui sont traites par les corticoides. Le moyen 
diagnostique le plus sur pour confirmer la fistule 
est le lavement baryte. Le traitement preferential 
est la resection gastrocolique en un temps et 
I'anastomose primaire.
G astrocolic fistula is a rare complication 
of benign gastric ulcer. To date 56 cases 
have been reported in the English litera­
ture.1 18 Many of those recorded were re­
viewed in this journal by Sterns and Bird;18 
this communication presents an additional 
case report.
C ase R eport
In September 1973, a 44-year-old man at­
tended the emergency department of the Royal 
Victoria Hospital, Montreal because of a gas­
trointestinal hemorrhage. The patient had suf­
fered from rheumatoid arthritis for 10 years
*From the department of surgery, Royal Vic­
toria Hospital, and McGill University, Montreal, 
Que.
Reprint requests to: Dr. K. Taguchi, department 
of surgery, Dill, Kingston General Hospital, 
Kingston, Ont. K7L 2V7.
and at the time of his admission the condition 
was controlled by methylprednisolone, 6 mg, 
and acetylsalicylic acid (ASA), 3.6 g, daily. 
He denied any history of ulcer disease. Fever 
and left lower abdominal pain 3 months be­
fore admission were followed by foul eructa­
tions and an increased frequency of defeca­
tion. On the morning of his admission he was 
awakened by an urge to move his bowels; 
hematemesis and melena developed before he 
was admitted to hospital.
He appeared extremely anxious. Cushingoid 
features were evident. Abdominal examination 
revealed neither tenderness nor a palpable 
mass The hemoglobin concentration was 10.7 
g/dl and the leukocyte count was 10 000/ 
mm3.
Gastric lavage with iced saline through a 
Levin tube quickly stopped the hemorrhage. 
Gastroscopy revealed a benign chronic gastric 
ulcer from which, at the time, there was no 
active hemorrhage; radiography of the upper 
gastrointestinal tract showed a spontaneous 
gastrocolic fistula (Fig. 1). A hemigastrectomy 
with Billroth I anastomosis was performed 5 
days after admission. The colonic fistula was 
dissected free, the scar tissue was excised and 
the colon was closed in two layers. Recovery 
was uneventful, and the patient was discharged 
on the 10th postoperative day.
Fig. 1.—Spontaneous gastrocolic fistula.
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D iscussion
Cancer of the stomach and of the colon 
are the most common, nonsurgical causes 
of gastrocolic fistula.1 !> Marshall and Knud- 
Hansen-" reported 11 such cases in a re­
view of more than 4700 cases of cancer of 
the stomach or colon (incidence, 0.23%). 
In a series of 29 cases of malignant gastro­
colic fistula reported from the Mayo Clinic, 
17 were due to cancer of the colon;21 at 
the same centre only a single case of gastro­
colic fistula from benign gastric ulcer has 
been observed. Nevertheless, peptic ulcer 
disease is the second most common non- 
iatrogenic cause of gastrocolic fistula. Other 
rare causes are tuberculosis, subphrenic 
abscess, trauma, ulcerative colitis,22 radia­
tion,23 pancreatic cancer,23 carcinoid tu­
mour,24 and lymphoma.19' 20
Usually the history of patients who have 
a benign gastrocolic fistula can be separated 
into two phases. The first is related to the 
gastric ulcer disease when the patient com­
plains of epigastric pain, burning, belching 
and anorexia. The clinical picture changes 
abruptly as the ulcer perforates into the 
colon: the patient now complains of diarrhea, 
weight loss and feculent vomiting. The diag­
nosis of a gastrocolic fistula can often be 
made on the basis of such a history. Fecu­
lent vomiting in the absence of obstruction, 
or the passage of undigested food per rec­
tum is virtually pathognomonic of a gastro­
colic fistula. The diarrhea noted by many 
of these patients is due to fecal reflux into 
the stomach. This was shown by Pfeiffer2”’-26 
and Jew, Levowitz and Fisher27 who dem­
onstrated that a proximal colostomy could 
completely control the diarrhea in these pa­
tients and that fecal contamination of the 
stomach and small intestine resulted in hy­
perperistalsis and diarrhea.
Table I indicates the frequency of symp­
toms in the 33 patients (including the pre­
sent case) with benign gastrocolic fistula 
whose cases have been reported since 
1920. Of these 33 patients 9 were tak­
ing steroids; 6 were treated with steroids 
alone and 3 with ASA as well—a striking 
finding when one remembers that steroids 
have been available for only about 20 years. 
Steroids have long been thought to be ul­
cerogenic.28 Recent investigation in man, 
however, indicates that steroids given for
cither short or long periods do not increase 
the basal secretion of acid from the stom­
ach.29'31 Furthermore, no significant dif­
ference in peptic ulcer formation was found 
between patients receiving steroids and con­
trols (incidence, 2.4 and 2 .3% ).32 Thus, it 
would appear that steroids are not ulcero­
genic.
Seven of the nine patients taking steroids 
suffered from rheumatoid arthritis. The re­
ported incidence of peptic ulcer in the gen­
eral population in an annual survey is 1 to 
3 % 33 and two to four times higher in pa­
tients with rheumatoid arthritis.34- 35 Al­
though much of this increased susceptibility 
may be attributed to the use of ASA, even 
patients with rheumatoid arthritis who do 
not use ASA have a greater incidence of 
dyspepsia (40%) and peptic ulcer (13% ).36 
The addition of steroids to the therapy ap­
pears to augment the tendency towards pep­
tic ulcer formation. In a cumulative study 
of 1713 patients on long-term steroids for 
various conditions, the incidence of peptic 
ulcer was 3.1% compared with 10.4% in 
1837 patients taking steroids for rheumatoid 
arthritis.37 Perhaps a truer incidence can 
be determined from the prospective study 
done by Kammerer, Freiberger and Rive- 
lis.3" Among 1 17 patients receiving steroids 
for rheumatoid arthritis who, regardless of 
symptoms, were given a barium meal, peptic 
ulcer disease was radiologically evident in 
36 (31 %); but among 33 patients with rheu­
matoid arthritis not receiving steroids such 
evidence was noted in only 3 (9%). In a 
control group of patients with arthritis other 
than rheumatoid, who were not receiving 
steroids, only 2 of 37 (5% ) showed radio- 
logic evidence of ulcer. It appears that 
steroids given to patients with rheumatoid 
arthritis greatly increase the incidence of 
peptic ulceration.
TABLE I.—Principal Symptoms in 33 Patients 
with Gastrocolic Fistula from Benign Gastric 
Ulcer
Sym ptom
N o. o f patients  
(and % )
Abdominal and epigastric pain 22 (67)
Diarrhea 20 (61)
Weight loss 21 (64)
Vomiting 17 (51)
Hematemesis and/or melena 11 (33)
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Steroids have been shown to retard the 
healing of acute gastric ulcers in dogs38 and 
to inhibit the incorporation of radioactive 
sulfur into the mucus-secreting glandular 
cells of the stomach.3" This interference 
with the healing process may explain the 
frequent association of gastrocolic fistula in 
patients with rheumatoid arthritis who are 
receiving steroids.
Thoeny, Hodgson and Scudamore4" 
claimed that barium enema was the most 
reliable means of diagnosing gastrocolic fis­
tula. They examined 41 patients by barium 
enema or barium meal, or both, and dem­
onstrated the fistula in all 30 patients who 
were given a barium enema but in only 9 
of 35 patients given a barium meal. In 
reviewing 33 cases recorded in the litera­
ture in which radiologic investigations had 
been carried out, the findings were essential­
ly in agreement with those of Thoeny, Hodg­
son and Scudamore; the discrepancy, how­
ever, was not nearly as great as suggested 
by the study of Thoeny, Hodgson and Scu­
damore. In all 19 patients who were given 
a barium enema, the fistula was demon­
strated by the enema, but the fistula was 
demonstrated in only 16 of 21 patients 
who had a barium meal. In the five patients 
in whom a barium meal failed to reveal the 
fistula, a barium enema was successful.
Management of gastrocolic fistula has 
generally been by a one-stage resection of 
the stomach and colon and primary anasto­
mosis. With respect to the procedures per­
formed on the 33 patients whose cases we 
reviewed, 26 were one-stage procedures, 
5 were staged procedures, 1 was a laparo­
tomy only and the details of the other were 
not described. With respect to mortality, 
one patient who underwent a staged proce­
dure died, both of those in whom gastric 
and colonic fistulas were closed without 
resection died, and the patient who had a 
laparotomy only died.
Complications have been few. There is 
only a single report of a colonic fistula 
which healed quickly after resection.
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EXPERIENCE WITH 300 LIVING 
RELATED KIDNEY DONORS
Renal transplantation is an everyday occur­
rence, and it is more than 20 years ago since 
Hume and his colleagues (at the Peter Bent 
Brigham Hospital) in Boston introduced the 
procedure by using a cadaver kidney. Two 
years after this, Brigham surgeons became the 
first to transplant a kidney from a living re­
lated donor, the first of some 350 kidneys to 
date that have been transplanted in this one 
institution. Bennett and Harrison (Surg Gy­
necol Obstet 139: 894, 1974) now describe the 
Brigham’s experience, almost exactly 20 years 
later, with the first 300 living related donors.
As the authors note, “Certain morbidity and 
mortality statistics are involved when a patient 
undergoes an extensive surgical procedure,” 
and the statistics are of especial interest when 
such a patient is generally healthy. Of this 
group of 300 donors, 251 were healthy and 
49 had physical abnormalities that were not 
serious enough to contraindicate surgery. The 
overall complication rate, however, was 
28.6%. There were 16 major complications 
among 13 donors (wound infection in 5, pneu­
monia in 5, acute renal failure secondary to 
sepsis in 1, wound hernia in 1, psychosis in 1, 
upper gastrointestinal hemorrhage in 1, serum 
hepatitis in 1 and postoperative hepatitis— 
which caused the only death in the series— in 
1 patient). There were 102 minor complica­
tions among 28 donors; the majority comprised 
pulmonary and urinary problems. The 49 
donors with miscellaneous diseases included 12 
with chronic pulmonary disease, 11 with hy­
pertension, 9 with recurrent cystitis, 6 with 
obesity, 4 with diabetes mellitus, 3 with in­
active pyelonephritis, 2 with inactive tuber­
culosis, 1 with recurrent vesical papilloma, and 
1 with Parkinson’s disease. An interesting find­
ing was postoperative psychiatric disorder in 
20 patients.
The mortality among the 350 donors who 
have undergone nephrectomy to date stands 
at 0.29%— a remarkable rate considering the 
seriousness of the procedure and the age range 
of the patients, which was from 12 to 80 years. 
Bennett and Harrison report the interesting 
item that, across the world, five living related 
donors have died from causes related to the 
procedure.
Perhaps unexpected was the incidence of 
psychiatric problems. Evidently the donation 
of a kidney, even to a close relative, engenders 
emotional strain within a family. The authors 
did note, however, that a number of donors 
said that information from other donors would 
have been helpful. Thus, though renal trans­
plantation is now rightly an accepted surgical 
procedure, it is one that is by no means 
straightforward. The findings reported by Ben­
nett and Harrison will therefore be of much 
interest to all physicians and surgeons.
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LA CHOLECYSTITE EMPHYSEMATEUSE: PRESENTATION DE 
DEUX CAS CLINIQUES
E SAMSON, MD, FRCS[C1, FACS,* A. KIBRITE, MD, FRCS[C], 
et J. P. ROY, MDt
Resume: Nous profitons de la presentation de 
deux cas de cholecystite emphysemateuse trai- 
tes dans notre institution, pour faire une revi­
sion de la litterature a ce sujet. Les differents 
aspects etiologiques, symptomatiques et patho- 
logiques sont exposes, et nous terminons en 
comparant les resultats de I'etude clinique de 
nos deux cas a celle exposee par les differents 
auteurs.
Summary: Emphysematous cholecystitis is rela­
tively rare: in 1971 the cumulative total of cases 
reported in the world literature was 115. Two 
cases seen in the period 1967 to 1972 can 
be added. The features of these two cases, 
and those described in the literature support 
the view that emphysematous cholecystitis re­
sults from a primary obliterative endarteritis 
and a secondary proliferation of microorganisms.
L a cholecystite emphysemateuse est une pa­
thologic rare, dont le diagnostic fut facilite 
par l’avenement de la radiologie. Cette ma- 
ladie semble avoir une etiologie differente1 
de celle de la cholecystite aigue habituelle; 
d’ailleurs I’etude de la centaine de cas 
existants1' - dans la litterature a permis a 
plusieurs auteurs1-8 de trouver des faits 
symptomatiques communs permettant de dif- 
ferencier cette maladie de la cholecystite 
aigue rencontree habituellement et de la 
traiter dans un chapitre a part au sein de la 
pathologie vesiculaire. L’etude de nos deux 
cas nous a permis d’etre en faveur de la 
theorie de May et Strong.1 Cependant pour 
l’affirmer completement, il est important de 
faire une etude sur un plus grand nombre 
de cas.
H istoire de C as
Cas no I .—Le 6 janvier 1967, un homme, 
age de 71 ans, presente une douleur abdomi-
*Chef du departement de chirurgie, L’Hotel-Dieu 
de Quebec, Quebec, PQ.
tAncien resident, departement de chirurgie, 
L’H6tel-Dieu de Quebec, 
tlnterne, L’Hotel-Dieu de Quebec.
Les demandes de tires-a-part doivent etre adres- 
sees au: E. Samson, MD, departement de chi­
rurgie, l’Hotel-Dieu de Quebec, 11 Cote du Palais, 
Quebec, PQ. G1R 2J6.
nale a debut assez subite, localisee a l’hypo- 
chondre droit avec irradiation para-ombilicale 
droite et vers la fosse iliaque droite. Cette 
douleur etait accompagnee de trois a quatre 
vomissements bilieux et d’une temperature a 
38.8°C. Le patient consulte un medecin qui 
lui donne de la penicilline en injection intra- 
musculaire. Le 8 janvier 1967, le patient se 
presente a l’urgence, avec une douleur a l’hy- 
pochondre droit et a la region para-ombilicale 
droite, temperature 38.3°C. Diabete mis en 
evidence depuis 1 mois.
L’examen physique montre un patient avec 
un etat general satisfaisant, a l’auscultation 
pulmonaire une diminution du murmure vesi­
culaire surtout a la base droite, avec diminu­
tion de l’amplitude pulmonaire a ce niveau. A 
la palpation de l’abdomen, douleur maximum 
a Fhypochondre droit et sensation d’un plas­
tron a ce niveau, peristaltisme faible. Le res- 
tant de l’abdomen est negatif. Les examens de 
laboratoire montrent: des globules blancs a 
13 600/mm:!, la glycemie a 182 mg/dl avec 
une glycosurie a 2.5 g/1. La radio-pulmonaire 
montre une atelectasie lineaire dans les deux 
poumons, avec leger comblement du cul de sac 
diaphragmatique. Une radiographie simple de 
l’abdomen donne le diagnostic de cholecystite 
emphysemateuse (Figs. 1 et 2).
II fut opere le 10 janvier. A l’operatiton, on 
note que la vesicule biliaire (Fig. 1) etait tres 
distendue, sa paroi etait necrosee. Elle conte- 
nait du gaz et des calculs.
Fig. 1.—Cas no 1. Radiographie simple de 
l’abdomen, qui montre une vesicule biliaire plei- 
ne d’air.
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Aucune fistule avec le tractus gastro-intes- 
tinal n’a ete identifiee. La cholangiographie 
par le cystique etait normale. Une culture de 
la bile est revenue negative.
Cas no 2 .—Un homme, age de 49 ans, 
refere d’un autre hopital le 26 juillet 1972, 
avec le diagnostic de pancreatite aigue. A son 
admission dans l’autre hopital, il presentait 
une douleur a l’epigastre et a l’hypochondre 
droit, avec irradiation dans le dos. Ses exa- 
mens de laboratoire ont montre: une leuko- 
cytose a 25 000/m m 3, une amylasemie a 
2501 unites Somogyi /100 ml.
La radiographie simple de l’abdomen mon­
trait un ileus paralytique. II fut traite medica- 
lement sans resultat et fut alors transfere a 
L’Hotel-Dieu de Quebec.
A son arrivee a L’Hotel-Dieu de Quebec, il 
etait souffrant, d’apparence toxique, tempera­
ture a 37.2°C, la tension arterielle a 120/75 
mm Hg et il presentait les signes d’abdomen 
aigu avec douleur tres importante a l’epigastre 
et a l’hypochondre droit, avec irradiation aux 
deux epaules, et a la palpation on a 1’impres­
sion d’une masse mal definie a l’hypochondre 
droit. L’interrogatoire met encore en evidence 
la prise de corticoi'de depuis 1 an.
Les examens de laboratoire ont montre une 
lenkocytose a l l  750/mm3, une amylasemie a 
697 U/ml et une bilirubine totale a 1.97 
mg/dl. La radiographie simple de l’abdomen 
montre une vesicule pleine d’air (Fig. 3).
A l’operation pratiquee le 29 juillet 1972, 
on note la presence d’une reaction inflamma- 
toire tres importante au niveau de la region 
pancreatico-biliaire. La vesicule biliaire etait 
tres distendue, oedemateuse et en voie de ne­
crose. On note la presence de gaz et de calculs 
a l’interieur. Aucune fistule avec le tractus
Fig. 2.—Cas no 2. Radiographie simple de 
l’abdomen en position debout centree sur la re­
gion vesiculaire. On voit la vesicule biliaire rem- 
plie d’air avec un niveau liquidien.
gastro-intestinal n’a ete mise en evidence. Il 
existe une pancreatite aigue necrosante avec 
abces.
Un prelevement de la paroi vesiculaire a 
ete fait pour la bacteriologie, aucun resultat 
ne nous est parvenu a cause d’une erreur tech­
nique.
La cholecystite emphysemateuse est une 
affection qui se caracterise par trois notions 
bien precises: sa rarete, son diagnostic qui 
est surtout radiologique et son cadre patho- 
logique de plus en plus individualise au sein 
de la pathologie vesiculaire.
H istorique
Depuis la fin du 19e siecle et le debut du 
20e, plusieurs auteurs ont rapporte des cas 
de cholecystite emphysemateuse. Les cas 
presentes etaient soit des decouvertes d’au- 
topsie, soit des decouvertes au cours d’une 
chirurgie abdominale.1' 7 10 Ces chirurgiens 
ont decrit, au cours des cholecystectomies 
pour cholecystite aigue, des vesicules biliai- 
res pleines de gaz et parfois meme avec une 
paroi crepitante signant un emphyseme a ce 
niveau. La premiere fois que le diagnostic 
fut pose preoperatoirement, ce fut en 1931 
par Hegner1’ 11 grace a la radiologie. D e­
puis les publications se multiplierent, Mc- 
Corkle et Fong1' 12 en 1942 rapporterent 
trois cas, dont le premier patient deceda
Fig. 3.—Cas no 2. Radiographie simple de 
l’abdomen, qui montre une vesicule biliaire plei­
ne d’air (fleche).
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d’une infection gazeuse fulminante de la 
paroi abdominale, les cultures ont montre 
du Clostridium perfringens et Escherichia 
coli.1
D’autres cas ont ete rapportes par Jeme- 
rin,1- 13 et Wilson.1- 14 Heifetz et Wyloge1'' 
en 1955 reproduisirent experimentalement 
l’aspect radiologique. Rosoff et Meyers3 
presentment 10 cas. Et en 1966, encore, 
Sarmiento2 presenta un rapport portant sur 
105 cas reunis a partir de la litterature mon­
diale. Enfin en 1971, May et Strong1 pre­
senterent une etude basee sur la revision de 
115 cas de la litterature mondiale et pro- 
poserent une nouvelle theorie physiopatho- 
logique.
Cliniquement, la cholecystite emphysema- 
teuse s’annonce comme n’importe quelle 
cholecystite aigue par une douleur sous-cos- 
tale droite avec irradiation dans le dos ou a 
l’epaule droite; ses sines cliniques sont iden- 
tiques. L’examen physique, en plus des 
signes trouves habituellement, montre sou- 
vent la presence d’une masse palpable.1 
L’ictere est note dans 23.8% des cas.2 En 
1958 Wilson1- 14 rapporte que ses patients 
semblent plus toxiques et plus malades que 
la clinique peut suggerer.1 Au point de vue 
age et sexe: la categorie d’age la plus fre- 
quemment atteinte se trouve entre 50 et 70 
ans; cependant dans les cas rapportes, on 
trouve des variations allant de 27 a 88 ans. 
A l’encontre de la cholecystite aigue, l’inci- 
dence de cette maladie est trois a quatre 
fois plus elevee chez les hommes que chez 
les femmes (73.3% hommes pour 26.7% 
femmes).2
Deux notions importantes ont ete rappor- 
tees par plusieurs auteurs: (1) 25 a 30% 
des cas avaient un diabete gras diagnosti- 
que1- 3 et (2) la cholelithiase existe dans 
50% des cas de la cholecystite emphyse- 
mateuse tandis qu’elle existe dans 85 a 
95% des cas de la cholecystite aigue.16
Le laboratoire montre une leukocytose 
plus augmentee dans la cholecystite emphy­
semateuse (dans 91.6% des cas les globules 
blancs >  10 000/mm3 tandis que le pour- 
centage est de 67% pour la cholecystite 
aigue.4)
R adiologie
Le diagnostic de cette affection est radio­
logique et se base sur la presence de gaz
dans la vesicule biliaire, dans sa paroi, ou 
dans le tissu perivesiculaire.
L’aspect d’un halo de gaz concentrique 
assez regulier prenant la forme d’un anneau 
dans la paroi vesiculaire est un diagnostic 
pathognomonique.3 Cette distribution peut 
etre parfois irreguliere et peut meme se trou- 
ver dans le tissu perivesiculaire; cet aspect 
est encore tres suggestif du diagnostic de 
cholecystite emphysemateuse. Quand le gaz 
est dans la lumiere vesiculaire, le diagnostic 
differentiel se pose avec: (1) une fistule 
cholecysto-duodenale ou une fistule chole- 
cysto-gastrique. Un repas baryte permettra 
de trancher le diagnostic,3 (2) gaz dans un 
abces du quadrant superieur droit, (3) in­
competence du sphincter d’Oddi. (La cho- 
langiographie intra-veineuse permet, dans 
ces deux derniers cas, de preciser le dia­
gnostic.)
Les etudes experimentales de Heifetz et 
Wyloge en 195513 ont montre que, une fois 
la vesicule biliaire remplie de gaz, une rup­
ture se fait dans la muqueuse pres du canal 
cystique oil la couche musculaire est defi- 
ciente, permettant ainsi au gaz de fuser dans 
la couche perimusculaire jusqu’a sa rupture 
vers l’exterieur (des radiographies prises du- 
rant ces experiences ont montre un aspect 
identique a la cholecystite emphysemateuse).
E tiopathogenie
Les differences etiologiques existantes 
entre la cholecystite aigue et la cholecystite 
emphysemateuse rendent les explications pa- 
thologiques ambigues. Ces differences etio­
logiques sont basees sur des notions statisti- 
ques a savoir: Affection deux a trois fois 
plus frequente chez les hommes que chez 
les femmes.1- 2 Approximativement 25 fois 
plus frequente chez les diabetiques;1, 2 50% 
avaient des cholelithiases associees, 8.9% 
choledocholithiase1’ 2- 6 (tandis que la cho­
lecystite aigue est associee a une cholelithia­
se dans 85 a 95% des cas).
Au point de vue bacteriologique, Sarmien- 
to2 a note dans son etude que les cultures 
de la bile ou de la paroi etaient positives 
dans 54.3% des cholecystites emphysema- 
teuses; un organisme clostridial a ete trouve 
dans 24.8%, le Clostridium perfringens dans 
20.9%, 1’Escherichia coli dans 17.1%. Dans 
le restant des cas, on a note la presence du 
streptocoque et du staphylocoque anaerobi,
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de l’enterocoque et du proteus. Rosoff et 
Meyers3 dans leur serie de 10 cas etudies 
noterent 7 cas de culture positive de la 
paroi et chaque fois des bacteries capables 
de donner du gaz ont ete identifies.
Gordon-Taylor et Whitby17 en examinant 
au point de vue bacteriologique 50 vesicules 
biliaires ont trouve le Clostridium perfrin- 
gens dans 18 % des cas et 1’Escherichia coli 
dans 30% des cas.
A la fin de cette etude bacteriologique, il 
est a noter que la bile peut rester sterile 
malgre des dommages parfois serieux a la 
vesicule biliaire. Andrews et Henry3’ 18 et 
d’autres auteurs ont demontre que la bile 
reste bactericide si la concentration des aci- 
des biliaires est 70% de la normale; cepen- 
dant les changements inflammatoires dans 
la vesicule biliaire peuvent amener une re­
duction de cette concentration qui peut etre 
le facteur permettant alors aux bacteries de 
se multiplier.
En revisant ces notions, il est difficile 
d’accepter comme theorie etiopathogenique 
de la cholecystite emphysemateuse, la meme 
que celle de la cholecystite aigue (Fig. 4); 
c’est d’ailleurs pourquoi, que May et Strong1 
ont precede a I’etude histopathologique de 
leur trois cas de cholecystite emphysema­
teuse publies. Ces deux auteurs ont note 
dans les sections histologiques examinees, 
que les vaisseaux des parois de ces vesicules 
sont considerablement retrecis par du tissu 
fibreux et que certaines lumieres etaient 
completement fermees. Dans d’autres cou­
pes, les vaisseaux apparaissaient partielle- 
ment recanalises. Afin de pouvoir faire une 
etude comparative May et Strong ont etu- 
die histologiquement les parois de 60 vesi­
cules biliaires enlevees pour cholecystite 
recidivante. Ils ont note alors une endarte- 
rite obliterante qui affectait quelques-uns 
seulement des vaisseaux sanguins, mais au- 
cun de ces vaisseaux n’a ete completement 
ferme. Ces trouvailles ont amene les deux 
auteurs a suggerer que la cholecystite em­
physemateuse peut etre le resultat d’une 
occlusion vasculaire primaire de l’artere 
cystite ou de ses branches, qui aboutit a 
une ischemie au niveau de la vesicule bi­
liaire qui a son tour fournirait les conditions 
necessaires pour la multiplication des micro- 
organismes qui peuvent exister dans la bile 
ou la paroi vesiculaire (Fig. 4). Toujours
selon ces auteurs, leur theorie pourrait ex- 
pliquer le debut aigu de la douleur, et l’inci- 
dence augmentee de la maladie chez les 
hommes et chez les diabetiques, tous deux 
plus affectes par les maladies vasculaires.
Discussion
Si nous comparons nos deux cas a ceux 
rapportes par les differents auteurs, nous 
notons beaucoup de similitude dans la cli- 
nique: Hommes, debut subit, diabete etc. 
Au point de vue histopathologique, l’image 
decrite par May et Strong1 existe dans le 
premier cas. Ce fait, de meme que la revi­
sion de la litterature, nous permettent de 
favoriser la theorie de May et Strong. Une 
etude sur un plus grand nombre de cas est 
importante cependant pour accepter ou re- 
futer cette theorie.
Au point de vue therapeutique, certains 
auteurs trouvent que la cholecystite emphy­
semateuse ne necessite pas toujours un trai- 
tement chirurgical d’urgence, et qu’elle re­
pond tres bien a l’antibiotherapie.5
Cependant, il ne faut pas oublier que la 
mortality en cas de perforation est de 40 
a 60% .- Ce qui nous amene a prendre une 
attitude aggressive envers cette affection, et 
chaque fois que nous diagnostiquons une 
cholecystite emphysemateuse, nous interve- 
nons sous couvert d’antibiotiques, sans ou­
blier cependant de bien evaluer nos patients.
I: Lithiase vesiculaire
1
Obstruction canal cystique
1
Pression /  dans VB
1
Ischemie
1
Phenomene inflammatoire 
1
Concentration sels biliaires N
i
Milieu favorable pour developpe- 
ment des micro-organismes
II (May et Occlusion vasculaire primaire de 
Strong): Part, cystique, ou de ses branches
l ,
Ischemie
1
Conditions favorables pour multi­
plication des organismes presents 
dans la bile ou la paroi
Fig. 4.—Etiologie des cholecystites emphyse- 
mateuses: deux hypotheses.
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SURGEONS’ HAND INJURIES
The hand is as vital to the surgeon as it is to 
the pianist, the painter or the horologist. All of 
these dexterous artists face disability as a result 
of serious hand injury, which is bad enough, 
but injured surgeons may even face the risk 
of death. In an account entitled “Some Sur­
geons and their Hand Injuries” (Practitioner 
213: 717, 1974), Bryan Williams describes 
hand injuries sustained by famous surgeons. 
The list of such surgeons is impressive; but 
every surgeon must subliminally if not con­
sciously be aware of the vulnerability of this 
part of the body during professional work, 
quite apart from times of leisure.
Semmelweiss based his ideas on the route 
of infection in puerperal fever on the course 
of fatal septicemia in his colleague Kolletschka, 
who had injured a finger during an autopsy. 
But Semmelweiss later suffered a similar tra­
gedy, for he died from the effects of infection 
of a finger that was injured while he was oper­
ating. Others who died from infection second­
ary to hand injuries include the gynecologists 
Pfannenstiel, Porro and Schuchardt and the 
pioneer chest surgeon, H. P. Nelson. Williams, 
however, does not mention the surgeon with 
whom all Canadian surgeons will be familiar: 
Norman Bethune.
Many other surgeons have escaped death
but have been disabled from hand injuries 
sustained during their work. Hamilton Bailey 
pinched his left index finger while operating 
on a patient who had peritonitis; a colleague 
amputated his finger, which had become stiff, 
but Bailey found that the smaller hand gave 
him greater dexterity. Others who overcame 
disability were William Blair Bell, the obste­
trician and gynecologist, John Bland-Sutton, 
the surgeon and pathologist, and the chest 
surgeon Hugh Morriston Davies, who learned 
to operate with his left hand, devising instru­
ments to hook onto his crippled right hand.
Surgeons, like other health professionals, 
have always risked contracting infection during 
their work. Conditions were worse in the pre­
glove, preantibiotic era; and infections such 
as active syphilis were rampant in years gone 
by. At least one surgeon is known to have 
noticed, with horror, a primary syphilitic in­
fection on a finger. Today, too, disposable 
equipment, “break-easy” glass tubes, and plas­
tic envelopes make the surgeon’s life safer. But 
even today surgeons must continue to be aware 
of dangers; for example, the risk of hepatitis 
is something that must be faced by anyone 
who handles donor blood or who works in dialysis units.
Williams’ account is short, direct and essen­
tial reading for all concerned with hospital 
safety.
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B O O K  R E V I E W S
ADVANCES IN CARDIOVASCULAR SUR­
GERY. Edited by John W. Kirklin. Clinical 
Cardiology Monographs. 279 pp. IUust. Grune 
& Stratton, Inc., New York; Longman Can­
ada Limited, Toronto, 1973. $18.00.
The appearance of “Advances in Cardiovas­
cular Surgery”, edited by John W. Kirklin, 
must be considered a major event in the med­
ical publishing world. The selection of topics, 
as well as of contributors, is authoritative and 
could only have been achieved by a person 
with a deep knowledge and vast experience in 
his specialty.
The first half of the book deals with correc­
tive surgery of congenital malformations of the 
heart and covers late results, complex con­
genital malformations, and primary definitive 
intracardiac procedures. In essence, this sec­
tion is concerned with pediatric open-heart 
surgery and therefore has limited appeal, but 
candidates for the fellowship examination in 
cardiovascular surgery will find it most en­
lightening and helpful in supplementing their 
basic reading. Late results will be of inter­
est to all cardiac surgeons as well as to car­
diologists. In chapters dealing with definitive 
intracardiac operations, the authors contrast 
the risks and mortalities of staged procedures 
with the results for primary repair. The trend 
is quite apparent and the weight of evidence 
is in favour of primary definitive repair, even 
in the youngest infant.
By accident of time, the chapter that deals 
with prosthetic valves is out of date and in­
complete in that it does not include reference 
to the Bjork-Shiley and Lillehei-Kaster valves. 
None the less, it contains a great deal of orig­
inal material on thromboembolism related to 
prosthetic heart valves and is worth while 
reading.
Another chapter details much of the recent 
work on myocardial flow and on subendo­
cardial ischemia during cardiopulmonary by­
pass. Every surgeon engaged in cardiac surgery 
should be thoroughly familiar with the con­
tents of this chapter.
A high standard of excellence is maintained 
throughout the book, although the author of 
the discussion on reconstructive surgery in 
coronary artery disease does not appear to 
have entirely crystallized the surgical indica­
tions.
The few mistakes are typographical; they 
do not change the meaning of the text and 
will, no doubt, be corrected in future editions.
This important book deserves a place on 
the library shelves of every clinician dealing 
with diseases of the heart—congenital or ac­
quired.
A. Z. P isko-Dubienski
Toronto Western Hospital,
Toronto, Ont.
ATLAS OF ORTHOPAEDIC SURGERY. 
2 vols. Louis A. Goldstein and Robert C. 
Dickerson. 1039 pp. and index. IUust. The 
C. V. Mosby Company, St. Louis, 1974. 
$91.90.
This book cannot be lightly reviewed. It is 
a major, profusely illustrated publication in 
two volumes, and the first edition of such a 
work presented for students and orthopedic 
surgeons. The illustrator, Walinitz, deserves 
recognition for his 1674 illustrations, and per­
haps his name should figure on the cover. At 
the price of $91.90 this beautifully produced 
and bound work must be one of the most ex­
pensive medical textbooks on the market. Ac­
tually, I am not prepared to complain of such 
a price for a tool of the trade; compare it with 
that charged for some small, simple, orthopedic 
instrument.
Is there a need for such an extensive atlas 
of orthopedic techniques? On consideration, 
there is indeed. How do we learn the steps of 
a procedure? How do we recall an unusual 
technique or the stages of an intricate oper­
ation? Possibly by repetition, or by example, 
but often by reference to a standard text, 
a monograph, a journal or by a chat with a col­
league. Unless we are engaged in a high- 
volume practice, repetition alone is not reliable 
so we depend on the other means. This atlas 
of Goldstein and Dickerson (and Walinitz) 
describes well the stages of most standard pro­
cedures but fails to list the advantages and 
disadvantages of others. Actually, a quick 
reference to an author’s original description of 
his procedure is a most valuable preparation 
for embarking on many a procedure; one is 
often surprised at the inaccuracies that have 
prept into the collected texts. I find myself 
referring more regularly to the original mono­
graph on many an operation. Unfortunately, 
it is often hard to lay hands on the right refer­
ence at the right time.
The two volumes are divided into a total of 
16 sections on various anatomical regions. 
There is a rather loose section entitled “Miscel­
laneous Operative Procedures” which includes 
advice about repairing tendons, arteries, arthro­
scopy, release of contractures, and even local­
ization of metallic foreign bodies.
One misses any reference to incisions and 
approaches. Within the sections there is usually 
a quite lengthy description of postoperative 
care, often repeated. Thus, the description of 
each form of ankle fusion is followed by a 
note that a cast is required and may be re­
moved when there is radiographic and clinical 
evidence of fusion—surely such details could 
be generalized in a preamble.
The scope of techniques described is exten­
sive; I have no quarrel with the authors’ (and 
Walinitz’s) choice. However, it may be un­
necessary to devote so much pictorial art to
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say, “disarticulation of the wrist” (surely a rare 
operation) and the “internal fixation of a frac­
tured clavicle”.
In each section the text (including general­
izations) and description appear on the page 
opposite to the handsome illustrations. This 
means that, in many cases, an almost blank 
page is found facing the reader, which perhaps 
explains the need for two volumes. There are 
extensive references but no mention is made to 
them in the text and this is irritating; for 
example, if I wanted to look up references to 
Dupuytren’s contracture I would have to 
search the alphabetical list of authors in this 
section on the hand to ferret out the original 
description of the condition—a most confusing 
arrangement.
This work will probably become established 
as a standard reference for orthopedic libraries, 
to whom I would recommend it. There cer­
tainly seems to be a need for collected descrip­
tions of this sort.
A. M. W iley
Toronto Western Hospital,
Toronto, Ont.
CLINICAL NEUROSURGERY. Proceedings 
of the Congress of Neurological Surgeons, 
Honolulu, Hawaii, 1973. Editor-in-Chief: 
Robert H. Wilkins. 387 pp. Illust. The Williams 
& Wilkins Company, Baltimore; Burns & 
MacEachern Limited, Toronto, 1974. $21.45.
This excellent book comprising the papers and 
discussions presented at the 1973 annual meet­
ing of the Congress of Neurological Surgeons, 
provides the most up-to-date authoritative 
work on the subjects presented. The book is 
published once a year following each meeting, 
and for every practising neurosurgeon, and 
to a lesser extent neurologists, neurophysio­
logists, and vascular surgeons, it is well worth 
the price. No one volume covers the entire 
field of neurological surgery but each volume 
covers all significant current developments, 
new techniques, and discussions of contro­
versial problems on the topics selected for 
that year. In this particular volume, 11 of the 
29 chapters are devoted to saccular aneurysms 
and the various forms of management, 10 
chapters to pain, 5 chapters to pituitary surgery 
and related conditions, and 2 to malignant 
tumours.
With the passage of time, each volume of 
“Clinical Neurosurgery” becomes more valu­
able, not only for the information it contains 
but as a library possession since it is printed 
in limited editions. This volume is a concise, 
up-to-date, well-printed ready reference. The 
publication is unsurpassed in its field.
D. P arkinson
The Winnipeg Clinic,
Winnipeg, Man.
SURGICAL PATHOLOGY. 5th ed. Lauren 
V. Ackerman and Juan Rosai. 1394 pp. Illust. 
The C. Y. Mosby Company, St. Louis; The 
C. V. Mosby Company, Toronto, 1974. 
$47.80.
The fifth edition of “Surgical Pathology” con­
tinues in the tradition of previous editions with 
emphasis on the most practical aspects of 
pathology as it pertains to surgery. The re­
ferences have been updated and over 300 new 
illustrations added. Sections on exfoliative 
cytology have been added where applicable. 
Mention is also made of electron microscopy, 
immunofluorescence and histochemistry where 
particularly relevant. The book is full of well- 
selected pictures illustrating the gross and 
microscopic features of all the common and 
many of the less common diseases encountered 
in general surgery and in specialty surgical 
practice. The book is not exhaustive and is not 
intended as a theoretical text. For instance, 
discussion of theories of etiology and patho­
genesis of diseases are not included. The main 
thrust of the text is clinical-pathological cor­
relation and prognosis. Most tumours are well 
discussed and the chapters on diseases of the 
skin, breast, gastrointestinal and respiratory 
tracts and on gynecopathology are particularly 
well done.
This is an extremely useful book for patho­
logists and surgeons. I strongly recommend it 
to both.
M. J. P h il l ip s
Division of surgical pathology,
Toronto General Hospital,
Toronto, Ont.
SYMPOSIUM ON AESTHETIC SURGERY 
OF THE NOSE, EARS, AND CHIN. Volume 
Six. Edited by Frank W. Masters and John 
R. Lewis. 207 pp. Illust. The C. V. Mosby 
Company, St. Louis; The C. V. Mosby Com­
pany Ltd., Toronto, 1973. $39.40.
This book comprises the papers that were 
presented at a limited symopsium organ­
ized by the Educational Foundation of the 
American Society of Plastic and Reconstruc­
tive Surgeons on plastic surgery of the nose, 
ears and chin.
Almost two-thirds of the book is devoted 
to the nose. An account of historical aspects 
is followed by a discussion of anatomy and 
physiology. Standard techniques for aesthetic 
rhinoplasty are described, including compari­
son of saw with osteotome techniques and 
management of the nasal tip. There are good 
sections on the cause, prevention and manage­
ment of complications. There are papers de­
voted to septoplasty and to the management 
of acute and late problems from nasal trauma. 
There is minimal coverage of reconstructive
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procedures after cancer excision, the use of 
cryosurgery for malignant tumours and the 
treatment of rhinophyma, for which only one 
method is mentioned.
The papers devoted to the ears merely pres­
ent a confusing array of different methods of 
set-back otoplasty without useful comparisons. 
The problems of cryptotia, microtia and the 
“lop-ear” are barely covered.
The final chapters on the chin simply dis­
cuss silicone implants in microgenia. There is 
no discussion of sliding genioplasty or the 
relationship between microgenia, micrognathia 
or retrognathia.
This book merits inclusion in the plastic 
surgery section of a hospital library but is of 
little use to the surgeon trying to learn tech­
niques or attempting to decide which technique 
is best.
I. R. M unro
The Hospital for Sick Children,
Toronto, Ont.
UROLOGY. A View Through the Retrospec- 
troscope. John R. Herman. 182 pp. Illust. 
Harper & Row, Publishers, Inc., Hagerstown, 
Md., 1973. $7.95.
In his preface, the author states that this book 
“should not be expected to serve either as a 
reference source or as a handbook for research­
ers in the field. If this work comes into the 
hands of medical students or residents and 
inculcates a sense of enjoyment of medical 
history, it will have served its purpose.” In 
compliance with these introductory remarks, 
the author seems to have achieved his purpose.
This is a small book of 16 short chapters. It 
opens with an account of ancient and medieval 
urology from the eras of Egyptian papyri 
and indu Vedas and Samhitas. Understand­
ably, prominence is given to urinary calculus 
because of its long and colourful history. Ca­
theterization is traced from the earliest primi­
tive methods to modern times. Reference is 
made to three important events in renal sur­
gery: Vesalius (1514-1564) contributed to the 
understanding of human renal anatomy; Do- 
menic Marchetti in 1680 performed the first 
nephrolithotomy; and Gustav Simon in 1869 
successfully carried out the first planned 
nephrectomy. The chapter on the development 
of the cystoscope gives a consecutive account 
of the various inventions that ultimately led 
to the modern instrument. The author aptly 
refers to the new diagnostic horizon intro­
duced by the discovery of x-rays, and to the 
men who participated in urological advances 
resulting from this invention. On the subject 
of the prostate gland, he begins with Hero- 
philus of Chalcedon about 300 BC and con­
cludes with the advent of transurethral resec­
tion—certainly not a thorough account but
enough to give an idea of the progress of 
events. Bladder tumours are surveyed from the 
first monograph on the subject, published by 
Lacuna in Rome in 1551, to the important 
work of Edwin Beer and others in the early 
20th century. Urinalysis is traced from the 
earliest period when uroscopy defined a multi­
tude of pathological observations. Other areas 
of discussion are syphilis and gonorrhea, ure­
thral stricture, aphrodisiacs, and dead-ends in 
urology. The last-mentioned form an interest­
ing chapter on odd urological procedures that 
have become obsolete.
There is no bibliography, but a list of titles 
of books for recommended reading is in­
cluded. While a number of important subjects 
have been omitted, this is in keeping with a 
small book which, in the author’s words, “aims 
only to impart some of the fascinating back­
ground of the oldest of surgical specialties”, 
l'he book is limited in scope but easy to read, 
and should constitute a welcome addition to 
a doctor’s bookshelves.
D. Swartz
The Winnipeg Clinic,
Winnipeg, Man.
THE YEAR BOOK OF SURGERY 1973. 
Edited by Seymour I. Schwartz. 479 pp. Illust. 
Year Book Medical Publishers, Inc., 1973. 
$15.00.
The annual “Year Book of Surgery” is always 
a welcome arrival. The book consists of short 
summaries of articles that were published dur­
ing the preceding year and that the editors 
regard as being of significant interest. Each 
article is followed by concise and critical edi­
torial comment, which helps to put it in per­
spective. This year’s edition follows the well- 
trodden path of previous success. The book 
is probably of major interest to the general 
surgeon, although articles on such general 
topics as food and electrolytes, wound heal­
ing, infections, burns, trauma, and shock may 
appeal to all surgeons. Orthopedics is not 
covered. Individuals with a research or clinical 
interest in a small area will find the coverage 
of that area somewhat meagre. The book, 
however, does cover most areas of immediate 
general clinical application. The “Year Book 
of Surgery” provides the busy surgeon with an 
excellent means of keeping up-to-date.
K. L. Bowes
Department of surgery,
The University of Alberta,
Edmonton, Alta.
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